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Abstract 
Background 
Anal Intraepithelial Neoplasia (AIN) is a well-recognised precursor for invasive squamous 
anal cancer.  The prevalence of anal cancer is increasing in people living with HIV.  This 
hermeneutic phenomenology study explores the perceptions and experiences of patients 
and clinicians in anal cytology screening and high resolution anoscopy in sexual health 
clinics in the UK. 
Methods 
This study was conducted in the interpretative paradigm using hermeneutic 
phenomenology informed by Heidegger.  A purposive sample comprising 14 patients and 
8 clinicians was recruited.  In-depth unstructured interviews were conducted between May 
and June 2014.  Interpretive phenomenological analysis (IPA) was used to develop in 
depth interpretations of participants’ perceptions and experiences of anal cancer 
screening. Data were analysed using the six stages in the analysis process i.e. immersion, 
understanding, abstraction, synthesis and theme development, illumination and illustration 
of phenomena, integration and critique.   
Findings 
Five themes emerged from the data from both patients and clinicians: psychological 
effects of anal cancer screening, screening procedures, education, knowledge and 
training, social and sexual activity, guidelines and practices.  Findings of this study 
demonstrate that anal cancer screening is acceptable, but tolerability is variable; 
education, knowledge and information on anal cancer screening is limited to the media, 
press, magazines and those clinicians offering screening at their sexual health clinics in 
the UK.  Although the social life of most patients was not affected, their sexual activity was 
affected.  This study suggests that a screening program as part of routine HIV care in an 
outpatient sexual health clinic. 
  Conclusion 
Anal cancer screening benefits outweigh any psychological harm caused by tests and 
diagnostic procedures for people living with HIV.  The emotional responses highlighted 
were not associated with significant psychological harm.  Anal cancer screening should be 
considered in future guidelines in the UK for people living with HIV. 
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1 Introduction 
I developed an interest in anal cancer due to a personal life experience with a family 
member and this has inspired and challenged my interest for this study. The human 
immunodeficiency virus (HIV) and human papilloma virus are both infections that can be 
transmitted through sexual activity and there is no link medically between the two 
infections, however, the sexual behaviors that put someone at risk of contracting HIV 
can also raise the risk for getting HPV.  According to Tong et al (2013), anal cancer is one 
of the most common non-AIDS-defining malignancies in the era of combination 
antiretroviral therapy; its precursor lesion, anal intraepithelial neoplasia (AIN), is highly 
prevalent in HIV-infected populations and more than 90% of anal squamous cell cancers 
are attributable to human papillomavirus.   The purpose of my study was to explore the 
perceptions and experiences of patients who have had anal cytology and high resolution 
anoscopy and clinicians undertaking anal cancer screening within sexual health clinics 
around the UK.  My study was to inform clinical practice and contribute to the evidence 
needed for the development of future guidelines for anal cancer screening in the UK. My 
study also included clinicians in sexual health clinics undertaking anal cancer screening in 
people living with HIV.  Hermeneutic (interpretive) phenomenology, the philosophy of 
interpretation embraces and seeks meanings embedded in patients and  
 
 
 
clinicians’ experiences, guides my study through the lived experience of each individual. 
 
 My study is a Heideggerian Hermeneutic Phenomenology using interpretative analysis to 
analyse the data on the perceptions and experiences of patients and clinicians in anal 
cancer screening.  Nursing research is conducted with the aim of developing the 
knowledge base that underpins the stability and growth of the discipline therefore nurse 
researchers have adopted and adapted a range of research methods from the human, 
social and natural sciences to examine questions of relevance to their practice (Mackey, 
2005).   I chose the interpretive approach for my study as nursing is a caring professional 
concerned with delivering quality of care and understanding individuals.  I appreciate the 
unique experiences of individuals and understand the individual experience as a whole 
being.  Nurse researchers have found the interpretive approaches more likely than the 
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positivist approach to reveal the depth and diversity of nursing knowledge therefore 
interpretive approaches allow for research which aims for understanding, rather than 
explanation of human phenomena; they allow for research that is conducted in a natural, 
uncontrolled setting which utilises the knowledge embedded in experience (Mackey, 
2005).  As a nurse, I find this particularly important as the interpretive approach is critical 
to examine the implications this may have on patients and clinicians in anal cancer 
screening as well as the impact it may have on practice.   Furthermore, I am a nurse 
practitioner undertaking anal screening and my practice is embedded in my experience as 
an anoscopist.   In keeping with the aims of my study in exploring the perceptions and 
experience of patients and clinicians in anal cancer screening, I can find meaning in and 
understand their experiences in their clinical environment and communicate this 
understanding to inform clinical practice. 
 
I chose to write in the first person “I” as I am an integral part of the research process 
(Hamill, 1999) and this is a personal account of my journey.  The essence of good first-
person narrative is sharing an experience, letting the reader see and feel it (Paquin, 2001).  
As a researcher, I recognised my pre-understandings of “being in the world” as a lived 
experience is an important element for my study.  This relation or connectedness required 
self-reflexivity so that the research I produce must be credible, trustworthy and 
transferable in the world of research.  In other words, being self-reflexive means that I had 
to be cognisant of my views and social position as a researcher to understand how this will 
affect the research process and those being researched.  This according to Allen (2004) 
gives researchers the opportunity to reflect on their own histories and theoretical stances 
as well as the way in which it may influence the research. 
 
This Chapter introduces my study by: 
• Introducing my story and in anal cancer screening with self reflexivity and reflexivity 
• Setting the scene discussing the background of anal intraepithelial neoplasia 
• Understanding anatomy and where AIN is detected 
• Discussing the process and procedure of anal cytology 
• Explaining the grading of anal dysplasia 
• Explaining digital anorectal examination 
• Explaining high resolution anoscopy 
• Discussing the prevalence of AIN 
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• Introducing anal cancer screening programs, anal cancer screening guidelines and 
the impact of publicity about celebrities in anal, breast and cervical cancer 
screening as well as the cost effectiveness if anal cancer screening 
• Presenting the purpose, research ains and research questions 
 
This introduction is set out to provide background information on anal intraepithelial 
neoplasia, anal screening and existing literature highlighting the psychological effects of 
anal screening in the UK.  To provide further context, reflexivity is discussed as a process I 
undertook in my chosen methodology and my personal background is included.  Attia and 
Edge (2017) mentions that such reflexive processes will have a powerful impact on one’s 
development as a researcher, raise awareness about the coherent expression of one’s 
values as a whole person who conducts, and ensures that research practice consistently 
reflects the principles the researcher embraces. 
 
1.1 Self-reflexivity and Reflexivity:  my story and interest in anal 
screening 
I am a registered nurse for over 24 years and working in sexual health and HIV for the last 
21 years.  I spent the last 17 years working in and specialising in Genito Urinary Medicine 
and HIV.  My father in law was diagnosed with anal cancer in 1999 and ended up having a 
colostomy and subsequently had chemotherapy treatment which was successful.  He lived 
in an economically developing country, and in the late 1990’s there was no anal cancer 
screening available which meant that my father in law had a tumour that grew up to 8cm 
which was invasive in nature and required large bowel excision. It was difficult to detect 
AIN or anal cancer unless a person had symptoms which often are too late.    
 
I worked in a speciality area of patients living with HIV in an outpatient clinic and pursued 
training in anal cytology at a local NHS trust in 2009.  My interests started growing in 
detecting AIN and I used to chaperone a consultant undertaking high resolution anoscopy 
(HRA).  From this point on I knew I wanted to pursue a special interest in a nurse led 
service in anal cancer screening and engaged with the head of school at Buckinghamshire 
New University about this new area of work in the UK.  I was excited and overwhelmed at 
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the prospect of a new research idea which could potentially help inform clinical practice 
and guidelines for the UK once my study is published.   
 
In 2011, I moved to my current hospital trust due to family commitments, started a 
professional doctorate with Buckinghamshire New University and in 2012 I went on to train 
to undertake high resolution anoscopy with an experienced consultant.  In 2013, I went to 
San Francisco to formally train and completed an accredited course on Colposcopy and 
High Resolution Anoscopy.  This was the only course offered in the world at that time.  In 
November 2013, I attended the International Anal Neoplasia Society (IANS) scientific 
meeting and in that same year I registered to be a member of the International Neoplasia 
Society and I continue to be a member of the Society.  I was the first UK nurse to register 
with IANS and attend the scientific meetings every two years.  In March of 2015 I was 
accepted for two oral presentations which I presented to an international audience at the 
IANS scientific meeting in Atlanta.   
 
I currently run a nurse led service providing an anoscopy service weekly, at my employing 
trust.  I took great interest in exploring patients and clinicians’ perceptions and experiences 
in anal cancer screening.  This is a new field of study in the UK and I found this a great 
opportunity to produce research and utilise a hermeneutic phenomenological approach to 
examine the implications for development of knowledge in practice.   
 
Reflexivity is an important process in research as it has an impact on the researcher 
(Spencer et al, 2003).  I managed my position as a researcher in the reflexive process as it 
is widely acknowledged that the assumptions and beliefs of the researcher will influence 
how data is collected and analysed therefore, it is important to be clear about what these 
assumptions and beliefs are and to own one’s own perspective in qualitative research 
(Elliot et al,1999 & Elliot, 2015 ).  I chose to use a reflexive approach where I could  
consciously acknowledge that reflexivity challenged my personal assumptions, clarified 
individual beliefs and any subjectiveness I faced, as alluded to by Ortlipp (2008).  This 
approach of reflexivity has become a tool for the development of my thesis. 
 
In Hermeneutic (interpretative) phenomenology, reflexivity is a person’s reflection on and 
experience of a situation that can help in interpreting the meanings discovered in the 
interpretations or even add value to a study (Sloane & Bowe, 2014).  Reflexivity is the 
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process where the researchers are conscious of and reflective about the ways in which 
questions, methods and subject position might impact on the data or the psychological 
knowledge produced in a study (Langdridge, 2007).  Without explanation or analyses, the 
means of describing essence may best be provided by the researcher’s personal reflection 
(Cohen et al, 2007). 
 
1.2 Background of Anal Intraepithelial Neoplasia:  setting the scene 
Anal intraepithelial neoplasia (AIN) is a premalignant or precancerous lesion of the anal 
canal and the risk factors for AIN and anal cancer consist of clinical factors and behaviours 
that are associated with the acquisition of persistent Human Papilloma virus (HPV) 
(Roberts et al 2017). AIN is a well-recognised precursor of anal squamous cell carcinoma 
and the incidence is increasing dramatically, especially in high risk groups, in particular, 
men who have sex with men (MSM) and those people living with human immunodeficiency 
virus (HIV) (Ajaz et al, 2007). Documented evidence shows that there is a relationship 
between AIN and HPV (Hoots et al, 2009).  The natural history of AIN is still unclear 
although there is an assumption, that it is similar to cervical intraepithelial neoplasia (CIN) 
(Ajaz et al, 2007).  Cervical and anal cancers are caused by HPV virus which is a viral 
infection; belonging to a family of approximately 100 different types of viruses and can 
present as genital warts to cancers (Aidsmap, 2011).  HPV causes almost 100% of 
cervical cancers (Bouvard et al, 2009) and 80% of anal cancer (De Vuyst et al, 2009).   
Like cervical cancer, squamous-cell anal cancer is caused predominantly by high-risk, 
oncogenic strains of HPV and occurs at a squamocolumnar transition zone (figure 1); HPV 
infects basal cells of the cervix and anal canal, causing progressive dysplasia (Swedish et 
al, 2011). High-grade anal intraepithelial neoplasia (HGAIN) is believed to be the precursor 
to squamous-cell anal carcinoma (Darragh & Winkler, 2011).  Anal cancer is caused by the 
HPV type 16 or 18 and is graded as high grade (grade 2 & 3) anal intraepithelial neoplasia 
(Palefsky et al, 2011).   
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Figure 1 An illustration of the Transformation zone 
 
Figure 1 is a partial view of the anal transformation zone indicating the transformation zone 
between the original and current anal squamous columnar Junction (Darragh et al, 2011)   
 
Anal cytology screening is similar to cervical screening where the Papanicolaou (Pap) 
staining is used.  According to Leeds and Fang (2016), a number of similarities exist 
between squamous cell anal cancer and cervical cancer; both occur at squamocolumnar 
junction epithelium; the transformation zones of the anal canal and the cervix are both 
characterized by high turnover epithelium that is thought to be particularly vulnerable to 
malignancy-inducing genetic alterations.  In the UK clinicians have used this very model 
for screening since 1999.  When I started to practice and undertook anal cancer screening, 
screening tools were already established in collaboration with the histoplathologists, 
clinicans and international colleagues.  The first cancer screening test was developed in 
1943 by George Papanicolaou, whose monograph provided a method for identifying both 
precancerous and malignant cervical cells (Wardle et al, 2015).  Cervical and anal Pap 
smears share histopathologic features and they share similarities in the genital areas such 
as the transformation zone in the cervix and rectum (Lindsey & DeCristofaro, 2009).  The 
transformation zone (figure 1) is an area where cells change and can develop into 
abnormal cells which can be detected with a Pap smear.  These abnormal cell changes 
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are called dysplasia (mild, moderate, and severe).  Almost all anal cancers develop in the 
transitional zone, where atypical, dysplastic and in-situ lesions are identifiable  
Histologically (Leiman, 2005). 
 
Anal squamous cell carcinoma is similar to cervical cancer caused by cancer-causing 
strains of HPV, which infects basal cells of the cervix and anal canal resulting in dysplasia; 
thus, high grade AIN is assumed to cause squamous cell anal carcinoma (Darragh & 
Winkler, 2011).  The study findings by Kristin et al (2011) showed that screening of high-
grade intraepithelial neoplasia and appropriate treatment could prevent its progression to 
squamous cell anal cancer. Lindsey et al (2009) stresses the importance of healthcare 
providers including cytology screening during health promotion practices as information 
from anal cytology can provide opportunities for early diagnosis of anal lesions; for 
observation and treatment to prevent anal cancer.  Data from a cohort study in the USA 
have indicated anal screening is useful in detecting AIN (Palefsky, 2011).  Fox et al (2006) 
suggested that there is a need for large prospective cohort studies in men who have sex 
with men and HIV-positive patients to further our understanding of this disease and to 
evaluate treatment strategies.  Rosa-Cunha et al (2011) provides an argument from their 
pilot study that anal cytology screening is feasible as part of the patient’s routine HIV care 
visits. 
 
The incidence of cervical cancer has decreased by more than 50% (Leeds and Fang, 
2016).  According to van Oortmarssen and Habbema (1995), this public health success 
story is largely attributed to the widespread and routine use of cervical cancer screening, 
primarily employing the cytology-based cervical Papanicolaou (Pap) test. It is thought that 
a similar screening effort applied to anal cancer could potentially reverse the disturbing 
recent trends in disease incidence (Leeds and Fang, 2016).  The introduction of National 
Health Service’s (NHS) organized cervical screening programme in 1988, the consistent 
increase in anal cancer incidence was noted in both men (from 0.88 to 1.06) and women 
(from 0.81 to 1.18) (Robinson et al, 2009). In specific groups, such as HIV-positive 
patients, the risk of anal cancer is 60 per 100 000 patient-years (mean value, 1984– 2003) 
and increased from 35 in the pre-highly active antiretroviral therapy (HAART) era (1984–
1995) to 92 in the post-HAART era (1996–2003) (Bower et al, 2004).  According to van der 
Zee et al (2013), incidence rates of anal cancer have increased in practically all Western 
countries during the last decades. Infection with oncogenic HPV is the most important 
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aetiological factor.   Several risk factors and risk groups for anal cancer have been 
identified during the last decennia, in particular smoking, men who have sex with men 
(MSM), MSM practising receptive anal intercourse, a history of sexually transmitted 
diseases, having had more than 15 sexual partners, HIV-positive MSM, organ transplant 
recipients and women with a history of cervical cancer or cervical intraepithelial neoplasia.    
 
The cervical screening model has led to its use as a template for anal cancer screening in 
high risks groups.  The parallels between the models for anal cancer screening and 
cervical cancer screening are based on the biologic and morphologic similarities between 
anal intraepithelial neoplasia (AIN) and cervical intraepithelial neoplasia (CIN) (Darragh & 
Winkler, 2011).  Anal cytology was first introduced into the College of American 
Pathologists (CAP) Interlaboratory Comparison program for gynaecology in 2005.  If 
cytological results from anal Pap smear are abnormal, which means there are squamous 
epithelial cell abnormalities, then patients undergo high resolution ansocopy (HRA) (Nayar 
et al, 2014).  The most accurate method for examining the anal canal is anoscopy as two 
prospective studies found that anoscopy detects higher percentage of lesions in the 
anorectal canal as compared to a sigmoidoscopy (Alonso-Coello & Castillejo, 2003). HRA 
is a procedure similar to colposcopy and is performed as part of a diagnostic evaluation, 
therefore clinicians have to have proper equipment and specialised training (Lindsey et al, 
2009).   
 
A study by Nathan et al (2010) in the UK demonstrates that the performance of anal 
cytology was assessed by comparing against HRA and histology was useful in the clinical 
setting.  This study was a retrospective analysis of prospectively collected data.  Cytology 
samples from 395 patients were used of whom 212 were HIV positive. They found that the 
sensitivity of anal cytology was dependent on the area of disease and HIV infection.  This 
study concludes that anal cytology is a good predictor of anal cancer warranting further 
investigation with high resolution anoscopy if the patient has a positive smear.  This study 
also supports the introduction of early screening in HIV positive patients.  The performance 
of anal cytology was assessed by comparing against HRA and histology. For comparison 
with histology, two separate definitions were used. The first defined a positive biopsy to be 
any abnormalities detected on biopsy.  Anal cytology was read by experienced 
cytopathologists, and all histology was read similarly in the same institution. All histology 
was interpreted using a system derived from National Health Service cervical screening  
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programme (NHSCSP, 1999), which provides guidelines for reporting histopathology, 
including cervical intraepithelial neoplasia (CIN) in cervical screening in the UK, and 
classified as AIN1, AIN2 and AIN3 for anal screening (Hamilton and Aaltonen, 2000).  
 
The psychological implications of cervical cancer screening have been demonstrated by 
many studies.  In cervical screening, it has been reported that there has been an increase 
in anxiety and worry about cancer which can be detrimental to sexual well-being (French 
et al, 2004; Gray et al, 2006; Landstra et al, 2013; Wardle et al, 1995).  Evidence shows 
that not only do high grade intraepithelial neoplasia (dysplasia) results have an adverse 
impact on individuals (Wardle et al, 1995) but low- grade intraepithelial neoplasia results 
have shown to have a negative psychological impact too.  Low grade intraepithelial 
neoplasia represents only mild dysplasia or abnormal cell growth and is confined to the 
basal 1/3 of the epithelium.  This usually corresponds to infection with HPV and has a high 
rate of regression back to normal cells.  High grade intraepithelial neoplasia or severe 
dysplasia has undifferentiated neoplastic cells that span more than 2/3 of the epithelium 
and may involve the full thickness of the epithelium. This lesion may sometimes also be 
referred to as cervical carcinoma in situ (Agorastos, 2005).   
 
Inadequate specimen results are associated with increased anxiety (Gray et al, 2006) and 
those patients most anxious are those who are not recalled for repeat testing even after a 
negative or normal Pap smear (French et al, 2004).  An inadequate test result means that 
the test must be done again because the laboratory was not able to see the cells properly 
to give a result (CSP, 2012).   In breast screening similar results as for cervical screening 
were found, however worry about breast cancer persists even after receiving reassurance 
of a false positive mammogram (Brett et al, 2005).  In prostate cancer screening findings 
show that worry about cancer persisted amongst a group of men after they receive 
negative biopsy results, these patients sought more medical follow up with their clinician 
compared to the control group who did not have a biopsy.  These patients were still 
anxious about a negative biopsy result and needed reassurance therefore made follow up 
appointments with their clinician (Fowler et al, 2006; McNaughton-Collins et al, 2004; 
Pickles et al, 2007).  Cervical, breast and prostate cancer screening studies show that 
participants have demonstrated levels of anxiety and worry.  This is related to any type of 
result whether results are low grade or high-grade neoplasia, inadequate or a negative 
result, this can have an impact on their psychological well-being.   
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Screening and treatment studies have been conducted around the world, but little research 
has focused on the psychological aspects of the anal cancer screening process, therefore 
there is a need to assess this under more naturalistic settings, i.e. researchers study the 
phenomena as they are without changing or manipulating the environment (Ching-Hong et 
al, 2008). Landstra et al (2012) carried out a study in Australia to explore the psychological 
consequences of anal cancer screening.  Reponses from participants included anxiety, 
worry about cancer, lower sexual well-being; changes in behaviours such as, increased or 
reduced medical follow up; a person’s knowledge about screening and disease and how 
this can influence psychological response to screening.  This study concluded that anal 
cancer screening had no significant effect on general mental health but increased their 
worry of having anal cancer.   A study by Tinmouth et al (2011) in Canada concluded that 
anal cancer is not associated with greater adverse psychological impact in most men who 
have sex with men. 
 
It is evident from the literature that there is limited evidence in the UK to support anal 
cancer screening.  This needs to be developed and included in the British HIV Association 
(BHIVA) guidelines like the way it has been included in the HIV guidelines in New York, 
where screening is well established and documented (The New York State Department of 
Health AIDS Institute, 2018).  The psychological effects of anal cancer screening need to 
be explored as there are only few studies published so far.   
 
1.3 Understanding Anatomy:  Where AIN is detected  
The anal canal is approximately 2.3-3.5 cm long and is the terminal part of the large 
intestine (figure 2) (Darragh, 2011).  It extends from the upper aspect of the pelvic 
diaphragm to the anus.  The anal canal extends from the perianal skin or anal verge to the 
rectal mucosa.  The dentate or pectinate line is an important landmark as it represents the 
end of the squamous mucosa and beginning of transition from squamous to the absence 
of squamous mucosa (Uronis & Bendell, 2007).  The transformation zone in the anal canal 
separates the columnar epithelium of the rectum from the keratinising anal squamous 
mucosa which lies above the dentate line.  This is a site where anal intraepithelial  
 neoplasms occur (Palefsky, 1994). 
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Figure 2 Anatomy of the anal canal and perianus (Darragh & Winkler, 2011). 
 
Figure 2:  The anus is the opening to the lower gastrointestinal (GI) tract and connects to the 
rectum, which connects to the colon, which traveling backwards connects to the small intestine, 
then the stomach, then the oesophagus and finally the mouth.  The squamocolumnar junction is 
the area most commonly affected by HPV and where many of the lesions are likely to arise 
(Darragh & Winkler, 2011). 
1.4 Process and Procedure of Anal Cytology 
Anal cytology screening involves a Papanicolaou (Pap) smear from the anal canal where a 
moisten Dacron swab is rotated in the anal canal with gentle pressure on the walls, and 
slowly withdrawn and placed into Liquid Based Cytology (LBC) preservative.  Experts 
recommend a Dacron swab to be used for anal cytology, which is a synthetic polyester 
fibre swab used for cell collection in anal canal while cotton swabs should not be used; 
cells adhere more to the cotton and are not as easily transferred to the glass slide or vial 
for liquid-based cytology (Darragh et al, 2011).  The Dacron swab is inserted blindly 
approximately 5 cm beyond the anal verge and withdrawn over 30 seconds  
in a circular rotational motion to harvest cells from the epithelium in mucosal folds of the 
anal canal circumferentially (Wiley et al, 2013), so that adequate cells are collected using 
this this method. The UK National Screening Committee (UK NSC, 2010) state that anal 
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cytology screening is similar to cervical smear therefore referred to as anal Pap smear.  In 
the UK, Liquid Base Cytology (LBC) has replaced conventional Pap smear method and 
LBC is used as the primary means of processing samples in cervical screening 
programme in England and Wales (NICE, 2003).  Liquid based cytology increases the cell 
yield while decreases the faecal contamination and air-drying artefact common on direct 
smears (Darragh & Winkler, 2011).   
1.5 Grading of Anal Dysplasia 
Anal dysplasia is a pre-cancerous condition which occurs when the cells of the lining of the 
anal canal undergo abnormal changes. Anal dysplasia may progress from low-grade 
changes to high-grade changes before it turns into cancer.  According to Wies (2017), 
High-grade anal intraepithelial neoplasia (HGAIN), the precursor of anal cancer, is 
identified by clinicians providing care for patients with anorectal disease and is increasingly 
being identified during screening of immunosuppressed patients for anal dysplasia. Anal 
cytology is currently one mode of screening for AIN (Roberts et al, 2017). 
 
Cytology tests are reported using the Bethesda (2001) classification system where smears 
are evaluated according to the morphological features of the cells which indicate the 
degree of cellular abnormality.  In the UK smears (NICE, 2003) are categorised using the 
British Society of Clinical Cytologists (BSCC) guidelines as negative cytology, borderline, 
mild, moderate, severe dysplasia, ‘? glandular neoplasia’ or inadequate (Appendix 1).  In 
the US (Appendix 1), the Bethesda system is used to classify smears as low grade 
squamous intraepithelial lesion (LSIL), high grade intraepithelial neoplasia (HSIL) and 
atypical squamous cells of undetermined significance (ASCUS) (Mallari et al, 2012).  
Histology findings after a biopsy are reported as AIN1, AIN 2, AIN 3 and CIS (carcinoma in 
situ) (Nayar et al, 2015).   
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1.6 Digital Anorectal Examination (DARE) 
The DARE is performed as an essential part of the anal cancer screening process after the 
anal cytology has been taken but before HRA.  The goal is to detect any palpable 
abnormalities which may guide the evaluation of anoscopic examinations and biopsies 
(Darragh et al, 2011).  Although DARE is carried out by clinicians which is a painless 
procedure, the British HIV Association recommends that patients should be encouraged to 
check and report any lumps they notice in the anal canal (BHIVA, 2014).  A water-soluble 
lubricant gel and lidocaine gel of 2%-5% is used for lubrication so that a gloved finger is 
inserted into the anus slowly with ease.  The entire circumference and length of the anal 
canal staring at the rectum is palpated; then the mucosa over the internal sphincter and 
walls of the distal canal is palpated for warts, masses, areas of induration, discomfort and 
pain.  Once DARE is completed in a systematic way, the perianal area is palpated and 
visually examined. Any findings on DARE should correlate with the visual examination.  If 
there are hard firm, indurated immobile areas it should be noted as it could suspicious for 
cancer.  Warts present a soft mobile, nodular and gritty to palpation (Darragh et al, 2011).   
1.7 High Resolution Anoscopy 
High-resolution anoscopy (HRA) is a procedure where patients with an increased risk of 
anal cancer and is fundamental procedure to detect high-grade lesions (Goldstone et al, 
2014).  An anoscope is introduced into the anal canal with a water-soluble lubricant and a 
gauze padded swab soaked in 3% to 5% acetic acid is passed through the anoscope.  The 
anoscope is withdrawn and the gauze swab left in anal canal for 1-2 minutes before 
removing it and reintroducing the anoscope.  Once the lubricated anoscope is reinserted 
into the anal canal, a colposcope is used with magnification and bright light is used to 
visualise abnormalities.  Biopsies are usually performed where acetowhite lesions showed 
punctuation, friability and highly vascularised appearances.  Biopsies are performed using 
endoscopic forceps (Wiley et al, 2013).   
 
In the UK, the laboratory reports cytology, as low, moderate, or high-grade dysplasia, as 
categorised, by the BSCC (NICE, 2003).  All patients living with HIV are offered anal 
cytology as part of their HIV care in the HIV outpatient department at the NHS trust sexual 
health clinic.  I developed an algorithm in figure 3 which I adapted from Park and Palefsky 
(2010).   
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for the HIV outpatient anal cancer screening process.  For my practice I set up this 
algorithm for anal cancer screening and currently use this to guide practice locally.  I also 
took into account the updated guidelines International Guidelines for Practice Standards in 
the Detection of Anal Cancer Precursors (AINS, 2016).   This is the proposed guidelines 
for practice standards in the detection of anal cancer precursors was developed using anal 
cytology and HRA.  If anal cytology results are normal or borderline, the cytology is 
repeated in 1 year and monitored.  Cytology results with low grade dysplasia HRA and 
biopsy undertaken.  If on HRA the results are normal, and cytology indicates low grade 
dysplasia, the cytology can be repeated in a year.  However, if HRA was normal and but 
cytology result is high grade dysplasia, HRA is repeated in 6 months.  High grade 
dysplasia on cytology warrants HRA and biopsy and follow up for AIN1, AIN 2/3 is 6 
monthly HRA and monitoring (figure 3).   
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Figure 3: Anal Cancer Screening algorithm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Algorithm I developed for anal cancer screening which I adapted from Park & Palefsky, 2010).  
 
  
Anal Cytology 
+ 
DARE 
Normal / Borderline Low-grade dysplasia High-grade dysplasia 
HRA + Biopsy 
Normal AIN 1 AIN 2/3 
Cytology 
Low-grade High-grade 
Repeat in 1 year Repeat HRA 6 Months 
Treatment 
Repeat in 1 Year 
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1.8 Prevalence and Incidence of AIN 
Anal squamous cell carcinomas are relatively uncommon tumours; there are between 350 
and 400 new cases per year in England and Wales (Scholefield & Nugent, 2011).  
According to cancer research UK (CRUK, 2018) there are around 1,400 new anal cancer 
cases in the UK every year, that's nearly 4 every day which are statistics between 2013-
2015.  In the UK, 33% of anal cancer cases are in males, and 67% are in females (CRUK, 
2015).     
 
Anal cancer although considered to be a rare tumour, has been rising over the last 25 
years where it was once thought that anal cancer develops as a result of chronic irritation 
in the anal canal (Uronis & Bendell, 2007).  People living with HIV and AIDS suffer from 
anal cancers, much more often than the HIV-negative population and persistent HPV 
infection is the basis for the development of malignancy (Oette et al, 2017).  Nowadays 
this is not the case as multiple risk factors such as HPV infection, infection with multiple 
HPV genotypes, cervical dysplasia or cancer, anoreceptive intercourse, smoking, 
immunosuppression following solid organ transplant and HIV infection is associated with 
anal cancer as more HIV positive patients are being diagnosed with this disease (Welton 
et al, 2004). 
 
Observational studies reviewed by Simpson and Scholefield (2011) have indicated that 
individuals with HPV infection, those immunocompromised, and those living with HIV are 
more at risk of developing anal cancer.  Several studies presented show that HPV is a risk 
factor for developing anal cell carcinoma which affects people living with HIV, MSM, and 
immunocompromised people. According to Swedish et al (2011) anal cancer is rapidly 
increasing in people living with HIV while Berry et al (2009) argues that irrespective of an 
individual’s HIV status, HPV is a risk factor for developing anal cancer. Berry et al (2004) 
mentions, that although anal cancer is increasing across the world, especially in people 
living with HIV, it is well documented in homosexual men.  However, the incidence of anal 
squamous-cell carcinoma is increasing rapidly among MSM, those infected with HIV, and 
other immunosuppressed people (Park et al, 2010 & Salit et al, 2010).  HIV-positive MSM 
are at greatest risk, with a reported incidence of squamous-cell anal carcinoma ranging 
from 60 to 160 per 100,000 (Crum-Cianfliane et al, 2010 & D’Souza et al, 2010).  The 
National Cancer Institute (2010) estimated in the United States (US), anal carcinoma 
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would be diagnosed in 5260 men and women and that 720 men and women would die of 
anal cancer in 2010. 
 
It has been estimated that approximately 14 500 cases of anal squamous cell cancer in 
women and 12 500 in men occurred in 2008 worldwide. Previous studies have reported a 
relatively rapid increase in the incidence rate in some very high-income countries, 
including Australia, Canada, Denmark, France, the Netherlands, the UK and the USA 
(Islami et al, 2017). The incidence rates of anal squamous cell carcinoma are 
approximately 2 per 100 000 in the general population globally in both men and women 
(Grulich et al, 2012).  This represents a two-fold increase compared to 30 years ago, and 
is attributed to populations at high risk, primarily MSM and immunocompromised people. 
There has been a steady rise in anal cancer among MSM concurrent with the HIV 
epidemic in the 1980’s and does not seem to decline with HIV infected individuals living 
longer with antiretroviral therapy.  Prior to the HIV epidemic (mid-to-late 1970’s), the 
incidence of anal cancer was 35 per 100 000 presumed to be MSM (Daling et al, 1987).  
More recent data show that the incidence of anal cancer among HIV infected MSM is 60 
per 100 000 and at the time of an AIDS diagnosis is 137 per 100 000 (D’Souza et al, 2008) 
while women who are infected with HIV; there is seven-fold higher risk of anal cancer after 
the diagnosis of AIDS (Frisch, 2000).  There have been marked increases in anal 
squamous cell carcinoma (SCC) in recent decade with an annual rate of greater than 5 per 
100 000 reported in Australians with 48% of cases diagnosed in people over 65.  The 
increasing incidence of anal SCC in the general population may be related to changing 
sexual practices over time, such as earlier age of sexual intercourse and higher number of 
life time partners (Grulich et al, 2012).  The increase in anal SCC in Denmark commenced 
in the 1960’s and was greater in women than in men including residents of Copenhagen 
(Frisch et al, 1993, Nielsen et al, 2012).  In the US, between the years of 1998-2003 anal 
SCC increased by an average of 2.6% per year and this trend was similar in men and 
women (Joseph et al, 2008).   
 
The prevalence and incidence of anal squamous cell carcinoma is on the increase in the 
studies from UK, Australia, America and Denmark primarily in high risk groups like MSM 
and immunocompromised individuals.   
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1.9 Anal Cancer Screening 
Most of the anal cancer is squamous cell carcinoma (Roberts et al, 2017).  Several anal 
cancer screening techniques can be used to screen for anal cancer and lesions which may 
develop into anal cancers.  Potential screening modalities include digital anorectal exam, 
anal Papanicolaou testing, human papilloma virus co-testing, and high-resolution 
anoscopy (Leeds and Fang, 2016).  Pre-cancerous lesions are generally called Anal Intra-
epithelial Neoplasia (AIN).  The combination of anal cytology, possibly paired with anal 
HPV molecular testing, followed by HRA in individuals with positive results, represents a 
reasonable strategy to screen for AIN (Roberts et al, 2017).  All types of AIN need 
monitoring and anal cancers need High Resolution Anoscopy to obtain a visual image of 
the anal canal and for biopsies to be taken to define exactly what the lesion is. All types of 
AIN (AIN 1-3) or anal precancers are very susceptible to treatment and have a good 
prognosis. Prior to the 1970’s anal cancer was treated with abdominoperineal resection 
but the standard of care these days is concurrent chemoradiation therapy with surgery 
reserved for patients with residual disease (Uronis & Bendell, 2007).   According to Weis 
(2013) HGAIN can then be ablated with several modalities, including infrared coagulation, 
CO2 laser, and electrocautery. These methods for HGAIN ablation can be performed with 
local anaesthesia in an outpatient clinic and are relatively well tolerated. Another treatment 
approach for HGAIN is topical treatment, principally with 5-fluorouracil or imiquimod. 
 Anal Cancer Screening Programs 
The goals of anal cancer screening programs are to detect those patients with high grade 
AIN (HGAIN), locate these lesions, and treat lesions before it develops into cancer.  The 
tools for anal cancer screening have been adapted from the tools used to screen and 
detect cervical lesions (Palefsky et al, 1997).  The first clinic for anal dysplasia was 
established in 1993 at University of California, San Francisco, and this became the model 
for development of clinics in other cities throughout North America, Europe, Australia and 
New Zealand as the recognition of anal cancer screening is growing, and Jay et al (2011) 
states that anal cancer screening should be considered for HIV infected patients. Some 
clinicians have adopted a similar model of screening in the UK, but services are limited.  
According to a survey by Vera et al (2013), 15(21%) of the sexual health clinics in the who 
responded to the survey, are planning to set up a screening service in the future, while 
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other clinics are waiting for national guidelines.   
 
The decrease in cervical cancers prior to cytology screening from 35 per 100 000 to its 
current incidence of 9 per 100 000 is attributed to the implementation of cervical cytology 
screening followed by colposcopy for identification and treatment of high grade CIN, thus 
preventing its progression to cancer (Watson et al, 2009).  However, cervical screening 
programs were established on assumptions and without proof of efficacy, but still led to a 
decline in cervical cancers (Rotkin, 1967).  Colposcopy enables the clinician to locate 
suspicious areas using a powerful light source and magnification, and colposcopy-directed 
biopsies remain the gold standard of diagnosis for cervical disease (Jay et al 1997). 
Colposcopy was first used in anal canal lesions in 1977 (O’Connor, 1977), and in 1997 the 
colposcopic descriptors and terminology were validated for anal lesions.  Lesions 
(descriptors) were characterized by colour, contour, surface configuration, and vascular 
patterns using colposcopic criteria standardized for the cervix.  Terminology for example 
for cervical high-grade squamous intraepithelial lesion (HSIL), was adapted and used for 
anal HSIL as this is analogous to precursor for cervical cancer (Jay et al, 1997).  High 
resolution anoscopy (HRA) was the term used to describe anal colposcopy more than 15 
years ago, by a colorectal surgeon in the US and was first published in literature in 2001 
(Goldstone et al, 2001).  In San Francisco, many at risk patients receive anal cancer 
screening and rates of HGAIN detection have increased.  This can be attributed to the fact 
that anal screening has been effective and anal cancer rates have not increased despite 
doubling elsewhere (Jay, 2011).   
 
The only established screening programmes available in the UK are for breast, bowel and 
cervical cancer screening.  According to Cancer Research UK, a screening programme 
must have a ‘good enough’ test for it to work (CRUK, 2016), and this test must: 
• reliably detect any cancers or abnormal changes that could lead to cancer 
• not cause too many false alarms 
• be acceptable, so that people will actually take the test 
• not be dangerous to health 
• be cost-effective. 
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According to CRUK (2016), if a test doesn’t meet the criteria mentioned above, then it is 
unlikely to be effective for whole population screening, it would not be an effective use of 
time and money to screen the entire population.  This would be harder for the benefits to 
outweigh the harms of anal cancer screening as this would cause unnecessary worry for 
those being screened. If good tests are available for rarer cancers, doctors will often offer 
them to people who have the highest risk of the disease. 
In 2012 the UK National Screening Committee (UKNSC) carried out a review for anal 
cancer screening and concluded that this issue did not meet the criteria for cancer 
screening programmes (CSP).  However, this committee agreed that it was an important 
issue and the CSP set up an evaluation of utility of HPV testing and liquid based cytology 
sampling (i.e. Pap smear) for the clinical management of patients at high risk of anal 
cancer.  The high-risk groups were MSM, HIV positive men and women, women who have 
anal receptive sex, women and men who have had solid organ transplant and this project 
was set up with GUM and the Lesbian and Gay Foundation in Manchester in the UK 
(UKNSC, 2013).  Results of this study called the Analogy Study, still needs to be 
published.  This study is investigating the feasibility and effectiveness of screening for the 
precursors of anal cancer in groups who are at increased risk of developing the disease 
(CRUK, 2016). 
One of the largest studies in the UK will be undertaken which is the “Laser Ablation versus 
Observation to Prevent Anal Cancer” (LOPAC) trial.  This trial will be funded by National 
Institute for Health Research Homerton University Hospital NHS Foundation (HUHFT, 
2016).  The Homerton Anal Intraepithelial Neoplasia Society (HANS) receives referrals 
from all over the UK and the aim of this study is to assess whether laser treatment is 
effective in preventing anal cancer in HIV-positive MSM identified to have high-grade AIN 
disease (precancer).  About 3,500 HIV-positive MSM will be recruited into the trial from 
four to five HIV units across London and screened for anal precancer.  These patients will 
be followed up every six months with a standard examination, consisting of HRA, DARE 
and biopsy of persistent or new AIN 2 and/or AIN 3 or other areas suspected of cancer. 
Recruitment into the study will last 36 months and the total duration of the trial is 72 
months.  It is unclear whether testing a sample of cells from the anus or other laboratory 
tests are suitable and is more accurate tool for anal cancer screening. There are many  
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tests being studied in laboratories, but to establish how good they are, this trial would be 
able to see how they perform in a ‘real-life’ setting.  Therefore, the aim of the LOPAC study 
is to find best tests to improve anal cancer screening. It is also hoped this study identifies 
what lifestyle and health behaviors’ may be associated with any anal abnormalities and 
cancer (HUHFT, 2016). 
A US-based multicenter study Anal Cancer HSIL Outcomes Research (ANCHOR) is 
underway which started in April 2015 and will last for 5 years. This study will help 
determine whether screening and treatment of HSIL should be the standard of care for 
people living with HIV and for other groups of people with a high risk for anal cancer. The 
tissue samples collected in this study will help advance understanding of different HPV 
strains and their role in causing anal and cervical cancers (The Anchor Study, 2016). 
The Study of the Prevention of Anal Cancer (SPANC) in Sydney, Australia, began in 
September 2010 and concluded in mid-2015.  The SPANC study is one of only a small 
number of cohort studies globally to perform HPV, cytology and HRA screening on all 
participants over multiple time points as well as performing HPV DNA genotyping.  
However, follow up of HIV negative and HIV positive homosexual men aged 35 and over 
will continue to 2018.The findings of this study will contribute to the understanding of the 
natural history of anal HPV and inform the development of guidelines for implementing 
anal cancer screening programs in this population (Machalek et al, 2013).   
 Anal Screening Guidelines 
In the absence of any national anal cancer screening guidelines in the UK, the British HIV 
Association only made recommendations that all major HIV units should develop clinical 
guidelines for the management of suspected anal cancer and precancer; these HIV units 
should develop either local clinical expertise, or referral pathways for suspected anal 
cancer and pre-cancer (BHIVA, 2008).  The updated published UK guidelines for the 
management of sexual and reproductive health (SRH) of people living with HIV infection, 
produced jointly by BHIVA, BASHH and FFPRHC, includes advice on anal cancer in HIV 
infection (BHIVA, 2014). These key points and recommendations have not changed the 
recommendations of BHIVA, BASHH and FFPRHC 2008 guidelines on anal cancer in HIV. 
Hence this has encouraged some HIV outpatient clinics in the UK to develop anal  
screening protocols locally once clinicians have undergone the appropriate training for  
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anal cytology and HRA.   
 
The Association of Coloproctology of Great Britain and Ireland (ACPGBI) Colorectal 
Disease Position Statement for Management of anal cancer multi-disciplinary team 
working group has become established in the last 10 years for colorectal cancer, and 
several sets of Local, National, and International Guidelines have been developed for the 
management of colorectal cancer (ACPGBI, 2011). In the existing guidelines for colorectal 
cancer, anal cancer receives only limited coverage because it is a rare tumour. Colorectal 
surgeons with a large AIN practice where there are many patients living with HIV, may 
require specific collaborations with their local GUM and HIV clinicians (Scholefield and 
Nugent, 2011).  Further to this position statement in 2011 by Scholefield and Nugent 
(2011), they seem to think that although there is probably no place for screening for AIN 
even in high-risk groups, some centres in the United States have started screening for AIN 
in HIV cohorts using anal cytology.  Scholefield et al (2011) states that anal cancer 
screening is probably only appropriate as part of a trial in high-risk groups in the United 
Kingdom.    
 
There is a growing concern that anal cancer screening, prevention and early intervention 
need to be implemented as it is for cervical, breast and prostate cancers (Darragh and 
Winkler, 2011).  In the United States of America, New York State is the only state to 
develop guidelines for anal cancer screening.  The New York State Department of Health 
AIDS Institute (2018) states that, HIV infection is an independent risk factor for anal 
neoplasia.  Individuals with a history of long cumulative periods of immunosuppression or 
high viral replication may be at higher risk for developing anal cancer (Guiguet et al, 2009). 
The New York State guidelines (2018) recommend that at baseline and as part of the 
annual physical examination for all HIV-infected adults, regardless of age clinicians should 
enquire about anal symptoms, such as itching, bleeding, diarrhoea, or pain; perform a 
visual inspection of the perianal region and perform a digital rectal examination.  These 
guidelines also recommend that clinicians should obtain anal cytology at baseline and 
annually thereafter in the HIV infected populations.  Clinicians should refer patients with 
abnormal anal cytology for high resolution anoscopy and examination with a biopsy of 
abnormal tissue (The New York State Department of Health AIDS Institute, 2018).  Some 
sexual health clinics in the UK, according to Vera et al, (2013), have adopted anal cancer 
screening for people living with HIV as stated in the New York State clinical guidelines.    
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According to the New York State department of Health Aids Institute (2018) HIV 
guidelines, clinicians should refer women with cervical HSIL; any patient with abnormal 
anal physical findings such as warts hypopigmentated or hyperpigmentated plaques or 
lesions; lesions that bleed or lesions of uncertain aetiology for HRA and/or examination 
with biopsy of abnormal tissue.  As part of these guidelines, clinicians should also obtain 
anal cytology at baseline (first visit to clinic) and annually in the HIV infected populations 
especially in MSM, any patient with a history of anogenital condylomas and women with 
abnormal cervical and or vulvar histology (Abramowitz et al, 2007; ; Anderson et al, 2005; 
Berry et al, 2005; Frisch et al, 2001; Frisch et al, 2000; Frisch et al, 1994).  These 
guidelines also recommend that in communities where there are no clinicians available to 
perform HRA then patients with abnormal cytology should be referred to a surgeon for 
evaluation (The New York State Department of Health Aids Institute, 2018). 
 
The European Aids Society (2014) is a not-for-profit organisation, whose mission is to 
promote excellence in standards of care, research and education in HIV infection and 
related co-infections, and to actively engage in the formulation of public health policy, with 
the aim of reducing HIV disease burden across Europe. The aim of the EACS Guidelines 
is to provide easily accessible recommendations to clinicians centrally involved in the care 
of HIV-positive persons.  These guidelines are to support anal cancer screening in MSM 
living with HIV.  According the EACS guidelines, screening methods should involve a 
digital anal rectal examination with or without anal cytology.  These guidelines are 
intended to provide the best guide to clinical management while it is recognised that the 
level of evidence varies, and there is limited evidence from randomised controlled trials on 
the management of non-infectious co-morbidities in HIV.  The current management of anal 
cancer screening is mainly derived from general medical guidelines and therefore 
represents the collective consensus opinion from a panel of experts in the field of HIV and 
range of co-morbidities (EACS, 2012). However, in 2017, recommendations for screening 
for anal cancer were extended to also include all persons with HPV-associated dysplasia 
(EACS, 2017). 
 
The European Society for Medical Oncology which is a leading European professional 
organisation for medical oncology have produced clinical guidelines for screening and 
prevention of anal cancer and proposed using anal cytology and HRA for high risk  
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populations, MSM and HIV, women with a history of anal intercourse or other HPV related 
anogenital malignancies (ESMO, 2015).   
Although recommendations exist for anal cancer screening in the UK (BHIVA, 2015), the 
challenge is certainly the paucity of clinicians with expertise in HRA as this has limited the 
introduction of screening guidelines for at risk populations (Bower &Newsom-Davis, 2010). 
Anal cancer is increasing in patients living with HIV.  An understanding of the natural 
history of AIN disease, improvements in the management of AIN and the prudent use of 
screening programs, the prognosis for anal cancer should continue to improve (Biggar et 
al, 2005). Smith and Mounzer (2014) agree with the fact that currently, the lack of 
experienced high resolution anoscopists is a major obstacle for the expansion of AIN 
screening programs.  A study by Patel et al (2014) on global practices of anal cancer 
screening practices, where data were collected using on line surveys, 82 providers from 80 
clinics in Canada, USA, Europe, Asia and Australia took part.  This study demonstrated 
that there is considerable variation in anal cancer screening practices around the world 
and there does not appear to be any universal consensus on optimal strategies for anal 
cancer screening, treatment and follow up.  In the United States, private insurance and 
public funds are the two most common methods of payment for anal screening whereas in 
Canada and other countries public funds are exclusively used for payment.  Most clinics in 
the US, bills are paid by insurance companies or health maintenance organisations, while 
clinics in other parts of world (i.e. Asia, Europe and Australia) receive funds from hospital 
budgets (Patel et al, 2014).   
These screening programmes have the potential to reduce morbidity but for some 
individuals screening programmes have the potential to decrease the psychological well-
being due to uncertainty associated with screening procedures and results (Barratt et al, 
2002; McCaffery & Barratt, 2002; McMaughton-Collins et al, 2004; Shaw et al, 1999; 
Stewart-Brown & Farmer, 1997).  According to Landstra et al (2013), this aspect has not 
been investigated. 
 Impact of Publicity about Celebrities in Anal, Breast, and Cervical Cancer 
Screening 
Research has demonstrated that celebrities disclosing their own illness can increase 
public interest in the specific disease and can change the public’s behaviour (Cram et al,  
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2003). The death of Farrah Fawcett, an American actress in 2009, gave anal cancer a 
higher profile.  She was first diagnosed in 2006 and died at the age of 62 (Ortoski & Kell, 
2011). The Farrah Fawcett foundation started in 2007 and has now collaborated with the 
HPV and Anal Cancer Foundation in helping to create the International Anal Neoplasia 
Society (IANS, 2013) which is the world’s first professional society devoted to prevention 
and treatment of anal cancer (The Farrah Fawcett Foundation, 2016). 
 
In Australia, the famous singer Kylie Minogue had a breast cancer diagnosis which caused 
an increase in bookings for mammography.  This publicity resulted in a 20-fold increase in 
news coverage of breast cancer, which emphasised that young women do get breast 
cancer and that early detection was critical. Screening bookings rose 40% in the 2 weeks 
of the publicity, with a 101% increase in non-screened women in the eligible age-group of 
40-69 years. Six weeks following the publicity, bookings remained more than a third higher 
in non-screened women (Chapman et al, 2005). 
 
In the UK in 2013, the unprecedented publicity of Angelina Jolie in hereditary breast 
cancer and her decision to have genetic testing for BRCA1 gene and having under gone 
risk reducing mastectomy (RRM) and the prelease of NICE guidelines on familial genetic 
testing in January with final release on 26th June 2013 created a lot of publicity.  The 
‘Angelina effect’ which is long lasting and went global appears to have increased referrals 
to centres for breast screening (Gareth et al, 2014).  Jade Goody the reality television 
celebrity died from cervical cancer on 22nd March 2009.  Her illness increased media and 
public interest in cervical cancer (Metcalfe et al, 2010).   
 
Celebrities disclosing cancer diagnosis in public has influenced peoples’ views and interest 
in cancer screening. Celebrity cancer diagnosis can significantly influence public health 
behaviour, including the uptake of prevention programmes (Chapman et al, 2005, Twine et 
al 2006). This study shows that public information, searching behaviour and interest in 
screening are associated with key events in a high-profile celebrity illness and this 
suggests a role for the media in influencing public health information seeking (Metcalfe et 
al, 2010).   
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 Cost-Effectiveness of Anal cancer screening 
Anal cancer requires a multidisciplinary team approach with regards to treatment which 
often requires complex interventions despite it being a rare condition, and these cancer 
patients have placed a significant burden on the NHS resources (Keeping et al, 2014).  
Czoski-Murray et al (2010) as cited by the UKNSC (2012) found that screening for anal 
cancer is very unlikely to be cost-effective and the determinant of this finding was the low 
observed incidence of anal cancer.  The conclusion of this study was supported by 
research done by Gaisa et al (2011), where they critically reviewed the literature, 
conducted a comparative analysis and discussed treatment modalities for anal HPV.  
Findings from the study by Gasia et al (2011) on cost effectiveness were apparent that, 
screening only for high risk groups i.e. MSM is cost-effective. Lam et al (2011) provides an 
argument that for HIV infected MSM, anal cancer screening should be initiated with the 
direct use of HRA as this is the most cost-effective strategy for detecting AIN 2&3.  Ong et 
al (2016) provides an argument that detection of HSIL using anal Pap smears, lack of 
trained anoscopists for HRA and insufficient evidence that screening reduces anal cancer 
morbidity or mortality, has led to many conflicting responses for anal Pap and HRA as an 
intervention to be cost effective.   
 
1.10  Purpose of my Study 
The overarching aims and objectives to be addressed in my study is to consider the 
UKNSC (2012) criterion 15 which states that the benefit from the screening programme 
should outweigh the physical and psychological harm caused by tests and diagnostic 
procedures.  Under criterion 15, point no 50 concludes that no evidence was identified and 
therefore there is no update to the conclusions of Czoski-Murray et al. (2010:70): “The 
screening process does not appear to present any physical harm; however, any 
psychological effects of anal cytology screening or pap smears have not been evaluated in 
the studies included in this review.” 
 
The purpose of my study involved the paucity of research undertaken on the psychological 
aspects of cancer screening as in breast, prostate, cervical, colorectal screening. 
Clinicians have identified that there are varying practices on anal cancer screening 
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worldwide, that there are no universal optimal screening strategies for anal screening; 
there is a lack of clinician training and resources available to set up an HRA service.   
 
My study is designed to produce evidence which could help inform several criteria as 
identified in the UK NSC (2012) which is necessary to inform decisions about future 
screening or introduction of routine anal cancer cancer screening programmes.  My study 
is unique in that it includes patients and clinicians to address the research question so 
decision‐makers will be better equipped to design and deliver health services which meet 
their needs for future development of anal cancer screening programs and guidelines.  
While addressing patients’ and clinicians’, either reflecting on their perceptions and 
experiences of anal cancer screening and health services, or engaging with research itself, 
I will be able to identify important areas for research and address any gaps needed for 
future research.  My research aims were to explore the perceptions and experiences of 
patients and clinicians in anal cytology screening and high resolution anoscopy in the UK.  
The UK NSC (2012) criterion 18 states, “There should be a plan for managing and 
monitoring the screening programme and an agreed set of quality assurance standards” 
and point 57 states: “This have not been established for anal cancer although quality 
assurance guidelines for the screening of other cancers (such as cervical screening) will 
provide a model for the development of an anal cancer screening program”.  However, in 
2017 the UKNSC reviewed the recommendations on anal cancer screening and states that 
a national screening program is not recommended as there is not enough evidence and 
understanding of the condition to be sure a screening programme would deliver sufficient 
benefit (UKNSC, 2017). The UKNSC (2017) does state that anal cancer remains a rare but 
important condition, and anal cancer has been removed from the UK NSC’s list of topics 
as this topic is confined to high risk groups. While anal cancer is rare and not 
recommended for national guidelines at present, my study will provide findings to 
contribute to the research and evidence needed on the psychological effects on anal 
cancer screening.  My study will also aim to contribute evidence to the advisory groups i.e. 
BHIVA, BASHH so that consideration for evidence to be included in HIV guidelines for 
people living with HIV 
 
There are numerous studies on the psychological effects of screening on cervical 
(Szarewski, 2011), prostate (McNaughton-Collins, 2004), and breast (Brett et al, 2005) 
cancer.  Landstra et al (2012), state that these studies can provide valuable insights into 
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potential psychological effects of anal cancer screening.  The lack of clear guidelines for 
anal cancer screening or the availability of standardised screening programs, may 
increase the worry felt by people living with HIV and these authors believe that increasing 
screening programmes may be accompanied by an increase need or participants to 
receive some form of psychological support depending on their results and psychological 
response (Landstra et al, 2013).  Although anal cancer can be detected, the British HIV  
association produced recommendations in the HIV guidelines in the UK in 2008 on sexual 
and reproductive health of people living with HIV infection, to provide advice on anal 
cancer in HIV infection.  In 2014, BHIVA advocated that all major centres should develop 
local guidelines for anal screening (BHIVA, 2014).  Research is needed on the potential 
impact screening programs may have on individuals undergoing anal cytology screening 
and high resolution anoscopy and its impact on future uptake of healthcare.    
1.11 Research Aims and Questions 
The overall aim of my study is to: 
1. Explore the perceptions and experiences of patients and clinicians on anal         
    cancer screening 
2. Generate findings to help inform clinical practice for anal screening in  
    sexual health clinics in the UK.    
 
These aims will be achieved by asking the following question: What are the perceptions 
and experiences of patients and clinicians in anal cytology screening and high resolution 
anoscopy in the UK? 
 
This chapter has explained how I came to undertake the research on anal cancer 
screening in the UK.  The use of me in my personal account of experiences in anal cancer 
was necessary to justify why I undertook this study.  I used reflexivity to enhance 
credibility, trustworthiness and transparency is evident in my account which embraces the 
philosophy of hermeneutic phenomenology.  The research aims, and question is made 
explicit to the research community.   
 
Chapter 2 introduces the review of literature, search methods, studies from varying 
perspectives around AIN, anal cancer and screening programmes available around the 
world.    
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2 Literature Review  
A literature review is a process of studying what has already been written on a particular 
topic and it can serve multiple purposes at different stages of the research and writing 
process; often it takes place throughout the qualitative research process since the process 
itself is iterative and new questions and concepts are arise (Creswell, 2009).  The process 
of reviewing the literature requires different kinds of activities and ways of thinking.  The 
activities involve searching and preparation for the review and getting access to sources of 
information.  By understanding ways of thinking, connecting this to how the researcher is 
engaged in the literature review, and is self-reflective in the process which means that the 
researcher is engaged in the research process (Baker, 2000).  With the help of literature 
review, the researcher finds a fresh and original research question, identify unknown gaps 
in the literature or make connections (Shields & Rangarajan, 2013). However, Holloway & 
Wheeler (2010) suggest some sort of trawl and search for literature should be carried out 
because an answer to the research question may exist in the public domain.  Therefore, 
when I reviewed the literature, I considered my research question and identified any gaps 
in the literature to be able to find new research.  The role of a literature review in 
qualitative research depends on the methodology in use, and on the goals of the research 
itself, and can generally only be determined by consulting available research literature.  
Literature review can also be used to refer to a section of a research report that describes 
prior research on the topic (Cresswell, 2009).  
 
I searched a broad range of platforms to identify all relevant information for my study. 
According to Aveyard (2010), the literature search strategies can be defined as systematic 
processes followed by the researcher to locate the evidences appropriate to inform the 
research aims and objectives.  For any research to reach firm and relevant conclusions 
and to inform practice there must be a detailed literature search process.  This must detail 
how data are retrieved, explain the inclusion and exclusion criteria and collate the most 
relevant data to make firm and relevant judgements.  Harvard (2007) states that a well-
structured literature search is the most effective and efficient way to locate sound evidence 
on the subject being researched, that evidence may be found in books, journals, 
government documents and organisational websites. 
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This chapter explores the study within current research evidence by: 
• Describing the literature search strategy 
• Reviewing the literature on the psychological effects of anal screening from 
participants and clinicians’ perspective 
• Discussing the findings and relevance of previous studies to present studies 
• Demonstrating gaps in the literature 
 
2.1 Inclusion and Exclusion Criteria 
Researchers must set inclusion and exclusion criteria for their studies as these facilitate 
the retrieval of significant literature (Aveyard, 2010).  The exclusion criteria for my study 
were minimal due to the scarcity of publications on this topic.  The exclusion criteria for my 
study were evaluation of treatments for AIN.  My study is to explore the perceptions and 
experiences in anal cytology and high resolution anoscopy i.e. to explore the physical and 
psychological harm caused by the test (anal Pap smear), and diagnostic procedures 
(HRA).   All studies on patients and clinicians in anal cancer screening were included and 
reviewed for the following inclusion criteria:  
• Screening for anal cancer 
• Original research on psychological/psychosocial aspects of anal cancer screening 
• English publications from 1997 onwards 
• Local, national and international/global publications 
 
The inclusion and exclusion criteria of studies may be defined by factors including 
population characteristics, health or clinical topic, methods and methodology (i.e. 
philosophical approach), language, time frame or type of publication.  This should be 
justified for readers to make an assessment about the transferability of the findings to their 
own setting, as description of the study characteristics and screening and reasons for the 
excluding studies is needed (Tong et al, 2012).  The PEO search strategy method used in 
my search clearly outlines the characteristics for inclusion criteria.   According to Bettany-
Saltikov (2012), the PEO methods are used widely in nursing and health research to help 
manage and break down research questions especially in qualitative. 
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2.2 The Literature Search Strategy 
I used the PEO search strategy where I was able to break down the research question 
which helped me to identify the key concepts in my research question so that I could 
develop search terms (discussed below) to describe these concepts and determine my 
inclusion and exclusion criteria for my study.  A researcher should take precautions when 
applying phrases as it could lead to exclusion of relevant evidences or inclusion of data not 
necessary to inform the study question (Aveyard, 2010).  This acronym PEO is:  
Population/Problem, Exposure, Outcome and I applied this to my study as follows: 
 
P= Patients living with HIV undergoing anal cancer screening and clinicians 
     undertaking anal cancer screening 
E= Anal cancer screening (anal cytology, DARE and HRA) 
O= Perceptions and experiences of anal cancer screening 
 
The PEO question for my study: what were the perceptions and experiences of patients 
and clinicians in anal cytology and high resolution anoscopy?  The population is patients 
living with HIV (i.e. the community affected) and clinicians undertaking anal cancer 
screening to include anal cytology, DARE and high resolution ansocopy.  Exposure was 
patients undergoing anal cancer screening and clinicians undertaking anal cytology and 
high resolution anoscopy.  The outcomes included the perceptions and experiences of 
patients and clinicians in anal cancer screening.  According to Bettany-Saltikov (2012), the  
PEO format in qualitative research includes the population and their problems, who are the 
users, patients or community being affected? What are their symptoms, age, gender etc?  
Exposure use is for a specific exposure (this term is used loosely) such as “anal cancer” or 
“anal cancer screening”.  Outcomes or themes for example are if you are looking for 
improvements in pain, responsiveness to treatment, mobility, quality of life, daily living? 
Usually there will be an element of looking at patient’s experiences 
 
I employed structured search strategies and focused on databases, using specific key 
words searches as discussed using the PEO format (such as anal cancer screening, AIN, 
people living with HIV and clinicians undertaking anal screening, psychological effects of 
anal cancer screening), so that I could yield valid and reliable data from these healthcare 
databases.  Given the nature of my study, the following databases were searched for 
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relevant studies: British Nursing Index (BNI), PsychInfo, Cumulative Index of Nursing & 
Allied Health (CINHAL), Embase and Medline. Several databases could be used as 
sources of retrieving the most relevant evidences to inform studies (Cormack, 201g0).  It 
must be noted that one of the best approaches to ensuring valid and reliable data are 
retrieved, is the use several data bases (Baker, 2010) and to set inclusion and exclusion 
criteria as art for ensuring that data included are valid and reliable (Ellis, 2010). These 
candidate databases I used, covered all aspects of AIN, anal cancer, psychological effects 
of anal screening.  According to Wakefield (2015), the purpose is to present an in-depth 
examination of the main themes isolated from the data sources accessed, while 
simultaneously establishing the reliability, credibility and trustworthiness of the sources of 
information targeted.  I did a literature search in two phases.  My first literature search run 
was undertaken in 2011 (Updated October 2017) where I accessed literature from 
databases such as EMBASE, MEDLINE, BNI, PyschInfo and CINHAL.   
 
The method I used in collection of literature was a computerised database search, 
snowballing, grey literature search and hand searching.  The purpose of my literature 
review is to investigate the evidence on anal cancer screening and to explore the 
psychological effects it has on participants.  I undertook a comprehensive review of 
scholarly articles to gain a deep understanding of the psychological impact of anal 
screening studies like knowledge, attitudes, and willingness to undertake screening, 
acceptability and evaluation of screening procedure.  The purpose of my study involved 
the paucity of research undertaken on the psychological aspects of cancer screening as in 
breast, prostate, cervical, colorectal screening.   
 
Another method I used in my literature search was the snowballing approach.  Snowballing 
is defined as a method where the reference list of a paper or the citations is used to 
identify additional papers.  This can also complement searches with a systematic way of 
looking at where papers are cited and referenced (Wohlin, 2014). Snowballing retrieval of 
information does not require predetermined search strings but is likely to introduce 
subjectivity to the process and a researcher bias to studies included (Hagen-Zanker & 
Mallet, 2013).   
 
Hand searching was also an important and useful process in my literature review strategy.  
This search is beyond using data bases for searches as it involves a manual page-by-
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page examination of the entire contents of a journal issue or conference proceedings to 
identify all eligible reports of trials. In journals, reports of trials may appear in articles, 
abstracts, news columns, editorials, letters or other text (Armstrong et al, 2007). By hand 
searching healthcare journals and conference proceedings is a useful adjunct to searching 
electronic databases for at least two reasons: (1) not all trial reports are included in 
electronic bibliographic databases, and (2) even when they are included, they may not 
contain relevant search terms in the titles or abstracts or be indexed with terms that allow 
them to be easily identified as trials (Dickersin et al, 1994).  To support this argument, a 
Cochrane Methodology Review has found that a combination of hand searching and 
electronic searching is necessary for full identification of relevant reports published in 
journals, even for those that are indexed in MEDLINE (Hopewell 2007a).  
 
To keep up to date with current published literature on AIN I also registered on 
“ResearchGate”, a social networking site for scientists and researchers (OSC, 2015).  
ResearchGate indexes self-published information on user profiles to suggest members to 
connect with others who have similar interests (Lin, 2012).  However, since this site is 
designed with academics in mind, it contains many features that allow and encourage its 
user base to connect and converse around research interests and publications.  It also has 
useful features where this site can recommend relevant articles and other researchers in 
the same area just based on the research interest that the user has entered (Neal, 2012).  
I receive regular emails on all published articles from authors, even current publications on 
AIN which is on the ResearchGate site.  I can request articles directly from authors too 
around AIN from all over the world. 
 
Grey literature (e.g. technical reports, working papers, thesis publications, report literature, 
government publications, policy documents, fugitive literature, nonconventional literature, 
unpublished literature, non-traditional publications, electronic publications, online 
publications, online resources, open access research, and digital documents) other than 
databases was considered for my research.  To locate relevant studies, reviewers can 
search organisational websites, Google Scholar, thesis databases, specialist journals, and 
consult with experts (researchers, providers, policy makers) in these fields and librarians 
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are resourceful, in assisting with searches (Tong et al, 2012).  A focus on grey literature 
can really help increase the breath, relevance, topicality and ultimate utility in literature 
review (Hagen-Zanker & Mallet, 2013).  I explored the literature available on anal cancer 
screening and Google Scholar was particularly helpful for me in identifying the literature I 
required for my study.   In the UK, NHS regional Research Design Services (RDSs) for the 
National Institute of Health Research (NIHR) provide a wide range of services for NHS 
staff in research including support for literature searching (Gerrish & Lacey, 2010).  I used 
most search strategies as the information available in the UK is very limited on anal cancer 
screening, so I accessed wider search databases, made use of the librarian at my 
employing trust for literature searches.   
 
There is a need to provide healthcare professionals with reliable evidence in which to base 
decisions has led to the increasing importance of published reviews (Docherty, 2003).  
Nurse researchers usually start their research with certain assumptions as they often have 
the knowledge of the field they wish to explore.  Their professional experience and reading 
of the literature can enhance their research.  It generates theoretical sensitivity to concepts 
and issues that are important for developing a theory.  Researchers do not need to be 
explicit; however, need to uncover their own preconceptions (Holloway & Wheeler, 2010).  
For my study, literature was revisited after data collection and analysis.  This affirms that 
trustworthiness is demonstrated throughout and that my study findings have come from 
the data and pre-informed by the literature review process.   
 
In my first run of searches (Figure 4: Phase 1), I initially I used search phrase “anal 
intraepithelial”, “ti” (title), “ab” (abstract) on databases EMBASE, MEDLINE, BNI and 
CINHAL which yielded 625 results.  I then searched using search phrase “anal cytology”, 
“ti”, “ab” using same databases, and this yielded 337 results.  I also used synonyms like 
“screening OR tool* OR strategy, “ti” which produced 411841 results. The Boolean 
operators “OR” and word truncation symbol (*) like tool* helped me locate data relevant to 
my study. I then combined the search phrases “anal intraepithelial neoplasia”, anal 
cytology” and synonyms “screening or tool* to narrow down evidence and came up with 
114 results. I combined all the searches and limited it to 1997 to 2016 which produced 102 
searches and duplicates were filtered.  I used this as the basis of my initial research into 
the study.     I used phrases like ‘anal intraepithelial neoplasia’, ‘anal cytology’ and  
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‘screening’ or ‘tool’ to make sure that all relevant information I needed met my inclusion 
and exclusion criteria as this was a broad search relating to my research question. These 
102 articles relating to AIN, screening tool, cost effectiveness, cytology, HRA, screening 
strategy in title were retained.  
 
I did a second run of literature search (Figure 4: phase 2) and included studies of patients 
and clinicians from 1997 to 2016.  I chose this timeframe as the first anal dysplasia clinic 
was set up 1999 and I searched for literature two years prior so that I did miss out on any 
prior research on anal cancer screening.  CINHAL and Medline databases filtered out any 
duplicates and 50 results were found using key phrases “psychological”, “Anxiety”, 
“Depression”, perception* OR experience*.   
 
Of these 23 articles with reference to phrases above, were full reports of original research.  
27 articles were rejected as they did not meet the inclusion criteria.   I hand searched and 
found one article while another two articles were sent to me via ResearchGate (Figure 4: 
total of 26 papers).  This chapter focuses on 26 papers arising from the first and second 
set of searches (phase 1 & phase 2) which were full reports of original research and is 
discussed in section 2.4.  The type of papers I found during the literature review process 
were 6 cross-sectional, 2 cohort studies, 12 surveys, 2 prospective studies, and 2 
evaluations which were quantitative research while, 2 qualitative studies undertook 
interviews.    
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Figure 4: Illustration for Literature search strategy 
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Retained 23 papers of full reports of original research 
ResearchGate: 2 articles of original research 
 
  
Hand searched:  1 paper 
Final Result: 26 papers 
Key words, Boolean operators, word truncations 
combined as above, and search done: Result 114 papers 
Phase 1 
“anal intraepithelial neoplasia” Result 625 papers 
“anal cytology”                     Result 337 papers 
“Screening OR tool*                 Result 411841 papers 
Databases: BNI, PsychInfo, CINHAL, Embase, Medline 
 
 
Duplicates filtered:  Result 102  
Retained articles with reference to AIN, screening tool, 
cost effectiveness, cytology, HRA, screening strategy 
Phase 2 
Searches 
updated 
2017 
“Psychological”, “Anxiety”, Depression” 
“Perception* OR experience* 
Result: 50 papers 
27 articles rejected as did not meet inclusion criteria 
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2.3 Literature Review Process 
For my literature review, qualitative and quantitative papers were included.   According to 
Aveyard (2010), a very detailed review of literature on the topic and good quality reviews 
are useful as they summarise all available literature, either quantitative or qualitative.  For 
this review of qualitative and quantitative papers, a combined analysis framework was 
developed based on the Critical Appraisal Skills Programme (CASP) guidelines 
(www.casp-uk.net).  This appraisal tool enabled a standardised assessment of the 26 
selected papers I used to critique the articles (Table 1).  According to Hart (1998) and 
Silverman (2000a), a systematic process for critiquing literature encourages focus and 
ensures consistency.  The points I used to appraise to make this a systemtatic combined 
framework analysis guided by the CASP appraisal tool for both qualitative and quantitative 
studies, I included the purpose of the study, methodology, sampling, data collection 
methods, data analysis, findings, consideration of ethics, limitations of each study, and the 
value of each research findings.   
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Table 1: Analysis framework used to review selected papers arising from literature 
searches, based on CASP guidelines for reviewing qualitative and quantitative 
studies 
 
Points to 
consider 
Questions to be addressed 
Purpose of the study Was there a clear statement of the aims, goals and rationale clearly 
stated, its importance and relevance clearly stated? 
Methodology Is the methodology appropriate and seeks to fit with the purpose of 
the study? 
Sample Was the recruitment strategy appropriate to the aims of research and 
explains how the participants were selected? 
Data collection Were the data collected in a way that addressed the research issue; 
is it clear how data were collected (e.g. focus groups, interviews, 
questionnaires) and how indicate how methods were made explicit 
i.e.  topic guide for example if interviews were conducted? 
Data analysis Was the data analysis sufficiently rigorous and if there is an in-depth 
description of the analysis? 
Findings Is there clear statement of findings and explicit; if there is adequate 
discussion of the evidence; if the researcher discussed the credibility 
of findings 
Ethics Are there enough details on how the research was explained to 
participants; if issues of confidentiality, consent addressed and if 
approval has been sought from ethics committee?   
Limitations Are there any limitations of the study and has this been addressed by 
authors? 
Value of the research Did the researcher discuss the contribution the study makes to the 
existing knowledge or understanding; if they identify new areas where 
research is needed or if the researchers have discussed whether or 
how the findings can be transferred to other populations or consider 
other ways the research can be used? 
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2.4 Results of search 
Twenty-six papers were reviewed to support the purpose of my study by demonstrating the 
gaps in evidence currently.  The twenty-six studies (Table of literature appraisal-Appendix 
2) were summarised describing the diverse psychological domains being investigated.   
 Characteristics of Included Studies 
Of the twenty-six studies, twenty-four studies were quantitative and two studies were 
qualitative.  Most participants in the studies were MSM living with HIV, and of the twenty-
six studies, two studies included both HIV infected MSM and HIV uninfected MSM while 
two studies included women only which did not stipulate if they have HIV infection and 
were from the general population.  Most participants were MSM/bisexual, and some were 
women.  The included studies reported ages between 16-75 years infected with HIV or 
uninfected with HIV who have undergone anal screening.  Characteristics of participants 
are explained below and in Appendix 2.  There is very limited research available on 
clinicians’ perspectives on anal screening and it is important to discuss these limited 
articles in view of the rationale for my study to add to the body of knowledge. 
 Quality of Included Studies  
The quality of the 26 included studies is critiqued below and in Appendix 2.  Qualitative 
and quantitative designs have a role to play in research as long as the method used is 
dependent on the question asked.  Rolfe (2006) states that we need either to acknowledge 
that the commonly perceived quantitative and qualitative differences require a range of 
quality criteria or to recognise that each study is individual and unique.  However, quality in 
qualitative research can be assessed with the same broad concept of validity and 
relevance used for quantitative research where the research is systematic and has self-
conscious design, data collection interpretation which is a basic strategy to enhance rigour 
(Mays and Pope, 2000).  Rigour is enhanced when the sampling method, design, data 
collection, data analysis and reporting techniques, fit with the overall aims of the study.   
 
 Sampling Methods 
In quantitative research the representative sample is important because in this way the 
findings can be extrapolated to the wider population and several factors affect how 
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representative a sample is i.e. size (Shields & Twycross, 2008).  Blankenship et al (2015) 
recruited participants wanting to be seen in Obstetrics and Gynaecology clinic at an urban 
university medical centre while Ferris et al (2013) sample comprised of women from the 
general population, and these 2 studies used convenience sampling.   Truesdale and 
Goldstone (2010) stratified participants into 3 groups according to compliance and follow 
up recommendations.  Consecutive participants were approached for the study by 
Tinmouth (2011) as they enrolled for the study in Toronto Research for Anal cancer 
evaluation (TRACE study).   
 
Ten quantitative studies did not identify sampling methods but explained eligibility criteria.  
Pitts et al (2007) sampled 384 men who attended a large gay community event were 
approached and invited to participate in a short survey while Fenkl et al (2015) used a 
sample during an education event as part of a cruise vacation for HIV-infected persons.  
D’Souza et al (2008) recruited participants from a Multicentre Aids Cohort Study (MACS) 
in 2005-2006, at their 43rd visit.  Reed et al (2010) recruited men who were existing 
members of the US household maintained by knowledge networks (Menlo Park, CA).  
Sampling for this study were men who self-identified as gay or bisexual.  Similarly, Joshua 
et al (2015) used a sample from the national panel of US households maintained by 
Knowledge Networks for sample 1 while sample 2 for this study a sample was drawn from 
the Harris Interactive LGBT Panel, a subset of the Harris Poll Online Panel (Rochester, 
NY). 
 
Landstra et al (2012) recruited any HIV infected MSM that attended the HIV clinic during 
the study. Debnath et al (2015) surveyed 55 women scheduled for anal screening before 
and after HRA. Likewise, Kaufman et al (2015) identified their sample of 150 women from 
the EVVA study ((Evaluation of HPV, HIV, and AIN in women) which is a cohort study.   
Botes et al (2011) included all participants between October 2008-January 2009 and in the 
study and Hillman et al (2011) included all participants who underwent HRA.  Volunteers 
were recruited among a population of men and women undergoing anal dysplasia 
screening at a single surgical unit.  Moores et al (2015) included all MSM as they 
registered for health services at an STI testing and treatment clinic in Ottawa.  Although 
some studies clearly state sampling methods, the above studies use purposive sampling.  
The purposive sampling technique, also called judgment sampling, is the deliberate choice 
of a participant due to the qualities the participant possesses (Etikan, 2016).  The 
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researcher decides what needs to be known and sets out to find people who can and are 
willing to provide the information by virtue of knowledge or experience (Bernard, 2006). It 
is typically used in qualitative research to identify and select the information-rich cases for 
the most proper utilization of available resources (Patton, 2002).  Koskan (2016) used 
snowball sampling where past participants recommended that friends call the study 
number and screen for eligibility where participation was voluntary, and no issues 
identified.   
 
Six quantitative studies with clinicians/providers did not define/state the sampling method 
instead explained how the samples were recruited into their studies.  In the US clinicians 
and providers are used interchangeably to refer to clinicians that provide a service to 
patients.  Scott et al (2015) stated that 6 providers received in service training on anal 
cytology procedure and offered anal cytology to all HIV-infected patients seen at the clinic 
in the hospital as part of routine care, provided the sample.  Sowah et al (2015) contacted 
47 active HIV providers via email in an academic outpatient HIV clinic to complete an 
online questionnaire.  Fifty medical students and physicians participated in an educational 
activity and all were given the survey to complete (Ortiz et al, 2013).  In the study by 
Kwong et al (2011) a sample was drawn from the University of Colorado’s Infectious 
Disease Group Practice offering DRE, anal cytology and HRA, while Colon-Lopez used a 
sample of 104 HIV healthcare professionals in Puerto Rico.  Patel et al (2014) sent out 
over 300 fax and email invitations to 82 providers from 80 clinics in Canada, Europe, Asia 
and Australia.   
 
In the only qualitative study of Clinicians/Providers, Ong et al (2015) used purposive 
sampling, where 20 HIV physicians from Infectious Diseases, Immunology, Sexual Health 
and General Practice in Australia were recruited into the study.   
 
Table 2 below shows an example of how the CASP framework was used to review 
quantitative and qualitative studies by author, year published, journal, type of study, 
purpose of studies, sampling methods used, design of the studies, data collection and key 
findings of the research studies to provide arguments and references to my study.  I was 
able to identify and reveal an evidence gap which proves the need for my study.  
53 
 
Table (2) Example of how CASP framework was used for this study 
 
 
Author, year 
published, 
Journal 
Type of study Purpose Sample Design Data collection Key Findings 
Landstra et al 
(2012), 
Psycho-
Oncology 
Journal, 
Australia 
Quantitative The psychological 
impact of anal screening 
cancer screening on HIV 
Infected men 
291 HIV 
MSM 
Prospective 
Longitudinal 
survey 
Self-reporting 
questionnaires 
There was no evidence that general anxiety, 
depression or quality of life was significantly 
affected by the process.  Those who had 
biopsy recommended were more about anal 
cancer; rated their anal health worse, were 
less optimistic about their future health than 
those who did not need further 
investigations.  The group receiving high 
grade histology results remained worried  
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 Ethical Approval of the Included Studies 
All twenty-six studies had ethics approval from their respective countries and states.  
Research on sensitive topics like HIV/AIDS is very challenging and researchers need to 
strictly follow ethical procedures and maintenance of anonymity and confidentiality are the 
key factors for encouraging participants to become involved in such sensitive research 
(Poudel et al, 2016).  Therefore, research ethics is the first and broadest objective to 
protect human participants, second is to ensure that research is conducted in a way that 
serves interests of individuals, groups and/or society as a whole, and thirdly the objective 
is to examine specific research activities and projects for their ethical soundness, i.e. 
looking at issues such as the management of risk, protection of confidentiality and the 
process of informed consent (Walton, 2016).   
Fifteen studies carried out in the USA sought approval from the Institutional Review Board 
of their respective states (Davis et al, 2013; D’Souza et al, 2008; Fenkl et al, 2015; Joshua 
et al, 2015; Reed et al, 2010; Truesdale & Goldstone, 2010;).  The study by Ferris et al 
(2013) was reviewed and approved by The Medical College of Georgia Human Assurance 
Committee in USA.  Three studies carried out in Miami were approved by the University of 
Miami Human Subjects Institutional Review Board (Blankenship et al, 2015; Blankenship 
et al, 2015; Koskan et al, 2016).  Four Australian studies obtained approval from the 
Human Research Ethics Committee of their respective hospitals, centers or clinics (Botes 
et al, 2011, Hillman et al 2011; Landstra et al, 2012; Pitts et al, 2007).  Tinmouth et al 
(2011) obtained approval from the Research Ethics Board at the University Health Network 
in Toronto, Canada and this study was conducted in accordance with the Declaration of 
Helsinki while Kaufman et al (2015), Moores et al (2015), Patel et al (2014) obtained 
approval from Ottawa Public Health’s Research Ethics Board.   
 
Six studies of clinicians and providers obtained approval from the Institutional Review 
Boards in their respective states in the USA (Colon-Lopez et al, 2016; Kwong et al, 2011; 
Ortiz et al, 2013; Patel et al, 2014; Scott et al, 2015; Sowah et al, 2015).  The Australian 
study obtained approval from the Alfred Health Human Ethics Committee (Ong et al, 
2015).  These studies have obtained ethical approval from their respective states and 
countries to protect participants and researchers.   
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 Design Methods and Measures of Included Studies 
Studies on Patients 
Fourteen quantitative studies used fully tested and validated tools.  Validated 
questionnaires used by Tinmouth et al (2010) in the psychological impact of being 
screened for anal cancer in HIV-Infected men who have sex with Men in Canada 
comprised of Impact of Events Scale, Illness Intrusiveness Ratings Scale, Psychological 
Questionnaire, Hospital Anxiety and Depression Scale and HIV Symptom Index.   Other 
validated questionnaires were an Anal Screening Questionnaire (which was created by 
modifying the Cervical Screening Questionnaire), Cancer Worry Scale, Distress 
Thermometer, Medical Outcomes Study Short Form Health Survey (MOS SF-12:  is a 
measure of health-related quality of life that is well validated in Australia) and Depression 
Anxiety Stress Scale was used in the study of the Psychological impact of anal cancer 
screening in men with HIV by Landstra et al (2012) in Australia. Blakenship et al (2015) 
used the visual analogue scale to assess knowledge, acceptability, perceptions, pain, 
discomfort and embarrassment during HRA among women.  Fenkl et al (2015) used the 
HPV anal cancer knowledge questionnaire (B-HPV/AC KQ) as a validated tool in their 
study.  Kwong et al (2011) used a validated patient satisfaction questionnaire adapted 
from colon cancer screening.  Patel et al (2014) used a web-based survey monkey tool in 
their study of environmental scan of anal cancer screening practices.  Data were analysed 
statistically and presented in the form of tables, graphs, numbers and percentages.  There 
were 6 cross-sectional studies, two prospective studies, 12 surveys, two evaluation 
studies, two cohort studies on anal cancer screening.   
 
Anal cancer screening studies produced many variables that were investigated with 
regards to patients. Ten quantitative studies and one qualitative study assessed 
knowledge, attitudes and willingness to have anal screening.  Two quantitative studies 
evaluated the screening procedures i.e. anal cytology and HRA (including biopsy).  Only 
two studies produced results on the psychosocial or psychological impact of anal 
screening (Tinmouth et al, 2010; Landstra et al, 2012).   
 
The only qualitative study used an interview guide of open-ended questions when  
conducting in-depth interviews which audio were recorded.  Demographic information and 
themes were in a table.  This study explored perceptions of anal cancer screening and 
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behaviours among gay and bisexual men infected with HIV.  The broad themes identified 
were, levels of knowledge, facilitators and barriers experience of anal cancer screening 
Studies on Clinicians 
Four quantitative studies by clinicians/providers undertook surveys (Kwong et al, 2011; 
Patel et al, 2014; Ortiz et al, 2013; Sowah et al, 2015), one cross-sectional analysis done 
by Colon-Lopez et al, 2016), one evaluation study by Scott et al (2015).  Validated 
questionnaires were used in the quantitative studies.  Kwong et al (2011) for example used 
a validated patient satisfaction questionnaire adapted it from colon cancer screening, while 
the provider used same principles, but descriptive analysis was used.  Data were analysed 
statistically using software for quantitative data analysis.  This was presented in counts, 
percentages, proportions and graphs.  Patel et al (2014) for instance exported data from 
web based surveymonkey (a web-based tool) and undertook descriptive analysis.   
 
One study assessed cancer screening practices worldwide (Patel et al, 2014) to include 
knowledge of procedure and attitudes towards screening algorithms and provider 
perceptions.  Other studies that assessed the knowledge component of anal cancer 
screening in providers/healthcare professionals included Ortiz et al (2013) and Colon-
Lopez et al (2016).  Scott et al (2008) and Sowah et al (2015) described the experiences 
and perceptions on anal cancer screening.  Kwong et al (2011) in their study describes the 
quality improvement initiatives to increase anal cancer screening in HIV speciality by 
healthcare professionals in the anal health program.   
 
Ong et al (2015) undertook a qualitative study and used semi-structured in-depth 
interviews.  This study explored the perspectives of HIV physicians on anal cancer and 
screening in HIV positive MSM.   
 Findings of Included Studies:  Emerging Themes of Anal Cancer Screening  
Having reviewed the 26 articles, it was apparent that there were key findings relating to  
anal cancer screening, which are discussed below, from patients and clinicians/provider’s 
perspective.  The main findings I identified in the review from studies of clinicians/providers 
were knowledge, acceptability, attitudes and willingness to screen for anal cancer; worry 
about anal cancer screening; sexuality and sexual functioning; the psychological impact of 
anal cancer screening, evaluation of anal cancer screening procedures; education on anal 
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cancer screening; barriers to anal cancer screening.  Although the results are limited it is 
not exhaustive.  Additional findings may be reflected in my findings on clinicians’ 
experiences and perceptions on anal cancer screening.  The following studies assesses 
the knowledge of anal cancer screening in providers/health care professionals (Ortiz et al, 
2013 & Colon-Lopez et al, 2016; Vera et al, 2013), while cancer screening practices 
reported worldwide by one study by Patel et al (2014) to include knowledge screening 
algorithms and provider perceptions.  Scott et al (2008) and Sowah et al (2015) describe 
the experiences and perceptions on anal cancer screening.  On the other hand, Kwong et 
al (2011) describes the experience of quality improvement initiative to increase anal 
cancer screening in the HIV speciality.   
2.4.6.1 Knowledge, Acceptability, Attitudes and Willingness to Screen for Anal 
Cancer  
In this section I will discuss studies on anal cancer screening where the main themes from 
the studies were knowledge, acceptability, attitudes and willingness to screen for anal 
cancer from patients and clinicians’ perspective.   
Patients’ Perceptions 
Most of the studies covered knowledge, acceptability, attitudes and willingness to have 
screening (Moores et al, 2015; Fenkl et al, 2015; Joshua et al, 2015; Ferris et al, 2013; 
Reed et al, 2010; Truesdale & Goldstone, 2010; D’Souza et al, 2008 & Pitts et al, 2007; 
Blakenship et al, 2015; Debnath et al, 2015; Kaufman et al, 2015).  While majority of the 
studies have knowledge, component included on anal cancer, the study on knowledge was 
first published by Pitts et al in 2007 who found that more than half the sample answered 
questions incorrectly and awareness of risk factors such as HPV, smoking and anal  
receptive partner was poor.  This was a sample of 384 MSM of which 6% were HIV 
positive and 47% in a relationship.  A paper questionnaire was distributed at a community 
gay event in Australia which assessed health service use, knowledge, attitudes and 
beliefs. They also found that higher knowledge on anal screening was found in those with 
a higher level of education while those who have received a sexual health screen in the 
past 12 months did not have better knowledge of anal cancer screening. In a recent study 
by Koskan (2016), exploring the perceptions of anal cancer screening and behaviours 
among gay and bisexual men infected with HIV, most participants had never heard of anal 
cancer or had the need to screen unless directly affected by anal cancer.  Some 
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participants confused anal cancer with prostate and colorectal cancer.  Those who heard 
of HPV infection learned this through advertisements for the HPV vaccine and many 
believed that HPV affected women only.  One participant sought medical attention after a 
year of experiencing hoarseness in his voice.  He was diagnosed with condylomas on his 
vocal chords which were HPV related non-cancerous growths.  Although this participant 
was aware that these growths were warts and HPV caused these warts, he believed that 
the HPV infection only caused cervical cancer as opposed to other types of cancers. 
 
Fenkl et al (2015) collected data from an educational event as part of a cruise vacation for 
HIV-Infected MSM where the analysis of this data revealed an overall increase in 
knowledge in HPV and anal cancer after the event.  Participants' who had higher levels of 
knowledge, or awareness of anal cancer screening, showed more willingness to be 
screened (D’Souza et al, 2008 & Reed et al, 2010).  In the study by Ferris et al (2013) of 
women’s knowledge of HPV, anal cancer and knowledge and attitudes toward the anal 
Pap test, only 17.6% of women had previously heard of anal Pap test, 48.9% knew 
nothing, while 38.5% knew only little about anal cancer.  While most women (78.6%) knew 
anal Pap, tests help to prevent cancer, 86.2% knew that anal Pap tests were for people 
who have anal sex, i.e. men who have sex with men.   Lack of knowledge about anal Pap 
tests, pain, discomfort, costs were the main reason cited in this paper. In the study by 
Debnath et al (2015), 55 HIV positive women were surveyed, 36% were not familiar with 
HRA and 64% reported limited knowledge on HRA.  This study demonstrated that patients 
anticipated greater pain and discomfort than they experienced during screening.  A survey 
was undertaken by Blakenship et al (2015) in women from an obstetrics and gynaecology 
urban university medical centre to understand HPV and level of interest in anal cytology  
screening. 508 women agreed to participate, 24% had never heard of HPV, 51% were not  
familiar with anal cytology, 67% acknowledged regular anal cytology screening would be 
helpful to diagnose early cancer and only 31% affirmed they were interested in anal 
cytology screening.  Of those women that were not interested in anal cytology screening, 
48% did not know enough about it and 34% believed it might hurt. Kaufman et al (2015) 
studied 150 women living with HIV where biannual HPV testing, cervical and anal cytology 
over 2 years were done.  59 women completed the acceptability questionnaire, 78% 
(46/59) considered routine anal cancer screening as an absolute necessity.  HRA was 
found to be more painful in 83% (49/59) participants.  Moores et al (2015) conducted a 
survey on 280 MSM and 55% were aware that MSM are more likely to develop anal 
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cancer compared to the general population.  Their source of information was from news 
media and STI pamphlets while 25% listed their primary care physician or another 
healthcare provider as their source of anal cancer knowledge.   Anal cytology was very 
acceptable yearly 77% (44/59) and every 2 years by 93% (54/59).  DRE was very 
acceptable yearly by 80% (45/59) and every two years by 93% (53/59).  Pain was the main 
reason for low acceptability.  
 
Most of the studies demonstrated knowledge of risk factors like HPV; smoking and 
receptive anal intercourse was poor due to lack of awareness of anal cancer.  Some 
studies demonstrated people with higher education level and those who have had anal 
cancer screening did not have knowledge on anal cancer.  Other studies demonstrated in 
this review, those who have never heard of anal cancer did not have the need to screen 
unless they had anal cancer.  These studies also highlight that participants confused anal 
cancer with prostate and colorectal cancer and some participants had the perception that 
HPV affected women only.  Those participants who never heard of HPV infection learnt 
through adverts.  Some studies in this review show that MSM were aware that they are 
more likely to develop anal cancer compared to the general population and their source of 
information were from news media, STI leaflets, primary care physicians or other 
healthcare providers.  Acceptability for anal cancer screening in some studies indicates 
that pain was the main reason for low acceptability including the anticipation of pain and 
discomfort during anal cancer screening.   
Clinicians’ Perceptions 
According to Ortiz et al (2013) the knowledge of medical students and physicians (34 
participants) on HPV and anal disease increased only after educational activity of 
participants while Colon-lopez et al (2016) suggests in their study that in anal cancer the 
number of years a participant is working with people living with HIV/Aids, the likelihood that 
this participant would have extensive knowledge increased significantly at least 10% per 
year.  In the study by Vera et al (2013), 73 clinics (62%) responded to survey of which 69 
(95%) provide care for HIV infected individuals with regards to knowledge of anal cancer 
risk factors.  67 (96%) of clinics responded that they were aware of the increased risk of 
HPV associated anal cancer in HIV-Infected individuals, and particularly HIV-Infected 
MSM.  In relation to the acceptability of anal screening process, clinicians anticipated that 
patients would experience less pain than reported therefore clinicians need to enhance 
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patient education, address patients concern regarding the anticipated pain and discomfort 
associated with HRA procedure (Debnath et al, 2015). These studies concluded that 
clinician’s knowledge only increased after an educational event while other clinicians 
gained extensive knowledge on anal cancer with working with patients living with HIV for 
several years.  These studies also highlight that acceptability of anal cancer screening will 
be successful if clinicians enhance patient education on anal cancer screening and anal 
cancer, address any concerns with regards to discomfort associated with HRA and 
anticipated pain.   
 
Participants willingness to participate in screening was investigated by five studies only 
(Joshua et al, 2015; Truesdale & Goldstone, 2010; D’Souza et al, 2008; Reed et al, 2010, 
Koskan et al, 2016) and being HIV infected was related to being more willing to screen 
(D’Souza et al, 2008 & Reed et al, 2010).  However, Reed et al (2010) mentioned that 
83% of men were more willing to screen if it was free and those with higher incomes were 
also willing to screen than those with lower incomes.  MSM with both low and high-grade 
lesions (LSIL and HSIL) returned for screening after 1 year.  This study found that having 
more sexual partners led to greater return for screening (Truesdale & Goldstone, 2010).  
Also, factors investigated in this study led to 12 % of MSM not returning for anal Pap 
smear as it was ‘too painful to make it worthwhile’ to screen.  In the study by Koskan 
(2016), patients were willing to screen and prevent disease if prompted by a health  
professional this is often their physician.  These studies demonstrate that willingness to 
screen was related to being HIV positive, those with higher incomes than lower incomes or 
if screening was free for men, having LSIL and HSIL, multiple sexual partners and those 
encouraged by a health professional. 
2.4.6.2 Worry about Anal Cancer Screening 
Participants had a variety of worries related to knowledge of anal cancer and willingness to 
screen in three studies (D’Souza et al, 2008; Reed et al, 2010; Truesdale & Goldstone, 
2010).  According to Truesdale & Goldstone (2010), when participants learned that they 
had HPV, they were upset and worried therefore, three times more likely to have regular 
follow up than be lost to follow up.   When participants perceived a higher likelihood of 
getting anal cancer or having a worry about anal cancer, they were more willing to have 
screening.  Strong motivators for the regular follow up group reported that if they had 
physical symptoms, they were 10 times more likely to return for screening after being lost 
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to follow up as they were worried.  Worry about the severity of diagnosis was also a factor 
and to compliance for screening increased.  Participants with HSIL in the regular follow up 
group were four times likely to return for screening than those with LSIL as being 
diagnosed with HSIL created worry in these patients (Truesdale & Goldstone, 2010).  
D’Souza et al (2008) mentioned in their study that HIV infected men who were worried had 
a greater or higher concern about anal cancer than those with anal warts in last 6 months 
or ever.   When men were concerned about the accuracy of the test, or were embarrassed 
about asking for a pap test, willingness to have screening was lower (Reed et al, 2010).   
Conversely, Moores et al (2015) have cited that of the 280 participants that took part in the 
survey, almost half of the respondents were unaware they were at increased risk of 
developing anal cancer which partially explains why they do not approach the subject with 
their primary care physicians. Thus, these studies concluded that participants’ who worry 
about anal cancer is linked to willingness and knowledge to screen mainly when symptoms 
return, but equally participants that were unaware of the risks of developing anal cancer do 
not approach their physicians.   
 
Only two studies (Landstra et al, 2012 & Tinmouth et al, 2011) have investigated the 
psychological impact of anal cancer screening process longitudinally.  Both studies have 
been prospective studies where as the study by Landstra et al (2011) used three time 
points of screening over a 3-month period and study by Tinmouth et al (2011) used four 
points over 6 months.  In the study by Tinmouth (2011) the swab and HRA was done at 
the same time and participants had a one timeframe to wait for both results and in contrast 
the study by Landstra et al (2012) demonstrated a two-stage screening process where 
results of swabs determined if participants were recalled for HRA.  This meant that some 
participants had to wait and return for results.  There was no general impact on 
psychological health, i.e. depression, anxiety, effects on stress or quality of life (Tinmouth 
et al, 2011; Landstra et al, 2012).  Those with AIN grade 2&3 were no more impacted than 
others (Tinmouth et al, 2011) but in contrast participants referred for HRA led to higher 
worry and those with HGAIN or AIN (2&3) continued to be worried (Landstra et al, 2012).  
Waiting for results to be given has the most negative impact on participants (Tinmouth et 
al, 2011) while waiting for further investigation by HRA was the time of most impact 
(Landstra et al, 2012).   
 
62 
 
Participants who received negative results from the HRA were more optimistic about their 
future health than those who did not need HRA (Landstra et al, 2012).  Tinmouth et al 
(2011) describes characteristics that were predictive of worry were being younger, living 
with more HIV symptoms and greater baseline psychological distress.  It is evident from 
both these studies that there is some psychological impact in anal cancer screening with 
increase worry and concern.   
2.4.6.3 Sexuality and Sexual Functioning 
Two studies (Truesdale & Goldstone, 2010; Landstra et al, 2012) explored some aspects 
of sexuality and investigated sexual function or beliefs.  Patients who attended for regular 
follow up were up to two times more likely to agree that if they found out they had HPV it 
made them feel promiscuous (Truesdale & Goldstone, 2010).  Higher levels of sexual 
activity in this study was associated with improved compliance to screen for anal cancer 
and this could have resulted from an increased knowledge or a general awareness of 
sexually transmitted infections and harm reduction that leads to protected sex and a 
willingness to adhere to provider directed guidelines.  The most compelling findings of the 
study by Truesdale & Goldstone (2010) is that the factors contributing to emotional upset 
such as severity of diagnosis, physical symptoms and feelings of promiscuity increased 
compliance for screening.  
 
In the study by Landstra et al (2012) participants who were recalled for further  
Investigation after anal cancer screening, rated their anal health lower than those who did 
not need further investigation. This was based on cytology and histology results where  
three groups were formed i.e. low ‘threat group’, the ‘reassured’ or ‘false’ positive group 
and the ‘high threat’ group.  The ‘low threat’ group received negative results or LSIL.   The 
two groups in this study which was the ‘reassured’ or ‘false’ positive group required HRA, 
and where a either a biopsy was not needed or had reassuring histology results which was 
negative, warts or inflammation.  On the hand the ‘high threat’ group needed HRA and 
received HGAIN histology results (Landstra et al, 2012).  This study shows that anal health 
was rated worse in the HRA group.  These studies demonstrate that sexual function or 
beliefs were influenced by having HPV and those participants who rated their anal health 
low participated in anal screening and attended regular follow up.   
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2.4.6.4 Evaluation of Screening Procedures 
Patients Perspective 
Evaluation of anal screening procedures was conducted by Botes et al (2011) where 291 
HIV positive between October 2008 and January 2009 were recruited into the study.  This 
study directly investigated the acceptability of self-collected swabs.  Participants took a 
self-collected anal cytology sample using a moisten Dacron swab.  The findings of the 
study indicated that 139 (52.9%) of men found it easy to do self-collected swab, 213 (81%) 
as a highly acceptable procedure, 172 (65.4%) reported no pain and 219 (83.3%) reported 
no bleeding.  A study by Hillman et al (2011) evaluated participants’ perspectives on high 
resolution anoscopy.  105 MSM were given the questionnaire and only 70 participants 
returned the evaluation forms.  75% of the participants found HRA acceptable while 3.8% 
needed paracetamol analgesia and 11.4% reported slight bleeding for less than a week.  
Participants’ also indicated the value of effective communication before and during the 
procedure.  The data from this study suggests that most participants found HRA 
acceptable with a few complications.  However, acceptability of HRA was strongly 
correlated with pain and bleeding during and after the procedure.  This Australian study 
demonstrated that although HRA was an acceptable procedure, new methods to improve 
participant experience are required (Hillman et al, 2011).  A study on tolerability of anal 
dysplasia screening by Davis et al, (2013) investigated anal HPV infection and HPV 
related disease in MSM.  296 patients enrolled in this study which was a 2-visit screening 
study.  During the first visit, anal cytology was taken using a swab while HPV testing was 
taken either with a brush or swab, followed by digital rectal examination and standard 
anoscopy.  At the second visit patients had repeated HPV samples taken with HRA and 
biopsy taken where indicated.  The results of visit 1 showed that standard anoscopy 
caused most discomfort while at visit 2 less discomfort was reported.  Patients who 
reported that discomfort at visit 1 would prevent them from having the procedures again 
returned for visit 2.  The overall conclusions on screening procedures for anal HPV related 
disease were well tolerated and did not reduce patient compliance (Davis et al, 2013).  
These studies evaluated anal cytology and HRA and both procedures were acceptable 
and tolerable for participants although the Australian study demonstrated initial HRA 
caused most discomfort and the subsequent HRA caused less discomfort as experienced 
by participants.   
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Providers and Clinicians’ Perspective 
Three studies provided evidence regarding providers’ and clinicians’ perspective on anal 
screening procedures.  Vera et al (2013) surveyed clinics that offer anal screening and 
found that only 4 (5%) clinics routinely offered anal screening for HIV positive individuals.  
However, one of the 4 clinics also screens HIV positive heterosexuals with a history of 
multi-centric HPV disease as well as HIV negative MSM.  While the 4 clinics use DARE 
and anal cytology for routine screening, only 3 clinics have a dedicated HRA clinic.  In the 
study by Sowah et al (2015) 24 providers responded to the survey and 13 (54.2%) 
performed anal smear on their patients.  Interestingly female providers were 11.7 times 
more likely to have performed this procedure compared to male providers as gender 
congruence of physicians and patients especially about intimate procedures and issues 
may be responsible for this observed difference. This study also highlighted that provider 
self-rated comfort in performing anal Pap tests were higher for female providers than male 
providers.  Female providers had more years of experience caring for HIV-infected 
patients in their Urban HIV practice.  Majority of the respondents in this study believed that 
anal cytology screening is important for their practice and recognised the current lack of 
screening as a gap in care.  Patel et al (2014) described the current practices globally on 
anal cancer screening and just one half of the clinics that responded required patients to 
have abnormal anal cytology to proceed to HRA.  Furthermore, this study mentions that  
two thirds of clinics offered HPV testing, including treatment for AIN, suggesting a lack of 
consensus about the best treatment strategy or difference in respondent expertise and 
access to necessary equipment.  These studies provide evidence on the varying practices 
around the world and the gaps in screening procedures globally.   
2.4.6.5 Education of Clinicians and Patients on Anal Cancer Screening     
Landstra et al (2012) in their study mentions that it is important to consider the clinical 
implications of anal screening and given the lack of or low knowledge identified in the 
studies with MSM’s and that of women, therefore, target campaigns should be aimed at 
the risk factors associated with anal cancer and the need for screening.  The most 
common point for sexual health screening and anal cancer screening are primary during 
visits to their physicians where they can encourage screening and educational efforts.  
These physicians should be prepared to counsel patients; be familiar with services in their 
local communities and explain the pros and cons of screening (D’Souza et al, 2008).  
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Moores et al (2015) study results across Canada provide evidence for the need of primary 
care physicians and other healthcare workers working with MSM to discuss anal cancer 
aetiology, prevention and screening options for this population. Fenkl et al (2015) suggests 
from their program evaluation that education awareness programs such as “Happy  
Hiney Health” may be a strategy for encouraging individuals at high risk for anal cancer to 
discuss screening options with their healthcare providers.  Furthermore, these authors 
believe an important step in developing a comprehensive education and awareness should 
be targeted to the HIV-Infected MSM and members of the healthcare team play a vital role 
in the dissemination of research to support initiatives aimed at HPV, anal cancer 
awareness and the need for cancer screening in all MSM, in particular, the HIV- infected 
MSM. 
 
 In the study by Koskan et al (2016), participants (58 MSM infected with HIV) gave 
feedback on the best ways to increase awareness among men infected with HIV with 
regards to the need to screen for anal dysplasia.  Participants suggested interpersonal 
health education methods to increase anal cancer awareness and how a one to one 
discussion after their interviews about HPV infection and anal cancer was the best way to 
teach HIV infected men about anal dysplasia screening.  Some participants recommended 
working with HIV/AIDS specialists and case managers to ensure that they discuss anal 
cancer, with their patients and recommend screening.  Other participants recommended a 
screening check list to use during their primary care visits as this would empower 
participants with the information, they require to make an informed conversation about 
screenings they need with their physician.  Other recommendations suggested by 
participants in this study included training local leaders and health care advocates to 
disseminate information; the creation of print media such as educational brochures, 
running health education messages in newspapers and magazines for HIV infected 
population and using posters to increase community awareness about anal cancer; 
specifically a recommendation was to leave educational brochures in the HIV primary care 
clinic waiting room as well as examinations rooms for patients to read; posting of 
informational fliers at bus stops and on buses to reach individuals that use public transport 
(Koskan et al, 2016).  The study by Ferris et al (2013) determined that a clear 
understanding of the reason for a screening test and targeted population facilitate 
acceptance and compliance to screening and given the nature of the screening test most 
women will be willing to have an anal Pap test if recommended by their physician.  Patient 
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education and cooperation as cited in this study, clinical skill and gentle technique can 
reduce severe discomfort for most individuals.  The findings in the study by Blankenship et 
al (2015), is that medical providers have an opportunity to educate women; regular 
gynaecologic encounters provide an opportunity for medical providers to capture at risk 
women and engage in discussions about anal cytology screening when discussing cervical 
cancer screening and HPV testing. 
 
These studies provide tangible evidence on how important education on anal cancer is 
and to consider the clinical implications of anal cancer screening, given the lack of or low 
knowledge identified on anal cancer.  These studies also suggest that the point of 
screening should be with physicians, it is important to target campaigns about risks of anal 
cancer, that education awareness programs may be a strategy and those members of the 
healthcare team play a vital role on disseminating research support initiatives.   
2.4.6.6 Barriers to Anal Screening of Patients and Clinicians 
Scott et al (2008) highlights barriers to incorporating a cancer screening program into 
routine clinical care.  Of the 74 patients who were identified with cytologic evidence of anal 
dysplasia, only 27 received HRA, and only 9 patients with visible lesions on anoscopy had 
biopsy. It was even more difficult to ensure adherence to surgical anoscopy and biopsy 
including follow up.  The barriers to surgical intervention in this study included patient 
centred difficulties such as perceived intolerability of anoscopy procedure, fear of cancer 
diagnosis, and difficulties with maintaining clinic appointments.  Another barrier identified 
includes substantial physician training and resources needed for anoscopy related 
activities.  Even in a group of physicians who were motivated to do anal screening 
program in this study, highlights the fact that there are difficulties and time involved in 
ensuring that everyone is appropriately trained.  Ong et al (2015) identified barriers on 
DARE at 3 levels in routine clinical care.  Firstly, systemic barriers included lack of 
opportunity to undertake DARE, unclear referral pathway, differences in HIV care practices 
and no financial incentives.  Secondly health provider barriers were the lack of evidence, 
difficulty in discussing DARE with patients and lack of confidence in doing DARE.  Thirdly 
patient factors covered DARE as a procedure that causes discomfort and low anal cancer 
awareness.  The barriers identified by Patel et al (2014) on their worldwide survey 
demonstrate a considerable variation in cancer screening practices.  This survey was sent 
to 82 providers from 80 clinics in Canada, USA, Europe (UK, Italy, and Spain), Asia, and 
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Australia and 80 clinics responded to the survey.  The findings of this study highlighted 
that there seems to be no universal consensus on optimal strategies for anal cancer 
screening, treatment and follow up and this is due to a lack of prospective controlled 
studies or well-designed observational studies.   
 
The barriers identified in these studies indicate that patients perceived intolerability, pain 
and fear of a cancer diagnosis as some of the barriers while clinicians’ barriers include 
lack of training and resources for an HRA service and lack of studies and no universal 
consensus on optimal screening strategies for anal cancer.   
 Limitations of Included Studies  
The included studies have identified limitations in their studies which is summarised in this 
section.  Most of these studies on patients were completed in gay men and only 2 studies 
(Ferris et al, 2013; Blakenship et al, 2015) included women from the general population.  
At-risk populations like women with HIV or prior HPV related cervical disease and 
immunosuppressed transplant recipients were not included (Landstra et al, 2012). This 
shows that there are studies conducted on gay men, but women need to be more included  
especially those women with other immunosuppression conditions.   Most participants in 
the study by Pitts et al (2007) were well educated and caucasian and in some studies, 
most participants had private health insurance which does not reflect the characteristics of 
MSM or the HIV infected population.  Furthermore, participants were voluntary, or 
convenience samples therefore may have skewed the results towards participants who 
were more interested, knowledgeable or connected to the gay community (Pitts et al, 
2007).  Data from the study by Koskan et al (2016) come from a convenience sample of 
men infected with HIV in primary care clinics who were adherent to antiretroviral therapy 
and therefore generalisations to other HIV infected individuals should be made with 
caution. Furthermore, the study interviews were not conducted in the Spanish language 
and seen as limitation. This indicates that generalising results to HIV infected people is not 
feasible to individuals not in HIV treatment and the population for the study were Spanish 
speaking people who did not have their interviews in their spoken language but English 
instead which shows some bias too.  The study by Reed et al (2010) used hypothetical 
statements which could have failed to anticipate any barriers to screening while D’Souza 
et al (2011) did not address independently the availability of screening therefore the lower 
perceived screening availability may not have reflected the actual availability of screening 
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programs.  Finally, these two longitudinal studies used different time points and medical 
procedures and swab collection which made comparison difficult (D’Souza et al, 2011 & 
Reed et al, 2010).  Most of these studies were done in America except for the longitudinal 
studies:  one in Canada (Tinmouth et al, 2011) and the other 2 studies in Australia (Botes 
et al, 2011 & Hillman et al, 2011).  
 
 In the study by Botes et al (2011) a range of perspectives were investigated e.g. 
acceptability, ease and potential hurts (i.e. pain and discomfort for example), but the 
weakness of this study was that a question asking about willingness to repeat the anal 
cytology swabs was not included.  If this study addressed willingness to repeat anal 
cytology, the authors of this study would have been able to assess if repeat tests were 
acceptable, less painful, and experience of less discomfort as they would be more 
prepared for procedure.   On the other hand, Hillman et al (2011) used anonymous take 
home questionnaires to maximise the validity of responses which meant they were unable 
to investigate the relationship between demographic data and acceptability.  Another 
weakness of this study was the failure to include a question on willingness to undergo 
repeat HRA.  This is to compare acceptability and tolerability of first HRA to subsequent 
HRA.  The study by Davis et al (2013) was that it was confined to a single practice where 
all procedures were performed by an experienced clinician on the MSM population 
although this study represented one of the largest sample sizes for tolerability and 
compliance with anal cancer screening.  To validate these findings Davis et al (2013) 
suggests that data from further follow up and repeated screening on more diverse 
populations with other clinicians must be collected.  This is to encourage clinicians to do 
more research on other populations like women, immunosuppressed transplant recipients 
to show how tolerability of anal cancer screening is reflected in other anal cancer 
screening practices/clinics.   
 
The limitations of studies on clinicians/health care providers/physicians, varies according 
to the country in which the study was undertaken.  This is a unique presentation of 
limitations as it shows differences in practices in anal screening and will be discussed 
below.   Ong et al (2015) mentions that in the current Australian practice of offering anal 
cancer screening which is virtually conducted in a research setting.  Another limitation 
meant that the vast majority of physicians interviewed were not participating in any anal 
cancer screening which influenced the tone of the study with multiple barriers identified.  
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Similarly, Patel et al (2014) states that the response rate to the study appears low but this 
is likely to reflect that the recruitment strategy includes a high proportion of persons who 
did not perform HRA.  Scott et al (2008) in their study highlight the fact that even in a 
group of physicians who are motivated to do anal screening program, there were 
difficulties and time involved in ensuring that everyone was appropriately trained.  Ortiz et 
al (2013) study’s limitation is that the results may have affected by selection bias as 32% 
of the activity’s participants did not answer the survey.   
 
Lastly, four studies discuss the generalisability of their studies and their limitations.  This 
shows how anal screening is different in whichever country or state research is being 
undertaken.  The sampling method in an under sampling of men who see the primary care 
physician directly for STI screening and oversampling of MSM who are more open about 
their sexual orientation, show that these results are not generalizable to all MSM (Moores 
et al, 2015).  Thus, limits the ability to determine casual relationships between attitudes, 
knowledge, interventions and anal cancer.  Sowah et al (2015) demonstrates that the 
study was relatively small as 55.3% of the 47 HIV providers in a large urban academic 
institution and may not be generalizable to all HIV providers.  In this case the suggestion is 
to include all anal cancer screening practices to be able to generalise results about HIV 
providers.  The results of the study by Colon-Lopez (2016) cannot be generalizable to 
entire populations of health care professionals working with HIV individuals as this is 
attributed to knowledge and experience of healthcare professionals working with people 
living with HIV.  Training regarding the pathogenesis of anal cancer is necessary for 
healthcare professionals, plus the information on the frequency of these services offered to 
people living with HIV and Aids was not assessed.  Although, according to Kwong et al 
(2011), the provider satisfaction survey was anonymous, the potential for biased 
responses existed as respondents were colleagues of the primary author and may have 
felt the need to rate services more favourably.  Additionally, some respondents were 
involved in the overall conception and design of the anal health program so there was a 
potential for investigator allegiance.   
 Conclusions from Reviewed Papers 
Anal screening does appear to increase health related worry about the procedure but does 
not have a general impact on mental health.  Anal cancer screening is not yet well 
established therefore there is an opportunity for producing evidence on the psychological 
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effects of screening which is the rationale or basis for my study.  So far, these studies do 
not suggest acute or significant clinical levels of mental health problems as the result of 
screening.  There were some individuals that experienced some psychological and 
physical impact but the variation in that individual experience suggests that having worse 
anal or HIV symptoms, being younger, and worry about anal cancer involved repetitive 
thoughts to screening and the possibility of having anal cancer.  Low willingness to screen 
was due to factors like poor knowledge of anal cancer, Pap testing and other risk factors 
like HPV. Clinicians have identified that there are varying practices on anal screening 
worldwide, that there are no universal optimal screening strategies for anal cancer 
screening; there is a lack of clinician training and resources available to set up an HRA 
service.   
 
The next chapter discusses the methodology of my study, an overview of my research 
approach, stake holder engagement, ethical considerations, sampling process, data 
collection, reliability, validity and trustworthiness of my study.   
3 Methodology 
The overall aim of my study is to explore perceptions and experiences of patients and 
clinicians in anal cancer screening to help inform clinical practice for anal screening in 
sexual health clinics in the UK.  While justifying the methodology for my study I had to 
examine the philosophical underpinnings in the choice of research methodology for 
hermeneutic phenomenology.  It was important from my point of view to understand the 
meanings of these realms in the context of the research to be done i.e., epistemology, 
ontology and methodology and how this fitted into my study.  Here again I sought to 
understand the meanings of these terms before applying it to the research methodology 
chapter.  
 
3.1 My Research Approach 
The goal of my research was to understand the perceptions and experiences of patients 
and clinicians in anal cancer screening.  The focus of my study was on an interpretive 
meaning and I chose Hermeneutic phenomenology a theory and methodology of 
interpretation; it is the art of understanding and of making oneself understood as a suitable 
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approach which is informed by Heidegger.  Heidegger developed interpretive 
phenomenology by extending hermeneutics, the philosophy of interpretation (Reiners, 
2012).  The interpretive paradigm was viewed suitable for my research because it has 
potential to generate new understandings based on the premises that reduction is 
impossible and the acceptance of endless interpretations of each participant’s experience.  
According to Kafle (2011) this is an effort to get beneath the subjective experience and find 
the genuine objective nature of the things as realized by an individual.  I was seeking 
practical knowledge which according to Ajjawi & Higgs (2007) interactions is embedded in 
the world of meanings and human beings therefore it was appropriate for me to investigate 
this phenomenon within the interpretive paradigm.  The usefulness of Heidegger’s 
philosophy for nursing research has the potential to provide a framework for investigating 
the meaning of individual’s experiences with in the context of their lives (Johnson, 2000).  
Heidegger believed that humans are hermeneutic (interpretive) being capable of finding 
significance and meaning in their own lives and believed context was a central concern 
(Draucker, 1999).  Heideggerian phenomenology is based on the perspective that 
understanding of individuals cannot occur in isolation of their culture, social context, 
historical period in which they live (Kumar, 2012; Draucker, 1999; Geanellos, 1998; 
Orbanic, 1999).   
 
Hermeneutic phenomenology was an appropriate methodology for me to investigate the 
perceptions and experiences of patients and clinicians in anal cancer screening as it is 
congruent with the aim of exploring the perceptions and experiences of participants of anal 
cancer screening.  It also allows for an added layer of abstraction and interpretation 
through my lenses as a researcher taking into account, my professional knowledge and 
the research objectives set out in my study.  Using this interpretive paradigm will enable 
me to gain a deeper understanding of the perceptions and experiences of participants as a 
lived experience.  Although using this approach may add to the body of knowledge of anal 
cancer screening, through its reflexive nature it will enable me to engage in my own 
learning journey towards exploring the perceptions and experiences of patients and 
clinicians in anal screening to gain a deeper understanding as well as create meaning to 
the phenomenon I am researching. 
 
Although hermeneutic phenomenology like descriptive phenomenology is concerned with 
the lived experience (Wilson & Hutchinson, 1991), Laverty (2003) highlights and discusses 
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the differences with exploration of a lived experience between the philosophers.  Husserl 
focused on understanding of beings or phenomena while Heidegger focussed on ‘Dasein’ 
which means the ‘mode of human being’ or ‘the situated meaning of a human in the world’ 
(Laverty, 2003). I used hermeneutic phenomenology to emphasise that individuals cannot 
abstract or withdraw themselves from various contexts as this influences their choices and 
meaning of their lived experience.  Therefore, Heidegger’s phenomenology attempts to 
address the situatedness of individuals “Dasein” to a broader social, political and cultural 
context (Campbell, 2001).  According to Mackey (2005), our understandings and 
interpretations reveal the world we live in and are the fundamental features of what 
Heidegger terms as Dasein, our being in the world, therefore our experiences must be 
addressed through interpretation (hermeneutics).    
 
Furthermore, specifically Johnson (2000) cites that meaning emerges because of the 
unitary relation between human beings and other things or people which is only possible 
because of the unique structure of being human.  Through this understanding, Heidegger 
believes a person’s history and background is important for understanding the world 
therefore, described the view that people cannot be made explicit as it is related in cultural, 
social and historical contexts (Munhall, 1989).  Johnson (2000) believes that Heidegger 
gives a phenomenological researcher a different understanding of how a human being is 
‘structured’, and the origin of the meaning as provided by Husserl’s philosophy whereas 
Heidegger asserts that present things get their meaning out of future purpose.  While 
people living with HIV and clinicians are situated on the assumption of a preunderstanding 
or as Heidegger called it a “fore-structure of understanding” of an experience or situation 
(Kumar, 2012).  The interpreting of something as something, or the making explicit of 
something that is understood, is in turn achieved on the basis structure, the structure that 
Heidegger calls “fore-structure” (Leung, 2011).  Fore-structure of understanding consists  
of all individuals who have come to a situation with practical familiarity or background 
practices from their own world that makes interpretation possible (fore-having); the 
sociocultural background gives a point of view from which to make an interpretation (for-
sight); and sociocultural background provide a basis for anticipation of what might be 
found in an investigation (fore-conception).  I felt that having fore-structure of 
understanding as alluded to by Kumar (2012) would give me a clear understanding to  
reflect on my experience with individuals undergoing anal cancer screening, living with HIV 
and who have complex needs.  
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There are apparent distinctions between descriptive phenomenology and hermeneutic 
phenomenology.  In Laverty (2003) phenomenological research is described as descriptive 
and focuses on the structure of experience, the organisation of principles that give form 
and meaning to the life world whereas hermeneutic research is interpretive and 
concentrates on the historical meanings of experience and their developmental as well as 
the cumulative effects it has on the individual and social levels.  In light of these two 
traditions and descriptions of their philosophical underpinnings I questioned their use in 
research methodologies by comparing them to see how it fits with my study.  The use of a 
philosophy in methodology requires the ability to be reflective, insightful; sensitive to 
language and constantly open to experience (van Manen, 1997).  When a methodology is 
used, it needs to follow from and reflect the philosophy chosen throughout the project 
(Osborne, 1994).  In Husserlian philosophy the main features are predominantly 
descriptive phenomenology where the aim is to describe the ‘things in their appearing’ 
(Langdridge, 2007: 86).  For Heidegger being-in-the-world is coloured and shaped by our 
always, already, being in a situation so that the historical and dispositional context of any 
lived experience is integral to being there, experiencing it (Dreyfus, 1991).  
 
Philosophical concepts like ontology, epistemology, axiology and methodology are 
considered in my study as it helped me to determine how I undertook my research 
activities.  The ontological perspective of my study focuses on revealing meanings of 
patients’ and clinicians’ perceptions and experiences on anal cancer screening rather than 
developing an abstract theory or arguing a point.  The first concept ontology is the form 
and nature of reality and what can be known about it (Lincoln & Guba, 1995).  This in 
effect is concerned with reality as perceived by the participants in my study.  The reality 
can be external to individuals or produced by the individuals’ consciousness (Cohen et al, 
2000).    
 
Secondly, epistemology is described as the nature of the relationship between the knower 
and what can be known; it refers to knowledge and the notion that the research work is 
supposed to contribute to knowledge itself (Kafle, 2011), while Hartley (2006) explains 
epistemology as a process through which the researcher makes a knowledge claim.  The 
participants in my study have subjective experiences and insights about anal screening 
and this will be transformed into knowledge to contribute, to what is known and what can 
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be known about their experiences and perceptions of anal screening.  As a philosophy of 
knowledge applied to hermeneutic phenomenology the epistemology is grounded on the 
belief that knowledge is possible through subjective experience and insights (Kafle, 2011).   
 
While ontology and epistemology deals with truth, the third concept axiology is about 
values and ethics (Mingers, 2003).  Values in axiology provide the standard for evaluation 
of epistemological and ontological claims and are also called value theory where the 
disciplines of ethics, pragmatics and aesthetics are included (Kafle, 2011).  In axiology, my 
values and opinions are considered for generation of knowledge produced in my study.  
With this connection, hermeneutic phenomenology aligns itself with the idea of practical 
form of knowledge generation that goes beyond enumeration of mathematical properties.  
The practical form of knowledge is generated through interviews with participants, eliciting 
knowledge from their subjective experience of anal cancer screening and interpreting their 
views and in turn I consider what is known about the truth, consider my values, ethical 
considerations and opinions I must generate and produce information on anal cancer 
screening.   
 
The fourth concept methodology is a principle I used to uncover how I was going to gain a 
better understanding of the perceptions and experiences of patients and clinicians in anal 
screening which was an engaging process for me.   Methodology as a paradigm is about 
how the inquirer can go about finding whatever they believe can be known which is 
essential in critiquing and conducting research (Kafle, 2011).  In simple terms Carter & 
Little (2007) mentions that methodology justifies method which in turn produces data and 
analyses; knowledge is created from data and analysis while epistemology modifies 
methodology and justifies the knowledge produced.   
 
I have provided a diagrammatic illustration (figure 5) below adapted from Ajjawi and Higgs 
(2007) for my research approach as I found it helpful in guiding me through the 
methodology chapter in view of my challenging but interesting journey.  Figure 5 provides 
an overview of the paradigm, methodology, data collection methods and stages of data 
analysis for my study.  The paradigm I use is interpretive, as the aim of my research is to 
explore and understand participants’ perceptions and experiences in anal cancer 
screening.  The methodology I use in my study is hermeneutic phenomenology where 
ethics clearance was obtained, consent sought from participants and information provided 
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to participants.  Data were collected using a reflexive preparatory phase (consideration of 
interviewing room and recording equipment, reflexive diary, trigger questions) followed by 
participant interviews.  The stages of data analysis included immersion, understanding, 
abstraction and synthesis of data.  According to Ajjawi & Higgs (2007), the interpretive 
paradigm fits with the philosophy, methodology and strategies used to gather data and 
deriving meaning from the data to underpin the quality in interpretive research, rigour 
(Lincoln & Cuba, 2000) and credibility (Denzin & Lincoln, 2000).  
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Figure 5: Overview of research approach adopted in this research 
 
 
 
 
 
 
        
 
 
 
Methodology 
 
 
 
(Adapted from Ajjawi & Higgs, 2007) 
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1. Immersion 
2. Understanding 
3. Abstraction 
4. Synthesis 
5. Illumination and Illustration 
6. Integration and Critique 
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 Key Distinctions in Descriptive Phenomenology and Hermeneutic 
Phenomenology 
Understanding the different types of phenomenology helped me strengthen my research 
approach.  The fundamental features of descriptive phenomenology and hermeneutic 
phenomenology both emphasise the lived experience. In Husserlian philosophy the main 
features are predominantly descriptive phenomenology where the aim is to describe the 
‘things in their appearing’ (Langdridge, 2007: 86).  Husserl developed descriptive 
phenomenology, where every day conscious experiences were described while 
preconceived opinions were set aside or bracketed (Reiners, 2012).  Heidegger, who was 
interested in interpreting and describing human experience, believed that bracketing was 
not warranted because hermeneutics presumed prior understanding (Reiners, 2012).  For 
Heidegger being-in-the-world is coloured and shaped by our always, already, being in a 
situation so that the historical and dispositional context of any lived experience is integral 
to being there, experiencing it (Dreyfus, 1991). Heidegger was concerned with the 
ontological question of the meaning of being, whereas Husserl’s phenomenology 
addressed the epistemological problem of how we can know and describe human 
experience (Zahavi, 2003).   
 
However, the methodological issues that I identified were in the apparent distinctions 
between descriptive phenomenology and hermeneutic phenomenology.  To add rigour to 
my chosen methodology, I have provided an overview of the differences in descriptive and 
hermeneutic phenomenology to strengthen my chosen methodology, hermeneutic 
phenomenology.  In Laverty (2003) phenomenological research is descriptive and focuses 
on the structure of experience, the organisation of principles that give form and meaning to 
the life world whereas hermeneutic research is interpretive and concentrates on the 
historical meanings of experience and their developmental as well as the cumulative 
effects it has on the individual and at social levels.  In light of these two traditions and 
descriptions of their philosophical underpinnings, the use of methodology according to van 
Manen (1997) requires the ability to be reflective, insightful; sensitive to language and 
constantly open to experience. When a methodology is used it needs to follow from and 
reflect the philosophy chosen throughout the project to be able to meet the aims of the 
study (Osborne, 1994).  Heidegger (hermeneutic phenomenology) was concerned with the  
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ontological question of what things are and the meaning of being, whereas Husserl’s 
phenomenology (Descriptive phenomenology) addressed the epistemological problem, of 
how we can know, and describe human experience (Dahlberg et al, 2008; Reiners, 2012; 
Zahavi, 2003). In this section I have outlined how Heidegger’s structural meaning of 
‘Dasein’, a concept which is an important feature to the interpretations of the clinicians and 
patients’ perceptions and experiences which denotes being-in-the-world and their real 
lived experience of anal cancer screening.    
 
In the preceding section, descriptive and hermeneutic phenomenology approaches are 
described in Table 3 below.  Both the approaches are useful for guiding inquiries of 
interest to holistic nursing science (Wojnar & Kristen, 2007).  The differences in the 
descriptive and interpretive approach by Koch (1995), cited by Wojnar & Kristen (2007) 
provides a summary between the two approaches (Table 3).  In descriptive approach the 
emphasis is on describing universal essences whereas the interpretive approach is about 
understanding the phenomena in context.  Bracketing is a key feature of descriptive 
phenomenology where the researcher ensures that interpretation is free bias (Dahlberg et 
al, 2008).  In interpretive phenomenology understanding and co creation by the researcher 
and participants are what makes interpretations meaningful (Lopez, 2004).  Those who 
tend to seek similarities in human experiences, look for patterns, seek universals and aim 
at finding solutions may be suited to a more descriptive mind set where as those who tend 
to relish nuances, appreciate differences, embrace ambiguity, and seek uniqueness in a 
contextualise lived experience may be more given to an interpretive mind set (Wojnar & 
Kristen, 2007). My study is hermeneutic (interpretive) phenomenology and presents the 
uniqueness of the perceptions and lived experiences of patients and clinicians in anal 
cancer screening in sexual health clinics in the UK.   
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Table 3:  Key Distinctions in descriptive (Husserl) and interpretive (Heidegger) 
phenomenology (Koch, 1995, adapted from Wojnar & Kristen, 2007) 
Descriptive Approach Interpretive Approach 
1. The emphasis is on describing     
     universal essences  
1. The emphasis is on understanding the 
     phenomena in context 
2. Viewing a person as one  
    representative of the world in which  
    he or she lives 
2. Viewing a person as self-interpretive  
     being 
3. A belief that the consciousness is  
    what humans share 
3. A belief that the contexts of culture,   
    practice and language are what  
    humans share 
4. Self-reflection and conscious”  
    stripping” of previous knowledge help  
    to present an investigator free 
    description of phenomenon 
4. A prereflexive being, researchers  
     actively co-create interpretations of 
     phenomenon 
5.  Adherence to established scientific 
    rigor ensures description of universal 
    essences or eidetic structures 
5. One needs to establish contextual  
    criteria for trust worthiness of 
    co-created interpretations 
6. Bracketing ensures that interpretation 
    is free from bias 
6.  Understanding and co-creation by the  
      researcher and the participants are  
      what make interpretations meaningful 
 
 
To summarise my approach hermeneutic phenomenology as a methodology, I found it 
useful for exploring participants’ experience of caring, healing and wholeness in relation to 
their historical, social and political influences that they live in for health and wellness in 
anal screening.  Lastly Kumar (2012) alludes to the fact that hermeneutic phenomenology 
is grounded in the belief that the researcher and participants come to the investigation with 
fore-structures of understanding shaped by their respective background, and in the 
process of interaction and interpretation cogenerate an understanding of the phenomenon 
being studied.   
 
 Why not a different qualitative Method? 
The methodological framework I chose for my study was based on many factors.   
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Hermeneutic phenomenology means that interpretations are all we have and description 
itself is an interpretive process in order to generate the best ever interpretation of a 
phenomenon (Kafle, 2011).  The focus of my study using this framework is toward 
illuminating details and trivial aspects within experience that may be taken for granted in 
our lives, with a goal of creating meaning and achieving a sense of understanding (Wilson 
& Hutchinson, 1991).  In my study, hermeneutic phenomenology was the most fitting 
approach although it did share similar characteristics with other qualitative methods as it 
focused on the lived experience, descriptive in nature, being situated in the world (Laverty, 
2003).  I further explored and explained the rationale for choosing hermeneutic 
phenomenology over grounded theory.  Firstly, there are distinct differences (see table 3 
below), as Hermeneutic phenomenology originates from the European philosophy which 
involves use of thick description and close analysis of lived experience; to understand how 
meaning is created and through embodied perception (Sokolowski, 2000).  On the other 
hand, grounded theory originates from sociology where it is symbolic of interactions which 
translate into meaning being negotiated and understood through social interactions and 
processes (Jeon, 2004).  Secondly my choice of hermeneutic phenomenology over 
grounded theory was that the analysis of data is ‘rich thematic description’ that provided 
insight into meaning of a lived experience whereas grounded theory analysis according to 
Starks & Trinidad (2007) produces an exploratory theory of basic social processes; 
patterns of analysis are only identified within and between categories which explains 
‘conceptual thematic descriptions’ rather than explanatory theories.  Finally, hermeneutic 
phenomenology provided me with the tools to understand, study participants’ perceptions 
and experiences in my clinical area with the idea that there is no distinction between the 
individual and experience; that interpreting them as co-constituting without being able to 
exist without the other (Laverty, 2003).   
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Table 4:  Comparison of Hermeneutic phenomenology and Grounded theory 
(Adapted from Starks & Trinidad, 2007) 
 Hermeneutic Phenomenology  Grounded Theory  
History European Philosophy Sociology 
Philosophy 
 
 
Concerned with life world or human 
experience as it is lived. 
Interpretation is primary focus over 
description. Ontology which is study of 
being, becoming, existence or reality 
and their relations. 
Develop and exploratory theory of 
basic social processes 
Goal Creating meaning and achieving a 
sense of understanding. 
“How does the basic social process of 
(X) happen in the context of (Y 
environment)? 
Sampling Those who have experienced the 
phenomenon of interest. Sampling 
procedure which selects those who have 
had the experience of interest 
(purposive sampling) 
Those who have experienced the 
phenomenon under different 
conditions 
Data 
Collection 
Observe participants in the context 
where the phenomenon is experienced 
Observe participants where the basic 
social process takes place 
Interviewing 
Strategy 
Participants describes experience and 
interview probes for details 
Participants describes the 
experience; the interviewer probes for 
detail and clarity 
Analytical 
Methods 
Identify descriptions of the phenomenon, 
cluster into discrete categories; taken 
together, these describe the ‘essence’ or 
core commonality and structure of the 
experience. 
Views set aside 
Reflective process 
Open, axial, selective coding: 
Examine concepts across their 
properties and dimensions; develop 
an explanatory framework that 
integrates the concept into core 
categories  
 
Bracket views 
Audience Clinicians, practitioners and others who 
need to understand the lived experience 
of the phenomenon of interest 
Researchers & practitioners who seek 
explanatory model upon which to 
design inventions 
Product  A thematic description of the pre-given 
‘essence and structures of lived 
experience 
Generate theory from the range of the 
participants’ experience. 
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 Limitations of Hermeneutic Phenomenology 
As my journey continued in choosing the appropriate methodology for my study I had to 
recognise, acknowledge and reflect on the limitations of hermeneutic phenomenology.  
This is a process I needed to address from the start of my study so that any challenges I 
faced with participants will be addressed as my study progresses.  According to Sharkey 
(2001) hermeneutic phenomenology challenges the researcher to reflect deeply on what it 
is that the texts of the field have to say. The researcher is called to play with the texts and 
to get lost in deep conversation with them. The goal of this type of research is not to clone 
the texts of the field for the reader of the research but to invite the reader to enter the world 
that the texts would disclose and open up in front of themselves (Kafle, 2013).  As with any 
research methodology there are limitations and hermeneutic phenomenology is suited for 
answering questions about human issues and concerns which are primarily the “what” and 
“how” questions (Benner, 1994).  My study aims to answer these questions from patients’ 
and clinicians’ perspective by exploring their perceptions and experiences of anal cancer 
screening in their sexual health clinics.   
 
However hermeneutic phenomenology will not help in predicting outcomes of a study but 
help to gain a better understanding of what the issues and concerns are which may help to 
anticipate future events, contribute to and add importance in clinical practice or work 
environment.  Predicting outcomes of a research study is usually a goal of empirico-
analytical paradigm (quantitative research) (Smith, 2009) and the goal of my qualitative 
study is to explore perceptions and experiences of participants in anal screening to inform 
clinical practice.   According to the interpretive paradigm, in which my research is situated, 
meanings are constructed by human beings in unique ways depending on their context 
and personal frames of reference as they engage within the world they are interpreting 
(Crotty, 1998). In this type of research findings emerge from the interactions between the 
researcher and participants as the research progresses (Creswell, 1998).   
 
Hermeneutic phenomenology has many challenges as such an undertaking requires 
commitment, time and it can be expensive.  Not all researchers or participants are willing 
or even able to take part in this type of research (Benner, 1994).  The risks of biases exist 
in all human sciences therefore the fore-structure of understanding and one’s own biases 
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have to be acknowledged.  In this type of study subjectiveness is valued.  There is 
acknowledgement that humans are not capable of total objectivity because they are 
situated in reality, and constructed by subjective experiences (Ajjawi & Higgs, 2007).  
There have been some criticisms about interpretive work especially towards the 
investigator’s knowledge and experience; and for not being true to the lived experience of 
participants (Tripp-Reimer & Cohen, 1987).  This is where I chose to use reflexivity to deal 
with biases and the subjective knowledge, I have on anal cancer screening from the 
participants’ perspective. I kept a reflexive journal to address distortions or preconceptions.  
It is for this reason that my reflexive journal is where my logs of the interview sensitised me 
to any prejudices and subjectivities.  I also reminded participants at the beginning of the 
interview of my background and experience in this field of study as it is new to me and my 
organisation, so it helped with clarification during the interview which I did not find 
problematic during data collection process.   
 
Finally, in this section I have outlined the philosophy, strategies and the intentions of the 
interpretive paradigm.  The interpretive research paradigm is based on four philosophical 
concepts of ontology, epistemology, axiology and methodology.  My study focussed on the 
interpretive understanding to access participants’ experiences where the important 
features to the interpretations is a key to generating knowledge from the interpretations of 
participants.  I chose hermeneutic phenomenology as findings will emerge as the research 
progresses which could be translated into the clinical practice area in sexual health clinics 
around the UK and inform criteria for screening as set out by the UK NSC.   
 Insider Researcher 
As an insider researcher, I felt that I was in a unique position to study anal cancer 
screening as an in-depth issue having specialist knowledge on screening.  Not only did I 
have insider knowledge but had easy access to participants and information to enhance 
that knowledge (patients and clinicians). The insider researcher is one who studies a 
group to which they belong (Breen, 2007).  The insider researcher knows how best to 
approach people and have a great deal of knowledge which Smyth & Holian (2008) argue 
that it takes an outsider researcher a long time to acquire and is a disadvantage for the 
outsider researcher.  The three key advantages of being an insider researcher is:  a) 
having a greater understanding of the culture being studied; b) not altering the flow of  
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social interaction unnaturally; and c) having an established intimacy which promotes the 
telling and judging of the truth (Bonner & Tolhurst, 2002).  I felt that I was confronted with a 
dual role of being a nurse practitioner and researcher and although I was part of the data 
collection and analysis process of my study, I had to adhere to ethical principles that apply 
to research which was addressed by the ethics committee.  I had access to sensitive 
information from participants which was fairly easy to achieve as I am the senior nurse 
practitioner with access to key gatekeepers.  The ability to successfully gain the necessary 
permissions from the ethical committees and have access to information made my position 
of an insider researcher sit firmly with the qualitative paradigm.  For my study, I made good 
use of the advantages of collecting the data every day of the week and any time of the day 
which an outsider researcher might not have achieved.  This provided me with the 
continuity of data collection and this made it possible for me to collect a more detailed, 
versatile and trustworthy research data.   
 
For insider researchers, the compelling rationale is to make a difference in a work-based 
situation so that to have an impact at national, regional and local level, even in the 
organisation you work in, and you would need evidence.  While work-based research can 
provide this evidence to influence policy and decision making, it can also make a 
difference to individual practice (Eraut, 2004).  I chose to use a reflexive approach where I 
could consciously acknowledge that reflexivity challenged my personal assumptions, 
clarified individual beliefs and any subjectiveness I faced (Ortlipp, 2008).  As an insider 
researcher, I was going through a learning process; reflection upon current practice, 
evaluation research work against the university criteria and the adoption of a reflexive 
approach are crucial aspects of work-based projects (Eraut, 2004).   
 
3.2 Stakeholder’s Engagement 
I realised through my research journey that stakeholders play an integral part in research 
projects as they are groups of people that have expert knowledge (Burton et al, 2008).  
These include individuals, organizations or communities that have a direct interest in the 
process and outcomes of a project, research or policy endeavor. This stakeholder 
engagement can be described as an iterative process of actively soliciting the knowledge, 
experience, judgment and values of individuals which represent a broad range of direct 
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interests in a particular issue, for the dual purposes of creating a shared understanding; 
making relevant, transparent and effective decisions (Barber et al, 2012).   
 
It was important to have early and ongoing communication with my employer about my 
study as the outcomes of this could have an impact on health policy, development of anal 
screening guidelines and decision making which is supported by Burgha et al (2000) as 
these authors concluded engagement often emphasise the potential to influence the 
actions of an organization, project or policy direction.  I met with the lead clinician of the 
sexual health department at the Trust to inform him of my interest in undertaking research 
with in the outpatient HIV clinic.  This clinician undertakes anal screening at my employing 
trust and supported the idea of my study.  I then met with the director of nursing, my 
manager and human resources from my employing trust to inform them of my study which 
again was fully supported.  The research and development department (R&D) manager 
met with me on numerous occasions to assist with the ethics approval process and with 
the necessary R&D forms for the trust.  The R&D manager was familiar with the Integrated 
Research Application System (IRAS) forms needed for approval and assisted me through 
a period of 8 months to gain ethical approval locally and other site-specific trusts.  Once 
the favourable opinion for my study was given a progress report had to be submitted 12 
months later and the annually until the end of my study to the Health Research Authority 
(HRA).  The same annual report is accepted by all R&D departments.  However individual 
sites may also be required to report on initiation, recruitment and completion to the local 
R&D office (HRA, 2016).  Two sites requested an update on my progress which I 
submitted a year after I started my study. At that point, all clinicians were recruited and 
interviewed, and no further reports were requested or sent out.  These sites involved 
clinician recruitment.  However, my local R&D department requests an annual report as it 
involved patients.    
 
Finally, I came to a realisation that involving the necessary people or stakeholders in my 
research process increased transparency.  This was important for maintaining scientific 
integrity and credibility (Stakeholder Guide, 2014). Those stakeholders not involved in all 
stages of research process can be targeted where they can have most impact like actively  
inform policy, decisions and for the dissemination of information.   
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3.3 Ethical Considerations 
As I began this chapter I reflected on what ethics and ethical behaviour meant and it 
seemed straightforward to me as it simply meant not hurting someone.  Ethics pertains to 
‘doing good’ and avoiding harm and that the rights of participants are protected.  This harm 
can be reduced by applying the appropriate ethical principles thus the protection of 
participants in any study is imperative (Orb et al, 2000).  In the sections below, I will 
discuss information to participants, informed consent, confidentiality and anonymity and 
how I addressed potential distress of participants.  My study is conducted in a setting 
involving the participation of participants in their clinical environment; therefore, it is 
imperative I am aware of ethical issues that may arise from such interactions.  The nature 
of my study dictated that potential ethical issues needed to be considered from the outset.   
 
People living with HIV and attending a sexual health service to access medical care in an 
outpatient clinic raises many ethical issues.  Given the vulnerable nature of the patient 
population and potential sensitive nature of my study and how is will affect all participants; 
I understand that ethical issues will arise as sexual health is private and confidential.  
Participants often regard any aspects of sexual health to be private and confidential.  I had 
to take care to address ethical issues throughout my study.  Parahoo (2006) mentions that 
while asking embarrassing and sensitive questions can be intrusive for participants and in 
turn invade their privacy.  Screening increases anxiety and worry about cancer and can be 
detrimental to sexual well-being (Landstra, 2012).  I will be addressing how I considered 
the key ethical issues in my study by ensuring I gained the necessary ethical approval, that 
participants came to no harm (consideration to psychological harm), informed consent 
sought, confidentiality maintained and I how I preserved patient anonymity.   
 
Before commencing my study, I made the necessary application for ethical approval from 
the Research and Ethical Committee (REC) and hospital trust REC committee.  The REC 
is a multidisciplinary, independent body charged with reviewing research involving human 
participants to ensure their dignity, rights and welfare are protected (ESRC, 2012). I 
completed an online IRAS application, which is a system for preparing regulatory and 
governance applications for health and social care.  The IRAS application is then 
considered by the REC committee as studies that involve “more than minimal risk”, and 
therefore require ethical review, may include: studies where the intention is to submit 
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findings for publication in journals, oral presentations, books, web-pages, and other media, 
or as part of coursework; studies involving the collection or analysis of data that could be 
used to identify participants (including email addresses or other contact details); physical 
contact with participants; any risk of discomfort or inconvenience to participants; any risk of 
psychological distress to participants or their families for example, require permission to 
undertake the study (HRA, 2016).  I obtained ethical approval from the National Health 
Authority/ National Research Ethics Service (NRES: 14/LO/0488) (see Appendix 3) and 
permission to undertake my study is sought from the Research and Development 
Departments from the participating Trusts with an arrangement to ensure anonymity of 
participants.   This was a rigorous process I undertook to ensure participants were 
safeguarded by completing the necessary documents for approval to begin my study 
 
 Participant Information Sheet 
Participant information is an integral part of any research ethical considerations as it 
provides a comprehensive overview of the processes I intended to use in my study.  I 
prepared patient information sheet (PIS) (see appendix 4) and clinician information sheet 
(CIS) (see appendix 5) which I will referred to during the presentation in obtaining consent.  
For the purpose of my study, I included potential risks which could have potentially 
resulted in psychological harm and the support that was available during interview 
process.  In case of a patient becoming anxious, tearful, distressed or if I perceived actual 
harm during the interviews, I would have stepped out of the role of a researcher, I stopped 
the interview, resume the role of a nurse and would have referred the participant to the 
clinical psychologist (see appendix 6). 
 
However, the basic principles of participant information which I included in my study 
covered all aspects as set out by HRA (2016).  The participant information sheet (appendix 
4&5) provided brief and clear information on the essential elements of my study: what the 
research is about, the condition or treatment under study, the voluntary nature of 
involvement, what will happen during and after the research has taken place, the 
participant’s responsibilities, the potential risks, inconvenience or restrictions balanced 
against any possible benefits and the alternatives. It allowed the participant to decide 
whether the study is of interest to 
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them and whether they wish to read and discuss it further (HRA, 2016).  
 
 Informed Consent 
As the participant information sheet is used as the basis for the invitations to take part in 
my study, informed consent (appendix 7&8) is important to safeguarding human subjects 
and protecting their right to self-determination therefore participants were given information 
regarding which enabled them to consent voluntarily and have the power of choice.   When 
I met with the participants, they read and understood the contents of the information sheet.  
When participants wished to participate in the study, I asked them to give written consent 
before being interviewed.  A signed copy of the consent form was given to the participant 
and another copy was placed in a folder in the researcher’s office cabinet who has sole 
access to this information only.   
 
I emphasised to the participants that they were not under any obligation to take part in the 
study.  Patients were told that if they decided not to take part in the study that it would not 
affect the quality of care, they would receive in the HIV outpatient clinic.   
 Confidentiality and Anonymity 
Participants were fully informed about confidentiality, anonymity and its limits in the study.  
They were also informed that I was the only person involved in the transcription of data.  
Participants were also made aware of the fact that quotes from the transcripts would be 
used in my thesis and for a journal article publication and that all identifying information 
like their names and places would be removed to ensure anonymity.  To ensure anonymity 
for my study pseudonyms were used where participants were given a fictitious name.    
Participants are named as Patient 1 and 2 and Clinician 1 and 2 etc. to avoid the 
possibility of pseudonyms being read as real names.  Since this study was part of my 
academic project for a professional doctorate, participants were made aware that my 
academic supervisors and academic institution would look at my study therefore all 
transcripts would be anonymised too.  As part of the consent process patients were 
informed that I would have to access to their electronic patient record with their agreement.   
 
One of the dilemmas I experienced in my study was that of power relationship that existed 
between me and the participants.  This power relationship that emerged was researcher-
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participant relations. This relationship is complex due to the researchers’ and participants 
conflicting roles (Karnieli, 2009).  The participants were patients who I (as a nurse 
practitioner) have direct involvement in their clinical care and clinicians who are my 
colleagues in the professional world of sexual health.  The unique contribution of 
researchers and participants to a project make them inseparable parts; participants feel 
involved because of the examination of their personal experiences while researchers are 
involved because of their in-depth study of others’ experiences (Karnieli et al, 2009).  
 
Identities of participants were protected in all communications and activities during 
research.  The anonymity of participants was protected by giving each participant a code 
number.  I kept a master list of participants’ names and their code numbers on a password 
protected computer in my office with restricted access.  Informed consent was filed and 
locked in a metal filing cabinet in my private office.  This is not a shared office.  All taped 
interviews were coded respectively and locked safely with restricted access.  Transcripts 
of data were entered on the NHS computer with code numbers for identification.  This was 
stored on the secure NHS computer, where I have a secure password only. This computer 
is password protected and encrypted which is in line with the Data Protection Act (1998), 
Caldecott principals as well as the NHS Trusts organisational policies.  No one other than 
me could access coded information to identify any participants. I was the only person who 
had access to participants' personal data.  Any identifiable data will be destroyed after 3 
years and according to archiving procedures in the Trust.  According to Sieber (1992) as 
cited by Kaiser (2009), data collected anonymously i.e. without identifiable information; 
researchers must collect, analyse and report data without compromising the identity of 
respondents.  Respondents with stigmatising traits or behaviours would be harmed if their 
identities were revealed as vulnerable populations face negative consequences of 
identities are revealed (Baez, 2002).  As discussed above I have ensured confidentially, 
and anonymity was maintained as patients living with HIV are a vulnerable group of 
patients that experience stigma associated with HIV, HPV and AIN.   
 
 During various stages of my project i.e. recruitment, data collection, analysis, validity 
check, it became apparent to me that ethical and methodological dilemmas were related to 
informed consent, confidentiality, privacy and power and relevance for the study emerged 
(Shaw, 2003).  In recognising this, negotiation of power was important and that there is an 
ability to change the power balance between researcher and participant.  During the initial 
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stage of recruitment in the research process the control was in my hands, during data 
collection control and ownership of the data was in the hands of the participant.  I 
mentioned to participants that my role was that of the researcher, using the “researcher 
hat” and this should not be concern for their medical care in the outpatients’ unit after the 
interview is completed.   
 
The balance of power may be problematic from a research point of view and could 
potentially influence data analysis (Payne et al, 2007).  I addressed this by providing all the 
information, a private, confidential and comfortable environment which transformed 
interviews into a dialogue between two people who share an experience.  The atmosphere 
in which interviews took place allowed the participants to willingly cooperate and contribute 
wholly in the study.   
 Potential Distress 
I acknowledged the risk of taking part in my study could have been potentially distressing 
for participants therefore; I addressed this by providing all the relevant information prior to 
an outpatient appointment about what the study would involve in taking part, so that 
participants could make an informed decision when they returned for their next routine 
appointment.  If participants became distressed during the interview, the interview would 
have stopped and they would have been referred to the clinical psychologist, a debriefing 
of interview would have taken place and we would have reflected on the distress. 
According to Pietkiewicz and Smith (2012), for ethical reasons, and because IPA studies 
are frequently concerned with significant existential issues, it is crucial that the interviewer 
monitors how the interview is affecting the participant. Experienced interviewers can easily 
determine when the participants avoid talking about certain issues, start feeling awkward, 
ashamed or become very emotional and by using counselling skills may then be useful, 
and if the interviewer has not developed such competence, he or she should follow 
specific ethical procedures (e.g., stop the interview and refer the person to a professional 
in mental care). Even though such situations are rare, the researchers should consider all 
possible risks.  Anal cytology screening and high resolution anoscopy formed part of the 
medical care provided by the department as best clinical practice therefore patients were 
offered counselling by the department’s clinical psychologist (see Appendix 6) should they 
have experienced any distress during the interview. There were no potential burdens for 
patients for example all patient interviews were arranged when they attended for their 
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routine clinic appointments therefore no extra appointments were needed for interviews.   
It was not anticipated that clinicians may experience distress but if this did happen then 
they would have been referred to their occupational health department for counselling or 
could access the psychologist at my employing Trust.  I endeavoured to conduct the 
interview as sensitively as possible and a debrief session followed each interview which 
was recorded in my reflexive diary.  However, my role as an interviewer was validated 
further by my work colleague who is a trained psycho sexual therapist, counsellor and HIV 
clinical nurse specialist within the HIV outpatient clinic where patient interviews were 
conducted (see Appendix 9-feedback from CNS).  The CNS provided a peer review on my 
interviewing style, assessed the environment and provide me with feedback on the 
interview session.   I invited the Counsellor (HIV Nurse specialist/psycho sexual therapist) 
to sit in my third interview and to avoid distress to patient.  I asked the patient for consent 
and it was agreed.  I also explained the role of the counsellor and that she was just sitting 
in as an observer on the far side of the interviewing room.  I also made it clear to the 
patient that the counsellor/CNS will not have any influence on the study in anyway or 
distract our interviews.   Apart from mastering active listening and the ability to ask open-
ended questions free from hidden presumptions, I had to build rapport and gain trust with  
each participant.  I started each interview with a ‘warm-up’ discussion which helped to 
reduce the participant’s tension or anxiety and get him or her ready to discuss sensitive or 
personal issues.  These factors helped to alleviate any distress during interviews.   
 Potentials Risks for Researcher 
The potential risks I identified as a researcher were that I was interviewing patients alone 
and safety was a concern.  Therefore, I chose to undertake interviews at the NHS Trust 
where an interview room was used and accessible to other colleagues or security in case 
of an emergency.  Researchers have the role and responsibility for flagging concerns 
especially when dealing with vulnerable adults and take action when concerns are 
identified (Williamson and Burns, 2014).  I am experienced in interviewing and regularly 
deal with vulnerable groups of people, therefore have the expertise to deal with an 
untoward situation.  I have also undergone risk management training and aware of how to 
assess any risks.  According to Williamson and Burns (2014), it is important to care for the 
health and wellbeing of researchers in the field and the participants in research.  I did not 
anticipate potential risks when clinicians were being interviewed.   
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3.4 Participant Selection 
The aim in sample selection with a hermeneutic phenomenology approach is to choose 
participants who have lived an experience and are willing to share this with the researcher 
(De Gagne & Walters, 2010).  I chose two sample selections for my study; one which 
included patients from an NHS Trust that attend HIV outpatient clinic situated within a 
sexual health service; second sample selection was from multi-site NHS trusts to include 
clinicians undertaking anal screening in sexual health services from around the UK. 
 
The aim of the sampling process for my study was to make certain that I actively selected 
the most suitable sample to answer the research question.  Any researcher needs to ask 
him or herself what exactly she or he wants to accomplish, what she or he wants to know 
and the appropriate sampling strategy will follow (Palys, 2008).  It involves the researcher 
deliberately choosing who to include in the study on the basis that those selected can 
provide the necessary data (Parahoo, 2006) therefore purposive sampling was appropriate 
for my study with patients and convience sampling used with clinicians. I employed 
purposive sampling where I targeted patients that best contributed to my study so I 
involved these patients who lived with the experience I was researching.  I conducted 
purposive sampling to attract patients who were willing to talk about their experiences.  
This is a recognised strategy for identifying and accessing a sampling frame which 
involves criteria that would suit the purpose of the study (Ritchie et al, 2003).  This 
sampling method helped me in optimising the chances of gaining insight into the research 
question as the patients were the ones with the lived experience of anal cancer cancer 
screening.  There were 40 patients that underwent anal screening which is the total clinic 
population.  Fourteen patients contributed to my study.   
 
Conveince sampling was used with clinicians in my study.  According to Etikan et al 
(2016), it is not possible to include every subject because the population is almost finite 
and this is the rationale behind using sampling techniques like convenience sampling by 
most researchers.  The main assumption associated with convenience sampling is that the 
members of the target population are homogeneous i.e. that there would be no difference 
in the research results obtained.  The entire population of 8 clinicians undertaking anal 
cancer screening in the UK took part in my study.  I wrote to them about my study and they 
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accepted the invitation to take part in my study and all 8 practicing clinicians who offered 
anal cancer screening in their specialist sexual clinics were included in my study. 
 
Two principles, appropriateness and adequacy guided me in the sampling process. The 
first principle, appropriateness is derived from the identification and utilisation of the 
participants who can best inform the research.  The second principle of adequacy means 
that, there will be enough data to develop a full and rich description of the phenomena until 
no new themes are identified (Morse & Field, 1996).  The sample size for my study was 
determined when data saturation was reached with patients and no new themes emerged 
from the interviews.  Determining adequate sample size in qualitative research is the 
researcher’s judgmental call for the intended study. Purposive sample sizes are often 
determined based on theoretical saturation (De Gagne & Walters, 2010).  The number of 
participants for a study cannot be determined in advance and recruitment can be stopped 
when no new descriptions can be found (Sherman & Strang, 2007). Typically, purposive 
sampling involves samples to enhance understanding of information rich case (Patton, 
1990).  I therefore, found that purposive sampling was successful as I reviewed the data 
and analysed this in conjunction with the collection of data.   
 
 Inclusion and Exclusion Criteria 
The inclusion criteria for patients at an NHS Trust are those that have a diagnosis of HIV, 
had an anal cytology and undergone high resolution anoscopy, 18 years of age and 
above, spoke and read English.  The inclusion criteria for clinicians are those clinicians 
who undertake anal cytology screening and high resolution anoscopy in their sexual health 
clinic. All patients who met the inclusion criteria were purposively selected and interviewed 
until no new information emerged, however all 8 clinicians that undertook anal cancer 
screening in sexual health clinics were selected. 
 
Exclusion criteria were patients who never had anal cytology and high resolution anoscopy 
as part of their medical care at the outpatients’ clinic.  Patients without mental capacity 
were not part of this study.  Exclusion criteria for clinicians included those clinicians that 
are not currently involved in the anal cancer screening process within sexual health clinics 
i.e. anal cytology and HRA. 
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 Patient Selection 
To place patient selection in the context of my study, the sample selected were patients 
living with HIV, attending the HIV outpatient clinic at an NHS hospital Trust only and those 
patients who have undergone anal screening in the sexual health clinic.  I approached 
patients face to face during their routine HIV outpatient clinic appointments to inform them 
of the study and they were given the Patient Information Sheet (PIS) with the invitation to 
take part in the study when they attended for their HIV outpatient clinic appointment (see 
appendix 4). The PIS contained the purpose, advantages and risks of taking part, 
information about how the results of the study will be published once complete, 
confidentiality, who has reviewed the study (i.e. ethical committees) and my contact details 
if they wished to take part.  Patients are followed up every 3 months for routine HIV 
medical care which coincided with their regular appointments therefore had 3 months to 
consider whether to take part or not.    Patients who were willing agreed to take part in this 
study were asked if they needed further information and when they were happy with this, I 
arranged to meet with patients to go through the consent form and interview them at that 
point.  I obtained consent once patients understood the given information about the study.  
Recruitment of patients were fast and fluid as the PIS was concise to the point, simple to 
understand and not too lengthy.  Patients were excited about the opportunity to take part in 
the research at their clinic as some of them have been attending this service for many 
years and wanted to be part of a new development in the HIV service.  During recruitment 
patients were informed that they would not benefit personally from the research but hoped 
that the findings of this study would guide future research and inform current clinical 
practice and screening in sexual health clinics in the UK.    
 
The place of interviews was convenient for patients as the interviews were carried out in a 
counseling room in the outpatient’s clinic and patients did not have to make an extra visit 
or journey for the interview.  Scheduling an interview at an amenable time and location is 
often particularly important to respondents (ELMIR et al, 2011).  The room was quiet with 
comfortable chairs and there were no interruptions.   The location I chose to undertake the 
interviews had a good ambience and I developed this rapport with participants which 
further contributed to the sound quality, so I could immerse in the data collection process.  
Participants could relax and at the same time their privacy maintained.  It is difficult to hide 
one's identity from the researcher in face-to-face interviews; however, confidentiality 
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protections are dependent upon interviewer integrity and data protection methods 
(Oltmann, 2016).   The quality of data collected during interviewing would not be affected 
in a quiet, confidential environment.    
 Clinician Selection 
Clinicians were informed verbally via telephone, meetings (multidisciplinary team 
meetings) or when we met at conferences to made them aware of my study.  Once ethical 
approval was obtained clinicians were sent out the Clinician Information Sheet (CIS) via 
secure NHS email to be able to agree to take part in the study. The CIS (see appendix 5) 
included an invitation, purpose, advantages, risks, confidentiality, study review and my 
contact details which was similar to the PIS.  Only eight clinicians met the criteria for 
inclusion in my study and I interviewed all eight clinicians working in sexual health clinics 
undertaking anal cytology and high resolution anoscopy.  I had to travel to different 
hospital trusts sites to interview clinicians.    At the point of my study there were only 8 
trained clinicians in total in the UK undertaking anal screening and were considered for my 
study.  Clinicians were informed that their perceptions and experiences on anal cancer 
screening would contribute to a body of knowledge to inform clinical practice in sexual 
health clinics in the UK.  It must be noted that Smith et al (2009) observed that the typical 
number of interviews analysed in professional doctorate projects are between four and ten 
with the emphasis that higher numbers are not indicative of better work.   
 
3.5 Data Collection 
Data were collected by in depth interviews that were unstructured. Ritchie and Lewis 
(2003) explains that in-depth interviews permit the researcher to explore fully all the factors 
that underpin participant answers, reasons, feelings, opinions and beliefs which provides 
the explanatory evidence that is an important element of qualitative research.  Polit & 
Hungler (2006) mentions, that the aim is to elucidate respondents’ perceptions of the world 
without imposing ones’ “own views”, while Hek, Judd and Moule (1998) suggest collecting 
information by in depth interviews, a theory can be generated.  Unstructured interviews 
can be beneficial to the researcher and will learn more about the topic as the interview  
progresses (Morse & Field, 1996). Unstructured interviews allowed me to ask open ended 
questions mainly to explore and build upon responses from the participants.  Participants 
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were able to answer in their own way expressing their perceptions and experiences 
without feeling restricted by standard questions as in structured interviews.   
 
Patient interviews were conducted at an NHS Trust where an interview room was 
accessible to other colleagues like the psychologist and security or in case of an 
emergency both the patient and I would have encountered.   Clinician interviews were 
conducted in their office at each individual trust location which was private and without any 
disturbance from their colleagues or patients.  To avoid any disruptions telephones were 
put on voice mail to accommodate the interview process.  Interviews were conducted face-
to-face and recorded using a digital tape recorder.  Fain (2004) proposes that the 
researcher must consider the possibility that participants might be sensitive to the 
presence of audio equipment therefore ask the participant permission to record.  I 
recorded the interviews and transcribed them verbatim.  The participants (patients and 
clinicians) were interviewed for approximately 60 to 90 minutes to allow for prolonged 
engagement (average interview was 70 minutes).  I asked one question (i.e., "What is your 
experience in undertaking anal screening in your clinic?") which set the scene for the 
interview.  This is a broad statement, flexible and opened ended to allow the participant to 
talk freely and openly.  This allowed me to explore all aspects of the phenomenon to gain 
sufficient information for generation of a theory.  By using an open and accepting 
interviewing style is important during interviews (Hallet, 1995).  Trigger questions were 
used to guide the interview for my study just so that I could explore an in-depth idea 
promptly, the structure of the interview can be loosely guided by a list of questions which is 
open-ended and flexible (see appendix 10&11).  An advantage of trigger questions is the 
opportunity they provide for rich insight and understanding beyond just mere answers.  
These questions were discussed with my academic supervisors, peer reviewed and 
approved by ethics committee.   
 
I chose not to undertake pilot interviews as I am an experienced trained practitioner in 
interviewing in my role.  After each interview, I debriefed with each participant each 
interview to elicit how they felt and to assess for potential distress and this conversation 
was not recorded.  I kept notes in my reflexive diary of the debriefing session to later 
reflect on my own.  I used these notes to reflect on my interviewing style and following 
each interview reviewed what trigger questions I could introduce to other interviews to 
expand on what could be explored further with other participants.  By the third interview I 
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sent interviews to my academic supervisors and we found gaps in research which are not 
explored in most studies.  In keeping with IPA, it shows I am not just duplicating existing 
research, and that I have a deep understanding of the status of the body of knowledge on 
the perceptions and experiences of participants in anal cancer screening.  Finally, it will 
mean that I have conducted a research which addresses that gap in the literature in what I 
could probe further with other participants in view of gathering rich deep experiences for 
my study.  My academic supervisors gave me feedback with the idea of exploring sexual 
activity and social life with patients.  I included one trigger question for the patients (i.e. 
having been diagnosed with AIN, does this in any way affect your sexual activity or social 
life?) in the interviews that were to follow.   However, I felt that my initial interviews were 
less informed at times as patients did go off track.  One patient started speaking about 
general health for example, and he started discussing the heart attack he had a few years 
ago.  I have the experience of interviewing therefore I stayed focused during interviews 
and this has helped me achieve the desired outcomes, and this has helped me improve 
the quality and depth of interviews with subsequent participants.  The data collection 
process of my study covered the interviewing style I used, data collection procedure, and 
liaising with my academic supervisors for feedback.  My reflexive diary allowed me to 
reflect on the data I collected.    
 
3.6 Rigour or Trustworthiness 
It was important for me to demonstrate rigour and trustworthiness in my study as 
qualitative research requires that the researcher demonstrates quality in their work which I 
will discuss in detail below.  Reliability and validity are ways of demonstrating rigour of 
research processes and the trustworthiness of research findings, therefore reliability in 
qualitative research is thought of as the trustworthiness (Stiles, 1993).  Reliability and 
validity are conceptualized as trustworthiness, rigor and quality in qualitative paradigm and 
that can be achieved by eliminating bias and increasing the researcher’s truthfulness of a 
proposition about some social phenomenon using triangulation (Bashir et al, 2008).  I used 
different data sources of information by examining evidence from the sources and used it 
to build a coherent justification for themes, whereas reflexivity according to Bashir et al 
(2008) is rigorous self scrutiny by the researcher through out the research process and is 
an important procedure for establishing credibility. 
 
98 
 
According to Noble and Smith (2015) qualitative researchers aim to design and 
incorporate methodological strategies to ensure the ‘trustworthiness’ of the findings.  Such 
strategies included:  
1. Accounting for personal biases which may have influenced findings 
2. Acknowledging biases in sampling and ongoing critical reflection of methods to 
ensure sufficient depth and relevance of data collection and analysis 
3. Meticulous record keeping, demonstrating a clear decision trail and ensuring 
interpretations of data are consistent and transparent 
4. Establishing a comparison case/seeking out similarities and differences across 
accounts to ensure different perspectives are represented 
5. Including rich and thick verbatim descriptions of participants’ accounts to support 
findings 
6. Demonstrating clarity in terms of thought processes during data analysis and 
subsequent interpretations 
7. Engaging with other researchers to reduce research bias 
8. Respondent validation: includes inviting participants to comment on the interview 
transcript and whether the final themes and concepts created adequately reflect the 
phenomena being investigated 
9. Data triangulation, whereby different methods and perspectives help produce a 
more comprehensive set of findings 
 
In keeping with IPA demonstrating rigour was essential for me so that my research 
findings would have the integrity to make an impact on practice and health policy.  For me 
validity meant the extent to which the data I collected was plausible, credible and 
trustworthy; so that it can be defended when challenged. Reliability and validity remain 
appropriate concepts for attaining rigor in qualitative research.  According to Roberts et al 
(2006), other methods for increasing reliability include ensuring technical accuracy in 
recording and transcribing, while some suggest that tape-recorded interviews and 
interview transcripts can help improve reliability.  Software programmes can be used to 
systematically explore basic material, creating a broad agreement amongst researchers 
about what is being dealt with the quality, rigour and trustworthiness of the research is 
enhanced (Welsh, 2002).  Any biases were reduced by the participant validating the 
transcripts. The transcripts were given to participants and this in essence means that as a 
researcher I was able to share any interpretations and theories with participants.  They 
99 
 
could check, make amendments and give feedback to me to validate if their accounts were 
consistent with their experience. It is useful for the participant to provide validation as this 
can provide researchers with an opportunity to rethink their interpretations (Lincoln & 
Guba, 1985 as cited by Roberts et al, 2006).  Transcripts were also sent to my two 
academic supervisors for review where they both read the transcripts and provided 
feedback.  We had a meeting and went through the transcripts where we compared their 
themes and codes to mine.  Both my supervisors and I had similar themes and codes 
which further validated my interpretations and quality of analysis.  This process has added 
rigour to my research where transcripts were validated by participants and my academic 
supervisors and reliability and validity demonstrated.   
Lincoln and Guba (1985) as cited in Noble and Smith (2015) offer alternative criteria for 
demonstrating rigour within qualitative research namely truth value, consistency and 
neutrality and applicability. 
 
Truth value recognises that multiple realities exist; the researchers’ outline personal 
experiences and viewpoints that may have resulted in methodological bias; clearly and 
accurately presents participants’ perspectives Noble and Smith (2015). I used a reflective 
journal to maintained and document any decisions.  A colleague who was a pyschothrapist 
and clinical nurse specialist provided me with a peer review of an interview or debriefing to 
assist me to uncover any biases, or assumptions, for example, the initial qualitative 
interviews with patients were focused mainly on anal cancer screening procedure but 
subsequent interviews took a more holistic approach.  The sample of 20 participants 
willingness to share their experiences in depth and over time enabled clarification of 
findings as an ongoing process showed representativeness of the findings in relation my 
study.  The audio recorded interviews allowed for repeated revisiting of the data to check 
emerging themes and remain true to participants’ accounts.  I used of rich and thick 
verbatim extracts from participants which assists the reader to make judgements about 
whether the final themes are true to participants’ accounts and the participants were 
invited to comment on the research themes that emerged from my data.   
 
Consistency relates to the ‘trustworthiness’ by which the methods have been undertaken 
and is dependent on the researcher maintaining a ‘decision-trail’; that is, the researcher’s 
decisions are clear and transparent. Ultimately an independent researcher should be able 
to arrive at similar or comparable findings (Noble and Smith, 2015).  This was achieved in 
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my study by having transparent and clear description of the research process from initial 
outline, through the development of the methods and reporting of findings. In addition to 
my reflexive diary helped me as I documented challenges and issues which assisted me in 
maintaining cohesion between the study’s aim, design and method.   
 
Neutrality (or confirmability) according to Noble and Smith (2015) is achieved when truth 
value, consistency and applicability have been addressed. Centres on acknowledging the 
complexity of prolonged engagement with participants and that the methods undertaken 
and findings are intrinsically linked to the researchers’ philosophical position, experiences 
and perspectives. These should be accounted for and differentiated from participants’ 
accounts.  This was achieved by giving participants the transcripts to comment on the 
interview transcript and whether the final themes and concepts created adequately 
reflect their perceptions and experiences on anal cancer screening.   
 
Applicability is the consideration is given to whether findings can be applied to other 
contexts, settings or groups (Noble and Smith, 2015).   The rich detail of context, from the 
patients managed within the HIV outpatient service, as well as clinicians in sexual health 
services from around the UK helped facilitate the evaluation of study conclusions and 
transferability to other sexual health clinics and inform practice, policy and guidelines for 
anal cancer screening.   
 
3.7 Data Analysis  
In keeping with hermeneutic phenomenology methodology, I adopted interpretive 
phenomenological analysis (IPA) to develop in-depth descriptions of participants’ 
perceptions and experiences of anal cancer screening.  IPA seeks to understand in detail 
how an individual experience a phenomenon from a perspective within a particular context 
and is concerned with ways in which people make sense of their experience and attach a 
meaning to life events (Smith et al, 2009).  IPA is one such framework which was 
developed as the techniques used can be further developed into theories, models and 
explanations that can help understand human experience better (Smith et al, 1999).  Reid 
et al (2005) explains that IPA is an exploration of a lived experience coupled with a 
subjective and reflective process of interpretation.  Reflexivity during the analysis process 
was important for me as I had to examine my own role within the study.  Reflexivity is 
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viewed as an optional tool which enables the researcher to formally acknowledge his or 
her interpretive role instead of using this technique to remove bias (Fade, 2004).    Any 
inferences that are drawn from the data are done so cautiously and with awareness of the 
culture and context within which the study is situated.   
 
The way in which the researcher understands the participant’s experience of the  
phenomenon under study – in this instance learning about transference, and the meanings 
participants made of this, is influenced by the researcher’s engagement with and 
interpretation of the participant’s account. IPA is both phenomenological and interpretive 
and necessitates researcher reflexivity throughout. Smith et al (1999) stresses the 
importance of IPA as an attempt to gain an insider perspective of the phenomenon under 
study whilst acknowledging that the researcher is the primary analytical instrument.   I 
collected, transcribed and interpreted all the data for my study using my experiential 
knowledge.    
 
I used the hermeneutic circle as a strategy for understanding and interpretation of data in 
my study.   This understanding involved repeated circular movements between the parts 
and the whole establishing real relationships between reader, text, and context so that 
reading a sentence involves these repeated circular movements of parts and whole 
relationships (see Figure 6 below).  According to Reiners (2012), interpretative 
hermeneutics utilizes the hermenuentic circle method of analysis where there is continual 
review and analysis between the parts and the whole text.  I transformed the lived 
experience of participants into a textual experience by reflection, thinking, reading and 
writing which occurred in hermeneutic cycles until meanings emerged from the text.  This 
text according to Smith (1997) cited in Ajjawi & Higgs (2007), may be viewed as both the 
data and product of research.  This can also be viewed as a movement between parts of 
data and whole of data which is an evolving understanding of phenomenon, giving 
meaning to the other so that understanding is circular and iterative (Bonteko, 1996 cited n 
Ajjawi & Higgs 2007).  Koch (1996) describes the experience of moving dialectically 
between the parts and the whole. As interpreter, I became part of this circle where I 
repeatedly moved between interpretations of parts of the text and interpretations of the 
whole text for an understanding.  Through the hermeneutic circle the interpreter attempts 
to understand “the whole through grasping its parts and comprehending the meaning of 
the parts divining the whole” (Crotty, 1998: 92). Using the concept and practice of the 
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hermeneutic circle, the inquirer (researcher) recognizes that the phenomenon or object of 
comprehension is understood, because its parts are integrated and comprise it. At the 
same time inquirers recognize how the whole contextualizes each of the parts, seeking to 
illuminate the phenomenon within its context. The process involves an examination of the 
parts, examining each component before it is reintegrated into the whole (Bontekoe, 
1996). 
 
 
Figure 6:  The basic form of the hermeneutic circle (Bontekoe, 1996, p. 4). 
 
I managed to maintain rigour by keeping a reflexive journal as an audit trial, checked and 
shared interpretations with participants as well as by my rigorous data analysis process.  I 
also shared the detailed description of the research setting (i.e. being open and 
transparent about the environment and a private interviewing room for example) with 
participants which maximised research rigour. The purpose of data analysis regardless of 
type of data, or the underlying research tradition, it is important to organise, provide 
structure, and elicit meaning from research the data (Polit & Hungler, 2006).  Whitehead 
(2002) states that, some phenomenological researchers advocate a step-by-step set of 
procedures to aid in the interpretation of phenomenological data.   There were six stages 
in the IPA framework process that I used for my study (see table 5 below) adapted from 
Ajjawi & Higgs (2007).  The six stages of interpretative analysis are immersion, 
understanding, abstraction, synthesis and theme development, Illumination and illustration 
of phenomena, and integration and critique.  Throughout all stages of the data analysis 
Experience 
Experience 
Parts 
Whole 
Contextualisation 
Illuminate 
Integration 
(Define) 
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process there was ongoing interpretation of the research text and exploration of 
perceptions and experiences of participants in anal cancer screening depicted in table 4 
below.   
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Table 5: Six stages in Data Analysis (Adapted from Ajjawi & Higgs, 2007) 
 
Stage Process Used 
1.  Immersion • Transcribed data organised into research texts 
• Constant or Iterative reading of texts 
• Initial or preliminary interpretation of text to 
enable coding 
2.  Understanding • Identifying first order (participant) constructs 
• Coding of data using Nvivo software 
3.  Abstraction • Identifying second order (researcher) 
constructs 
• Grouping second order constructs into sub-
themes 
4.  Synthesis and theme 
     development 
• Grouping of sub-themes into themes 
• Further elaboration of themes 
• Comparing themes across sub discipline 
groups 
5.  Illumination and  
     illustration of  
     phenomena 
• Linking literature to themes identified above 
• Reconstructing interpretations of perceptions 
and experiences in participants own words 
6.  Integration and critique • Critique of themes by researcher and 
academic supervisors 
• Reporting final interpretation of research 
findings 
 
 Stage 1:  Immersion 
Each interview was recorded and manually transcribed verbatim into a Word document.  I 
made notes as the interview progressed where I took note of verbal responses and 
expressions.  I transcribed each interview as I completed a participant interview as I 
captured what transpired at each interview while I could still remember events of each 
interview.  According to Fade (2004), it is helpful to keep field notes describing verbal and 
non-verbal communication and this should be inserted in the transcripts while it is still fresh 
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in the researcher’s mind.  I took some notes during the interviews to reflect on after each 
interview.  Transcribing took a long time, but it helped me immerse into the data.  The 
notes that I took during interviews were not integrated into my data, instead I used these 
notes during reflexivity to assess how other interviews could have been improved upon.  
Besides I took very few notes as I did not want to distract the participants or lose focus 
during my exploration of experiences and perceptions on anal cancer screening with 
participants.  According to Muswazi and Nhamo (2013) taking notes might distract 
participants or cause the researcher to miss important aspects of events as well as disrupt 
the effectiveness of communication between the interviewer and the participant.  By 
interviewing in an open style, I was able to immerse myself as a researcher in the 
participants’ perceptions and experiences related to anal cancer screening with minimal 
distraction by listening, rephrasing, creating a rapport with participants.   
 
The transcripts were read several times to identify themes for initial interpretation in the 
data or text (see figure 6 above shows the iterative process I used to understand the data).  
This was the first step that I undertook in the analytical process to get a sense of the data 
where I started making notes which described any striking issues to enable me to code.  
This is where I immersed myself in the transcribed data and manually highlighted with a 
colour highlighter the examples of these issues on the lines of the transcript and made 
notes on each transcript which helped me to identify different themes later.   I also used 
NVivo programme to help me speed up the process of manual work of identifying themes 
which is part of the immersive process.  This software indeed helped me reduce several 
manual tasks I was undertaking as NVivo has a feature to highlight tendencies.  Nvivo 
gives the researcher time to discover tendencies, recognise themes and derive at 
conclusions.  Whilst being immersed in the data I was alert, flexible and positive about the 
data I collected (Wong, 2008).  Any emerging thoughts were documented in the form of 
memos which was linked to sections in the text.  I then moved onto stage 2 of the analysis 
process. 
 Stage 2:  Understanding 
First order constructs were developed from participants when they expressed their 
experiences and this stage about understanding the individual experiences. 
 
106 
 
Table 6: Example of Understanding in stage 2 of data analysis depicting first order 
constructs developed in my study 
 
Experience of Participants First Order 
Constructs 
“I’m probably better than most, but even 2 years ago I let 
an appointment slip and I’m sure it was because of 
reluctance and then I almost got caught out that they 
found some cells that they weren’t happy about and that 
that really scared me and put the fear of god in me”-
Patient 3 
Felt scared for missing 
screening 
“Very anxious, didn’t want to walk out of the house even 
I almost became agoraphobic. My sleep wasn’t affected, 
it was just a very heightened state of being anxious all 
the time”-Patient 1 
Anxious about having 
anal cancer 
“I have had it done previously and I couldn’t tolerate the 
pain, it was awful. I don't look forward to it because it's 
painful”-Patient 12 
Pain during anal 
screening 
“The whole experience of anal exams and whatever, I 
can’t say its ever something that one looks forward to, to 
dropping your trousers and having someone look up 
your rectum, – whatever.  It’s invasive in every sense.  
It’s not invasive physically, it’s invasive personally”-
Patient 8 
Invasion during anal 
screening 
 
In this stage I identified first order constructs (Table 6) from the participants when they 
expressed ideas in their own words to capture in detail what the participant was actually 
saying.  My first order constructs were organised into experience and the emotions 
experienced by participants.   Smith and Hesse-Biber (1996) mentions that, Nvivo is 
mainly an organising tool and this software is designed to carry out administrative tasks of 
organising data efficiently.  Once I transcribed the data, I saved the transcripts in a folder 
as a Word documents on my computer so that these documents are easily visualised on 
screen (Appendix 12 & 13).  I then uploaded the transcripts onto the Nvivo software 
programme version 9 (see Appendix 13).  By using Nvivo software in data analysis 
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process in qualitative research adds rigour to the research process (Richards and 
Richards, 1991).  One way in which accuracy could be achieved and rigour of analysis 
process maintained, is by using the search facility in Nvivo which is seen by the 
developers as one of the main assets of interrogating data, thus carrying out such search 
electronically will yield more reliable results than doing it manually simply because it will 
rule out human error (Welsh, 2002).    
 
The first order constructs refer to participants’ ideas expressed in their own words or 
phrases, which capture the precise detail of what the person is saying.  This was checked 
by giving the transcript to the participants for feedback. My understanding of the first order 
construct e.g. “felt scared for missing screening” is derived from participants experience 
(“…that really scared me and put the fear of god in me).   Patients were given their 
transcripts when they returned for follow up outpatient appointment and I emailed the 
clinicians their interviews via secure email.  Patients and clinicians gave me feedback via a 
telephone me to confirm any changes. Participant feedback is a central aspect of 
producing findings from interactions between me and the participants as the research 
progressed (Ajjawi & Higgs, 1997).  I intended to validate these transcripts not only to 
provide rich deeper understanding of their experiences but to allow participants to correct 
any misinterpretations, clarify information and make any additions if they wished and 
continue in the research process.  
 
I had to anticipate errors or inconsistencies (e.g. incorrect language, spelling) in the 
transcripts, which Lapadat (2000) state may be significant and could alter meanings and 
affect research.  The transfer of transcripts to participants allows the researcher to 
preserve research ethics, empower interviewees by allowing them control of what is 
written (Mero-Jaffe, 2011).   On the other hand, Payne et al (2007) suggests that giving 
participants transcripts is an act of empowerment and this means that the researcher 
respects their experience and contribution to research.  The responses I received from 
participants helped me to authenticate what was said in the interview, correct any 
language and change the balance of power between me and participant.  The feedback I 
received from a telephone call from each participant to verify any changes was that the 
integrity of transcript was true reflection of interviews and only minor changes like incorrect 
language and spelling errors had to be made.  Researchers also send transcripts to 
participants to preserve norms of etiquette, individual wellbeing, and freedom of consent, 
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choice, and principle of justice, decency and equality (Kvale, 1996, cited in Mero-Jaffe, 
2001).  All of which maintains ethical standards as highlighted in my study.  Participants 
felt respected and their dignity protected by anonymity in transcripts and in my opinion 
alleviated feelings of embarrassment and threat due the sensitive nature of my study.   
 Stage 3:  Abstraction 
In the Abstraction stage second order constructs like fear, anxiety, pain, invasion was 
developed from first order constructs and grouped into sub-themes. 
 
Table 7: Example of stage 3 of analysis Abstraction where I developed second order 
constructs to form sub themes 
 
First Order Constructs Second Order 
Constructs 
Sub-themes 
Felt scared missing 
screening 
Fear Emotional response to anal 
screening, fear of missing 
screening 
Very anxious, didn’t want to 
walk out of the house even 
I almost became 
agoraphobic. 
Anxiety Emotional response to having anal 
cancer, feeling anxious  
Pain during anal screening Pain Physical experience of pain during 
screening 
Invasion during anal 
screening 
Invasion Physical experience of Invasion 
 
Once I coded the first order constructs; I generated second order constructs, e.g. ‘Fear’ 
using my knowledge of data and personal knowledge.  This was developed from first order 
constructs like ‘felt scared of missing screening’ and these were abstractions of the first 
order constructs.  This in effect was where I identified second order constructs (see table 
7).  The emergent sub themes were listed and organised to form clusters of related 
themes. Sub-themes were developed from second order constructs like ‘fear’ and ‘anxiety 
and grouped together to form a sub-theme ‘emotional responses’.  This process as 
discussed by Smith et al (2009) of how super ordinate (i.e. putting like with like and 
developing a new name for the cluster) themes can be identified through abstraction.  
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Thus, at the end of this stage all the relevant data were grouped under each construct for 
each subgroup to answer the main research question for my study.   
 
 Stage 4:  Synthesis and theme development 
Sub-themes:  Fear and Anxiety for example grouped together to form main themes for 
example, psychological effects of anal cancer screening.  Physical experience of pain and 
invasion grouped to form a theme-anal screening procedure 
 
Table 8: Example of stage 4 of synthesis in data analysis stage depicting the 
development of sub-themes into themes 
 
Second order 
constructs 
Sub-themes Themes 
Fear Emotional response to 
anal screening, fear of 
missing screening 
 
 
Psychological effects of 
anal cancer screening Anxiety Emotional response to 
having anal cancer, feeling 
anxious 
Pain Physical experience of 
pain during screening 
 
Anal cancer screening 
procedure Invasion Physical experience of 
Invasion 
 
 
In this stage, the second order constructs (e.g. fear or anxiety) were grouped together into 
a number of smaller broad themes e.g. emotional responses to anal cancer screening (see 
table 8).  These themes were developed from stages one to three of analysis stages and I 
interrogated the relationship between themes and sub themes by reading and re-reading 
all the data.  I found myself moving backwards and forwards between the literature,  
research texts and earlier analysis moving from parts to whole following a process as part 
of the hermeneutic cycle. This was an important part of the analysis process which 
ensured that I did a thorough analysis of data.  This in-depth interpretation of the 
experiences and perceptions of patients and clinicians in anal cancer screening and its 
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psychological impact it has on the participants helped me identify meanings that 
participants could not articulate due to the sensitive nature of the phenomenon being 
investigated.  Some participants found it difficult to express or discuss what they trying to 
say which required for me to explore and interpret what they actually wanted to say and 
attach a meaning or interpretation to their experience and perception. 
 
I presented the preliminary findings of themes and sub themes at the International 
Neoplasia Scientific Meeting (Conference) 2015 in Atlanta, United States to gain feedback 
on the credibility of the themes and sub-themes (as presented in table 7) to see how these 
findings could be transferred to clinicians, patients, research community and educators 
who attended the conference.  The preliminary findings of my study showed that patients 
and clinicians identified that cancer is a worry; the actual procedure is uncomfortable; 
associated with pain, is acceptable but tolerability was variable.  Information available on 
AIN or anal screening is very limited in the UK and that there are associated psychological 
effects like anxiety, fear, and embarrassment.  I found the research findings presented at 
the conference helped me refine and further develop a theme which is presented in my 
findings chapter.  The conference feedback provided me with supplementary information 
into the participants’ experiences and reflections which challenged my interpretations 
when I explored their perceptions and experiences on anal cancer screening.  The value of 
presenting research findings at the IANS conference was to get feedback, but most 
importantly according to Ajjawi & Higgs (2007) is an opportunity for researchers to reflect 
on their emerging interpretations in the process of writing and articulating the research 
process and content.  This also challenged my emerging interpretation through an 
experienced research community abroad which was seen through broad lenses which 
encourage explanations and arguments which was invaluable to the refinement of my 
study.  
 Stage 5:  Illuminating and Illustrating the Phenomena 
In this stage, I examined the themes and sub-themes from the data and looked for links 
with the literature.  I used the themes and sub themes, looked and interrelationships and 
constructed participants’ experiences and perceptions by quoting their own words (e.g. 
very anxious, didn’t want to walk out of the house even I almost became agoraphobic) to 
illuminate and highlight key findings from data.  I looked further into developing links 
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between main themes to support theoretical development.  In this stage I was able to 
present the findings with supportive literature as presented in chapter 5 of my study.   
 Stage 6: Integration and critique 
The final stage of data analysis involved critique by my academic supervisors, my work-
based lead Physician and feedback from the conference which had an impact and 
increased my understanding of the phenomenon.  Comments received were incorporated 
into the interpretation and adjustments made accordingly.  Verbal feedback via telephone 
conversation and email communication was sent to me and I included this in my study for 
example, I presented preliminary findings of my study at the IANS conference in Atlanta, 
comments received about women and anal cancer screening was the main topic at the 
conference by most presenters.  My study mainly included MSM who were interviewed as 
AIN was diagnosed mostly in MSM and only one female my study that had been screened 
and had AIN at my Trust.  I therefore had to justify the uptake of women in anal cancer 
screening in my study although all women were offered anal cytology screening during 
routine HIV outpatient appointments.   
 
Once the process of Interpretive phenomenological analysis was completed 
using the six stages of data analysis, I developed 5 main themes and sub-themes as 
illustrated in table (9) and appendix 14 (nodes/codes).  The main themes are presented 
below:  
• Psychological effects of anal screening (Worry, anxiety and fear about anal cancer; 
Embarrassment, shame, stigma and reassurance) 
• Screening procedures (Acceptability and Tolerability of Anal Cancer Screening; 
Pain, bleeding, and discomfort) 
• Education, knowledge and training in anal cancer screening 
• Social and sexual activity  
• Anal cancer screening guidelines and practices in sexual health clinics in the UK.   
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Table 9: Stage 6 of data analysis with 5 main Themes and Sub-Themes  
 
Themes  Sub-Themes 
1. Psychological effects of anal 
cancer       screening 
• Worry 
• Anxiety 
• Fear 
• Embarrassment 
• Shame 
• Stigma 
• Reassurance 
2. Anal Screening     Procedures • Acceptability and Tolerability of 
anal cancer screening 
• Pain 
• Bleeding 
• Discomfort 
• Invasive 
3. Education and Training • Knowledge and education on anal 
cancer screening 
• Training of Clinicians 
4.  Social and Sexual Activity • Social life 
• Sexual activity 
5. Guidelines and Practices • Anal screening guidelines in the 
UK 
• Geography of Clinics 
• Referrals to anoscopy Clinics 
• Multifocal disease 
• Evidence based practice 
• Cost effectiveness 
• Recommendations for anal 
screening 
• Benefits of anal cancer screening 
 
 
The themes and sub-themes are discussed in chapter 4 and a discussion provided in 
chapter 5.  Some sub-themes are grouped together under main themes as presented in 
the next two chapters.   
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4 Findings 
The aim of my study is to explore the perceptions and experiences of patients and 
clinicians in anal cancer screening.  Few qualitative studies have examined the 
perceptions and experiences of patients in anal screening.  Clinicians’ perceptions and 
experiences on anal cancer screening were only considered in few studies to date too. 
Interpretive phenomenological analysis of the unstructured interviews resulted in the 
following themes: Psychological effects of anal screening, Screening Procedures, 
Education and Training, Social and sexual activity, Guidelines and Practices.    According 
to Beins (2013), researchers can be in a position to recognise that there may be some 
psychological processes that manifest in participants depending on culture, race and 
ethnicity or even socio-economic status.  I have included patient demographics to give the 
reader an understanding of the participants involved in my study. 
 
4.1 Participant demographics 
Wyse (2012) describes demographics as characteristics of a population such as race, 
ethnicity, gender, age, education, profession, occupation, income level, and marital 
status, which are all typical examples of demographics that are used.  My study focuses 
on anal cancer screening by exploring the perceptions and experiences of participants and 
through some of these demographic descriptions e.g. MSM, HIV positive patients and 
clinicians in sexual health clinics in the UK can provide a context for the group of 
participants considered for my study.   According to Polit and Beck (2010), this will allow 
readers and other researchers to determine to whom these findings can provide a rich, 
contextualized understanding of some aspect of human experience through the intensive 
study of particular cases.  Furthermore, this inclusion of participant demographics will 
greatly add to the field’s knowledge base and understanding that variations exist among 
populations (Hammer, 2011). Twenty-two participants in total were purposefully selected 
from those who volunteered to create the sample for my study.  Thirteen patients identified 
themselves as men who have sex with men living with HIV and one patient identified as a 
heterosexual female, living with HIV (Table 10).  Patients were recruited from one HIV 
outpatient clinic and were 18 years and older.  People living with HIV are a challenging 
group of and it was not appropriate for me to ask them during interviews about their 
sexuality or for instance therefore I retrieved this information from the demographic data of 
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the electronic patient records at the HIV outpatient clinic.  The eight clinicians included in 
my study all work in a sexual health clinic undertaking anal screening. Clinicians were 
located throughout the United Kingdom of which there were two female doctors, one 
female nurse practitioner and five male doctors (Table 11).  Demographic information of 
clinicians was obtained during interviews.  Data were collected between May and 
September 2014. 
 
Table 10:  Patient demographics:  pseudonym name, gender, sexuality & Health 
status 
 
Patient Age Gender Sexuality Health Status 
Patient 1 44 Male Homosexual HIV positive 
Patient 2 59 Male Homosexual HIV positive 
Patient 3 54 Male Homosexual HIV positive 
Patient 4 29 Male Homosexual HIV positive 
Patient 5 65 Male Homosexual HIV positive 
Patient 6 50 Female Heterosexual HIV positive 
Patient 7 38 Male Homosexual HIV positive 
Patient 8 51 Male Homosexual HIV positive 
Patient 9 74 Male Homosexual HIV positive 
Patient 10 59 Male Homosexual HIV positive 
Patient 11 40 Male Homosexual HIV positive 
Patient 12 49 Male Homosexual HIV positive 
Patient 13 41 Male Homosexual HIV positive 
Patient 14 48 Male Homosexual HIV positive 
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Table 11:  Clinician demographics:  Clinician, gender, 
occupation/profession, specialty and location of clinic 
 
Clinician Gender Occupation/Profession Speciality Region 
Clinician 
1 
Female Advanced Nurse 
Practitioner 
HIV/GUM 
clinic 
London 
Clinician 
2 
Female Gynaecologist/Researcher HIV/GUM 
clinic 
North 
East 
England 
Clinician 
3 
Male Consultant Physician HIV/GUM 
clinic 
London 
Clinician 
4 
Male Consultant Physician HIV/GUM 
clinic 
London 
Clinician 
5 
Male Consultant Physician HIV/GUM 
clinic 
London 
Clinician 
6 
Male Consultant Physician HIV/GUM 
clinic 
London 
Clinician 
7 
Female Consultant Physician HIV/GUM 
clinic 
London 
Clinician 
8 
Male Consultant Physician HIV/GUM 
clinic 
London 
 
 
The next section of this chapter will include the findings of main themes and sub-themes 
from patients and clinicians.  The above section on demographic information demonstrates 
the supporting information I provide for my study.    
 
4.2 Psychological Effects of Anal Cancer Screening 
In this section I will discuss the main themes and sub themes on how anal cancer 
screening can provoke emotional responses like, worry, anxiety, fear, embarrassment, 
shame, stigma and reassurance.  Patients and clinicians in my study clearly explains their 
perceptions and experiences on anal screening where some common themes emerged.  
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Anal cancer can be viewed as a potentially life-threatening health condition that affects 
participants who undergo screening for anal cancer.  
 Worry, Anxiety and Fear about Anal Cancer 
There are a variety of worries highlighted in my study relating to anal cancer from patients’ 
perspective. Patients have become worried, anxious and scared even though they 
received information on the anal cancer screening process.  The patients worry is about 
getting anal cancer.  Clinicians worry because of the discrepancies with results of anal 
cytology and biopsies.  They also worry about those patients who go on to get anal cancer 
inspite of effective treatments as lesions do return in some patients. Fear is what links sets 
of stimuli to patterns of behaviours and this link in the case of an emotion like fear is much 
more flexible and the state of this fear can exist prior to and after the eliciting stimuli 
(Adolphs, 2013).  Therefore, fear is a response to a threat which can be real or perceived 
where having anal cancer diagnosis makes participants frightened.  Fear and worry are 
interrelated as fear causes anxiety and anxiety causes fear which is all related to a life 
threating disease like anal cancer.  These findings demonstrate that the emotions as 
experienced by participants are real as well as perceived especially in relation to anxiety.   
Patients-Worry 
“All the information I was given would not have prepared me, you still get worried and 
anxious and scared because you don’t know what is going to happen. So, the information 
itself does not prepare you. It makes you aware, of maybe what the procedure is going to 
be, what it’s being done for you, but you don’t really get prepared in term of relaxing and 
you know.” (Patient 6) 
 
“Yes.  I was anxious, well I should because I ... I always try to ... when I got the call, I 
thought there was an issue, and there was a problem.   So, then I panic, oh God why, what 
was the reason for anoscopy and I went on Google and found the reason for anoscopy 
and some things came out about anal cancer.  I was worried, yeah.” (Patient 13) 
 
Patient’s perception of worry on cancer or the perceived notion of getting cancer is a far 
greater worry than having HIV. This is a scary emotional experience for these patients.   
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“To be honest the thought of progressing to anal cancer probably worries me more than 
the HIV infection…  For me the whole anal cancer thing is scarier, I suppose than the HIV.” 
(Patient 2) 
 
Clearly, patients’ family history of cancer contributes to their worry and the realisation that 
cancer is difficult to treat in the anal area. 
 
“Yes of course I do worry.   I mean to be honest I worry about cancer more than HIV 
because my sister died of cancer and I think first my brother-in-law had …... I have friends 
who have got HIV and so once they got cancer …. it's very difficult to fight, that's what I 
think” (Patient 12) 
Clinicians-Worry 
Clinicians have also expressed their worry during anal cancer screening.  They worry as 
an anal Pap smear can show dysplasia but during anoscopy procedure no high-grade 
disease is found even with a targeted biopsy.  Another worry is around patients having to 
return for repeated anoscopies in a short period of time. 
 
“What I can tell you is that it worries me that you can smear somebody and it does show 
dysplasia and then when you do anoscopy with targeted biopsy you don't pick up the high-
grade disease and it worries me because I can't be bringing people back three or four 
times to do anoscopies in the short period” (Clinician 4) 
 
In clinician’s experience, many patients who have undergone treatments for  
AIN have developed cancers as the lesions are stubborn and keep returning which creates 
a worry for these clinicians. 
 
“…. even with all these clever treatments, even with excision, laser, and the lesions do 
stubbornly keep on coming back in some patients.   And that's a worry...a number of 
patients in that category who have gone on to get cancers.” (Clinician 6) 
 
Clinicians also believe that patients who have been worried about cancer stopped 
returning for follow-up appointments as they did not have the courage to do so.   
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“what I've already kind of said so the psychological impact is there's been a couple who've 
been worried they've had cancer and stopped having it done because were trying to get 
the courage to come in and have a screen” (Clinician 2) 
 
Patients have perceived the concept of anxiety differently. These patients that have 
received results of cytology and biopsies became anxious; described their experience as 
not wanting to leave the home or just feeling this emotion all the time.  This has affected 
their ability to be part of the screening process.  This left the patients feeling helpless or 
the feeling of being trapped and can result in them avoiding going into to clinic for 
screening.   
Patients-Anxiety 
“Emotionally, yes.  Very anxious, didn’t want to walk out of the house even I almost 
became agoraphobic.  I didn’t have dreams or nightmares.  My sleep wasn’t affected; it 
was just a very heightened state of being anxious all the time and that was torturous 
because that actually went on for quite a while” (Patient 1) 
 
“Like I once had a doctor say to me in the early days, when my immune system was 
failing, his exact words were ‘you don’t have to worry about going blind yet.’  It’s an 
extraordinary giveaway of what he was trying not to tell me, but the word ‘yet’ summarised 
everything. It was the fear of the unknown for yourself? So, that created worry and 
massive amount of anxiety. This would be the same for developing anal cancer” (Patient 
3).   
Clinicians-Anxiety 
In clinicians’ experience, patients overreact to their abnormal cytology result and describe 
patients experience as the ‘impending sense of doom’ or ‘like death for instance’ which 
results in a state of anxiety for these patients. 
 
“…patients completely over react so they have a slightly, you know they have some low-
grade cytology and they think they're going to die and they're in this huge state of anxiety 
ahead of having the anoscopy.” (Clinician 3) 
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Fear can be an unpleasant emotion or even a thought or perception that something is 
going to happen which is highlighted by patients and clinicians in my study.  This can be 
distressing for patients as it could mean impending danger.  Fear is described by patients 
as “cancer scare” or “scared me and put the fear of god in me” or “it’s like death” while the 
clinicians fear missing something while doing the procedure.  This is a reaction to 
unpleasant news creates fear of the possibility of patients having anal cancer.   
Patients-fear 
Patients experienced fear or describe it as ‘cancer scare’ when they hear of cancer due to 
a personal family experience therefore suggest monitoring for AIN is worthwhile.   
 
“My father had suffered and died of testicular cancer and… I had a cancer scare so it is 
always good to be monitoring such an area for concern as people may not think it will 
happen to them, so it is always good to stay ahead of the game.” (Patient 11) 
 
Some patients also explain that not attending follow up screening or the reluctance to 
screen made them afraid as the results of anal screening meant they had abnormal cells 
on anal Pap smear. This kept patients in the screening program.    
 
“I’m probably better than most, but even 2 years ago I let an appointment slip and I’m sure 
it was because of reluctance and then I almost got caught out that they found some cells 
that they weren’t happy about and that really scared me and put the fear of god in me; I’ll 
never miss an appointment again.”  (Patient 3). 
 
“Maybe scared because as a Doctor I know more than other patients and I know the 
consequences and everything so it’s a good way of monitoring and preventing?” (Patient 
7). 
Clinicians-Fear 
Clinicians have perceived their experience of patients and being scared as it may be 
associated with cancer.   
 
“I think that a proportion don’t attend their first appointment because they’re scared.  
Clearly anything that has cancer associated with it is scary and daunting so I think that 
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needs to that patients need to be reassured that an abnormal smear doesn’t mean they’ve 
got a cancer so we try to limit that worry.” (Clinician 8) 
 
Clinicians experience fear in most cases especially the fear of missing a diagnosis during 
anal cancer screening procedures.   
 
“I don't tend to fear of doing the procedure or doing the biopsy or anything like that, but 
you do have a fear of missing something” (Clinician 2) 
 
The psychological effects of anal cancer screening involved repetitive emotions about the 
screening process and the possibility of developing anal cancer.  Anal cancer screening 
has generated worry, anxiety and fear in participants which appears to be interrelated as 
fear and worry causes anxiety, and anxiety causes fear in response to anal cancer and 
screening.    
 Embarrassment, Shame, Stigma and Reassurance 
Embarrassment, shame, stigma and reassurance are emotions recognised by participants 
in my study.  Patients have constructed and monitored these emotions about their self-
image. Whilst these emotions are psychological issues, these emotions can also be social 
issues too.  This is highlighted in emotions like shame and stigma.  Embarrassment in the 
context of my study is clear as patients were self-conscious or felt awkward about anal 
screening.   This can result in loss of dignity and privacy.  
Patient Embarrassment 
“It just freaks me out a little bit knowing that there is a sort of exposed bit of  
my body down there and you have faeces rushing past.  I’m one of those people that are 
terribly, terribly fussy and terribly …….” (Patient 2) 
 
“Yes, it is a humiliation, a humiliating procedure really.  Yes, it is humiliating, you feel 
embarrassed, because you have to strip for other people.” (Patient 6) 
Some patients describe anal examination as an intimate procedure and are concerned if 
they were dirty in the perianal area. 
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“Just the fact you have it's a very kind of intimate procedure and I was worried that I would 
be dirty, so I don't know how I should prepare myself and so …I wanted to ensure that I 
was clean and there would not be an accident”. (Patient 13) 
Clinician-Embarassment 
Clinicians mention that patients feel embarrassed about their sexual activity and do not 
want to be reminded of how they acquired HIV and the possibility of acquiring AIN in the 
same way as HIV through sexual activity.   
 
“A lot of them fear I think that maybe the way it was acquired it like the HIV by having anal 
receptive sex and so it's not something they want to be reminded of” (Clinician 2) 
 
Shame as experienced by participants is one of humiliation or distress about how people 
perceive their AIN or cancer and the assumptions people would make like ‘they had done 
something to bring on cancer’.  This can also be described as an act related to sexual 
activity that brought on this condition, or shame in the eyes of the community as alluded to 
by the clinicians’ perspective on women.  Patients feel shame with screening for anal 
cancer, and having AIN, because HIV has been associated with shame and is a taboo 
subject.  This emotion ‘shame in anal cancer screening’ raises many questions about how 
AIN is acquired.   
Patient-Shame 
“The whole thing of HIV always comes with …the shame and people are always, even if 
it’s unspoken, there is always the question of ‘how did you  
get it? What did you do? or whether you “deserved” it or not’ – all of these issues come up 
on this.” (Patient 3)  
Clinician-Shame 
In clinician’s experience, HIV positive women who have had anal receptive intercourse for 
cultural reasons see this as a shameful act as HIV can be transmitted via anal receptive 
sex.  Therefore, women who acquire HPV through anal sex may have AIN in the anal 
canal, and this is a subject that’s not spoken about or a taboo.   
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“Women fear they have acquired the HIV having anal receptive sex and so it's not 
something they want to be reminded of.   So previously culturally they would have anal sex 
(a) not to get pregnant or (b) also to preserve their virginity and so now they see that as a 
shameful act because it's possibly how they acquired the HIV there's a lot of onus on anal 
receptive intercourse and I mean now we know the background and it is a contributory 
factor, we know HPV driven and I think unfortunately in society anal receptive intercourse 
isn't spoken about enough” (Clinician 2) 
 
Participants have explained their perception of stigma associated with anal screening on 
many dimensions like the association of HIV and AIN, people’s perception or people in 
society have strong feelings about sexual behaviours, associating AIN as being a ‘gays 
man’s’ disease, stigma that HIV positive women experience due to sexual practices as 
well as self-stigma. 
Patient-Stigma 
Patients experience stigma and it affects them psychologically as living with  
HIV is associated with stigma.  People label people living with HIV therefore if patients 
have AIN would be labelled the same way as being HIV positive. 
 
“Psychologically ……, because you know it’s a part of my past that I can’t ever erase, so 
you know like HIV in a way I feel it’s got a bit of undercurrent to it, a bit of a stigma.  I think 
people assume if you have AIN, that you’ve been I don’t know a dirty slut or whatever.”  
(Patient 1) 
 
Patients experience stigma of having AIN as some of them believe it is related to being 
gay. 
 
“I was surprised, you know, just wondering what could be going on, about things that can 
go wrong, you know because most people think like I did, and relate it to gay people. That 
it would just affect gay men really than the general population” (Patient 6) 
 
Patients have highlighted that stigma exists because of people’s perception of HIV and the 
association with sexual activity.  Sexual activity brings out issues of HIV and the 
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association of HIV with ‘black people’ but at the end of the day this raises the issues of 
stigma. 
 
“And in fact, even just this week it’s all in the news about the owner of the Los Angeles 
Laker Sterling making these racist remarks about people of colour, particularly black 
people, and he raised Magic Johnson’s (the great basketball player) HIV status.  I’ll just 
divert to this because it’s perfect illustration.  He criticised him for sleeping around, getting 
HIV etc etc etc, when in fact the same guy was defending his actions of what he said on 
tape that was released by a woman that he was associated perhaps sexually, that he was 
only saying those things because he wanted to get sex out of her.  So, the hypocrisy and 
the irony of his criticism, but what it does also raise is the stigma of HIV.”  (Patient 3) 
Clinician-Stigma 
There is still a lot of stigma experienced by women as perceived by clinicians when 
screening for anal cancer and it remains a taboo subject which in turn affects their 
attendance for screening.  The main reason for this is that anal receptive sex is not spoken 
of among women although it is practiced and creates a cultural barrier.   
 
“…t's still a lot of stigma attached to HIV care for these women and I think if it's something 
that was incorporated in the national programme they would attend… a lot of HIV positive 
women are all poor smear attenders… they know they are high risk group and I think that 
the test for them and the association even if it's not spoken when they have receptive sex 
it's something of a massive stigma for them especially cultural. I think unfortunately in 
society it's still a taboo subject even though it's something that's being practised regularly” 
(Clinician 2). 
 
Clinicians experience self-stigma in their practice of anal screening which is attributed to 
lack of experience in the field of anal screening.  Realisation of this stigma has led to 
learning that stigma can help improve practice through understanding.  Clinicians also 
have perceptions about anal cancer screening and the stigma they have themselves is 
unacceptable behaviour.   
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“I didn't realise that maybe I had stigma in my practice because I hadn't had exposure so I 
think it's been a good learning curve for me.  I had stigma about it.  I didn't realise I did but 
personally I thought well it's just not going to be acceptable.”  (Clinician 2) 
 
Patients felt reassured knowing that they could be part of a screening programme and 
found that the treatment offered helps alleviates their fears and doubts about AIN.  Being 
screened for anal cancer provides the comfort of feeling less worried and more confident 
as they are being monitored and treated.  Clinicians feel that patients who are given 
information regarding anal cancer screening procedures, an explanation of what anal 
smear results mean and rationale for looking at AIN or high-grade disease provides 
patients with a degree of reassurance.   
Patient-Reassurance 
Patients find it reassuring to be part of a screening programme and being able to stay on 
the programme 
  
“I found it wonderful that the programme was available… I found the fact that I have been 
able to find a screening programme that I have been able to stay in a great reassurance… 
I can stay in the screening programme, having already joined it and I find that very 
reassuring. (Patient 1) 
 
Patients also felt a degree of assurance that they can be offered some treatment for AIN 
and monitoring. 
 
I think you get reassured because you know that something can be done about it” (Patient 
6) 
 
“It was a slight shock but more reassurance that you are covering all aspects that could 
potentially be life changing or life-threatening situation so for me.  It is a bit more 
inconvenient as I have to keep coming back for other tests but on the flip side I would 
rather someone be proactive and ensure they monitoring so that it’s one thing that I 
shouldn’t have to worry about or keep thinking so someone there to say yeah you’ve been 
here in six months we need to check you every six months just as a precautionary 
measure so it’s one less thing to worry about so if it’s something like this has to be done so 
be it.” (Patient 11)   
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Clinician-Reassurance 
Clinicians have reported that by providing information to patients about anoscopy is 
reassuring.  
“We give them an information leaflet about the anoscopy which tells them why they’re 
having it, how to prepare, how not to prepare for it, what to do, what not to do and there’s a 
degree of reassurance …” (Clinician 4) 
 
Some patients who have had AIDS defining illness like Pneumocystis carinii pneumonia, 
Kaposi’s sarcoma, cerebral toxoplasmosis, or tuberculosis for instance, feel it is reassuring 
to be monitored every three months for AIN.   
 
“Extremely reassuring to be monitored every 3 months, extremely reassuring yes; also, I 
think because I’ve had life-threatening illness you know when I have had the AIDS defining 
illnesses and I thought I was going to die, especially on one occasion, something like this 
probably isn’t as scary…”  (Patient 2) 
 
Embarrassment, shame and stigma play an important part in how participants perceive 
and experience the anal cancer screening process. Reassurance as reported by patients 
meant they can be part of the screening program offered at the clinic.  Clinicians 
mentioned that by patients just being screed creates less worry, the information they are 
given about the procedure and rationale for screening creates a degree of reassurance for 
patients.     
4.3 Anal Cancer Screening Procedures 
Screening procedures in my study included anal cytology, digital anorectal examination 
(DARE) and high resolution anoscopy (HRA)which is undertaken by clinicians who have 
had specialised training in anal cancer screening. The following section will discuss how 
patients and clinicians experience and perceive anal screening procedures in the UK. 
 Acceptability and Tolerability of Anal Cancer Screening 
Acceptability in the context of my study refers to anal cytology, DARE and HRA as an 
acceptable screening procedure for patients, while the procedure a patient can endure 
which is bearable in the time frame in which procedure is undertaken explains their 
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tolerability.  Patients were informed of the anal screening procedures prior to an anoscopy 
appointment and information leaflets are sent to patients to inform them of AIN, anal 
cytology and HRA procedure.  The reasons for anal cancer screening are also explained in 
the leaflets as it is best practice in healthcare to inform patients so that they can make an 
informed choice about their health.  Once patients are informed as to why these 
procedures are performed, they accepted to undergo the screening procedure.  Generally, 
patients felt that the anal cytology, DARE and HRA are acceptable and tolerable.  
Clinicians on the other hand, felt anal screening procedure for a patient was an acceptable 
procedure although tolerability was variable.   
Patient-Acceptability 
Some patients tolerated the HRA procedure and found it acceptable while other patients 
tolerated the HRA once a numbing sensation was introduced by using an anaesthetic gel.    
 
“My experience in this clinic in terms of screening they are tolerable and acceptable, 
otherwise I wouldn’t come I would find somewhere else” (Patient 3) 
 
“I tolerated it very well” (Patient 10) 
 
“I have had it done previously and I couldn’t tolerate the pain, it was awful.  That’s what put 
me off having it done again, but this time I was ‘numbed up’ and it helped me so much.” 
(Patient 4) 
Clinician-Acceptability 
In clinician’s experience in anal screening, when the anoscope is inserted into the anal 
canal of an MSM who have had anal receptive sex, there is less resistance in the anal 
canal as the anal tone is not strong therefore are able to tolerate the procedure more than 
those who have not had anal receptive sex.   
 
“In terms of the anoscopy, there’s perhaps less resistance in men who have sex with men 
which is equivalent of vaginismus of the anus.  In gay men who’ve had receptive anal sex, 
perhaps there’s not such a resistance of the anoscope being inserted, that perhaps the 
anal tone is not as strong, resistance to scope isn’t so strong but those that have had 
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receptive sex tend to tolerate the procedure much better than those that haven’t.” 
(Clinician 8) 
 
Clinicians perceive that women do not tolerate the anoscopy procedure, but have it done 
and accept it as part of screening as these women want to contribute to evidence.   
 
“I find it very difficult for them…. You know it’s not very tolerable, but they have to accept 
the fact that it’s a screening process… They’re excited about that but I think they want to 
contribute to evidence… it is well accepted from our patient satisfaction surveys that 
patients have accepted it quite well…. we found it acceptable… a significant number of 
people found anoscopy, even though it was an invasive procedure, acceptable.” (Clinician 
7) 
 Invasive Procedure 
In my study patients and clinicians have experienced and perceived anal screening as an 
invasive procedure.  The anal Pap involves the insertion of a Dacron cotton swab in anal 
canal for anal cytology. DARE where a finger is inserted into anal canal to palpate any 
lumps, masses or polyps.  HRA is done by introducing the anoscope into anal canal, to 
visualise any lesions or warts for example and taking a biopsy, where a small piece of  
tissue is sampled for histology analysis.  This can be described as undesirable where 
objects or instruments are inserted into the body i.e. anus, as part of a medical procedure 
for anal screening.  This also invades the dignity and privacy of patients and is described 
both by patients and clinicians. 
Patient-Invasiveness  
Patients have experienced anoscopy invasive in every sense but will undergo anoscopy to 
protect their health and for their own well-being. 
 
“The whole experience of anal exams and whatever, I can’t say it’s ever something that 
one looks forward to, to dropping your trousers and having someone to look up your 
rectum, your ass, your butt – whatever.  It’s invasive in every sense. It’s always different 
having a rectal/anal exam from just having blood taken, even in the most invasive 
procedures and what makes the psychological obstacles go away for me is that I realise 
and tell myself that I’m doing this for my own wellbeing and my own health. I do that 
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dialogue with myself that I have to go to this appointment that I have to allow myself to be 
invaded and examined in order to protect myself.” (Patient 3) 
 
“My personal opinion as a user is, I don’t like them, for me it is an intrusion.  That’s why I 
dislike them. It’s going in to my body, I don’t like that feeling and I have no control of it.” 
(Patient 4) 
Clinician-Invasiveness 
Clinicians believe that anoscopy is the gold standard to identify abnormalities in the anal 
canal and to take biopsies.  However, they also believe it is not the most comfortable or 
dignified procedure.   
“it is an invasive test but it’s kind of goal standard … it’s a good way to identify certain 
things within the clinic and take biopsies there and it’s a goal standard…High resolution 
anoscopy is definitely an invasive procedure…it’s not the most comfortable procedure.   It 
is not the most dignified procedure so there are definitely those issues there.” (Clinician 7) 
 Pain, Bleeding, and Discomfort 
Pain was only experienced by patients during anal pap sample collection and during HRA; 
however, patients perceived pain through the sensation of swab and experienced pain 
when the anoscope was inserted.  
 
Patient-Pain 
There are different reports about how patients experience pain.  Patients found that the 
anal Pap smear was a bit painful but would rather have it done even though they 
experience some discomfort while the material of the ansocope made the procedure 
painful for some patients.   
 
“It was a little bit painful but wasn't like something that I would rather have done and have 
a bit of discomfort” (Patient 13) 
 
“And that one is painful the metal one, it’s called don’t know.  It’s hard and is it plastic? It 
feels hard anyway. (Patient 6) 
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Patients also experienced pain when a biopsy is taken and even after the biopsy was 
done.   
 
“When they do the biopsy that can be painful and I’m sure when they taking the sample 
you can feel quite painful after they've done the biopsy” 
 (Patient 14) 
 
It’s a really sharp sudden pain for me, but it was over with in two seconds.” 
(Patient 4) 
Clinician-Pain 
Clinicians have reported that they are aware of the patients’ experience of pain during 
HRA procedure. 
 
 “It can cause a bit of pain; it can cause some marked pain and some patients find it 
unpleasant.”  (Clinician 8) 
Patient-Bleeding 
During HRA examination a biopsy is taken from the anal canal and tissue is sampled for 
histology to determine the presence of AIN or cancer and graded as such.  This can cause 
bleeding as explained by patients which is minimal and stops after a few days.  Clinicians 
on the hand mention that patients may bleed for a week or two but are fine after some 
reassurance.  Patients do have bleeding after having a biopsy for up to three days in their 
experience, but bleeding did stop after 48 hours.  Patients were worried about the bleeding 
but were reassured bleeding will stop after 24 or 48 hours.   
 
“The only downside is I know that after the anoscopy, I’m going to be a little bit sore for the 
next 48 hours, but I think the worse thing is after biopsies when sometimes the bleeding 
goes on for maybe 2½ days, when you go to the loo or whatever, and it just freaks me a bit 
to see blood dripping in to the pan erm after going to the loo and blood on the tissue-paper 
on clean-up of course, but I know that’s only going to last for 3 days at the most and 
sometimes it stops within 24 hours.” (Patient 2) 
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“A small amount of bleeding.  No pain.  Just a little bit of sensation that things were going 
on and that’s it.” (Patient 3) 
Clinician-Bleeding 
Clinicians have experiences with patients who bleed for a week or 2 and these patients 
just need some reassurance that bleeding will stop. The perception of clinicians is that by 
reassuring patients that bleeding will stop meant they were fine and attended follow up 
appointments.   
 
“So here people might bleed for a week or two, there might be one or two that come back 
to the clinic and need reassurance but they're by and large fine.” (Clinician 4) 
 
The discomfort experienced as described by patients and clinicians is feeling 
uncomfortable physically during anal screening procedure.  Positioning plays an important 
role during anal screening and clinicians explain how the lithotomy position makes patients 
vulnerable.   
Patient-Discomfort 
Patients found the anal Pap smear uncomfortable and describe it as rough but perceive 
this as potentially life- saving.    
 
“It is only half an hour of your time of discomfort, but it is potentially lifesaving” 
“Remember the PAP thing was uncomfortable - it was quite rough”  
(Patient 11) 
 
Patients find the anoscopy uncomfortable and find it a horrible procedure while those 
patients that have never had anal receptive sex or procedure in their anus find it 
uncomfortable.  
 
“So, the Pap test isn’t an issue, but the anoscopy that I’ve just had and my views on that 
are basically it is uncomfortable and it’s horrible.” (Patient 4) 
 
“Well it is very uncomfortable, because I have not put in anything inside my anus. So, I am 
not used to putting anything inside my anus, so it is very uncomfortable.” (Patient 6) 
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Patients have also experienced discomfort with HRA describing this procedure as ‘very 
uncomfortable’ 
 
“It’s very uncomfortable. It feels like my bowels are about to evacuated. You know, when 
you put this instrument up somebody, and I don’t know if it’s different for other people, but 
it feels, it constantly feels like I am about to evacuate my bowels, it is a very uncomfortable 
feeling. And you …, I don’t know if you have had the procedure but that’s what it feels like, 
it feels constantly like I’m having a lot of traffic going through my anus.  You know, but 
there is nothing passing. But yeah, it’s uncomfortable.” (Patient 8)  
Clinician-Discomfort 
In clinicians’ perception of discomfort in patients, find that anoscopy is a foreign procedure 
for lots of individuals and is not comfortable.  
“The procedure itself is foreign to lots of individuals; I mean it’s not necessarily particularly 
comfortable.” (Clinician 8) 
 
Clinicians mentioned that position of a patient during anoscopy can be uncomfortable for 
patients.     
 
“I just wish there was a slightly easier way of being able to see inside because I know and 
especially the women, they find it so uncomfortable.  The actual procedure itself is not a 
very comfortable procedure for a lot of the patients. I think MSM feel vulnerable in 
lithotomy.  I think in America because they do it in left lateral and it feels less vulnerable so 
that's the first thing that I mean my facilities that way.   I've only got facility for lithotomy 
position” (clinician 2) 
 
I explored with patients how we could minimise discomfort during screening and asked the 
following question: “What can we do to minimise discomfort?” 
 
“I don’t know.  Something to do with positioning may make it easier, I don’t know.  Facing 
forwards rather than lying on your back with your legs up might be an easier way of 
relaxing your way through it, but I don’t know if that’s feasible from the inspectorial end, or 
not.” (Patient 5) 
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Patients have mentioned that they experience pain during anal Pap smear and when a 
proctoscopy in inserted into anal canal.  The sesation of the proctoscope can cause pain 
and discomfort.  Some patients have experienced pain when a biopsy was taken and 
describe this as a suddent sharp pain which lasts for a few seconds some patient s 
experience pain even a few days after a biopsy was taken.  Clinicians on the other hand 
allude to the fact that patients who have HRA procedure can cause some pain and some 
patients have marked pain after procedure and do find this procedure unpleasant.  
Patients described bleeding after a biopsy is taken can go on for up to 3 days but can stop 
24 hours after biopsy is taken and that bleeing is only a small amount. Clinicians believe 
that patients who bleed for for a week or two after HRA and biopsy need reassurance as 
bleeding will stop.  Although patients found anal Pap smear and HRA procedure 
uncomfortable, perceive these procedures as “potentially life-saving”.  Clinicians have 
mentioned that HRA procedure is foreign to most individuals and the position in which they 
are examined can be uncomfortable.  Patients have suggested that examining them face 
down (i.e. prone position) during HRA can cause less discomfort for instance.       
 
 Anoscopy versus Sigmoidoscopy in Anal Cancer Screening 
 Clinicians in my study have highlighted that anoscopy is the gold standard for detecting 
and diagnosing AIN and have explained the superiority to anoscopy versus 
sigmoidoscopy.  Clinicians believe that a sigmoidoscope is inserted too far in to rectum.  
Clinicians have mentioned that with anoscopy and the use of acetic acid, you would be 
able to visualise lesions in the lower distal anal canal. Clinicians believe that steady 
equipment like the anoscope is good especially if examining the rectal anal area.  
 
“Sigmoidoscopy is put too far in and you are interested in 5cm of anal canal …the key of 
the anoscopy is that you actually apply acetic acid to be able to see the lesions, and you 
won’t be able to do with a sigmoidoscope. it’s just a different organ…You are looking at the 
anal canal you are not looking at rectum, so I think that’s just basically case closed.” 
(Clinician 5) 
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“I think sigmoidoscopy cannot reach the terminal few inches of the anal canal effectively 
because to steady the equipment is very difficult in that part of the rectal anal area, so you 
need devices that can be easily applied steadied.  (Clinician 6)” 
 
“So, I think that HRA as Palefsky stated is the gold standard.” (Clinician 2) 
 
Generally, patients that have undergone anal cancer screening find it an acceptable and 
tolerable procedure while clinicians have reported tolerability was variable with patients but 
acceptable.  Patients have reported that anal Pap smear is painful, and they experience 
some discomfort.  Patients also experience pain after a biopsy is taken and clinicians have 
mentioned that biopsies can cause pain and can be unpleasant for them.  Bleeding after a 
biopsy according to patients persists for up to three days while clinicians reported some 
patients can bleed up to a week or two but all they need is reassurance.  Patients have 
also experienced discomfort when a Pap smear and anoscope is inserted into anal canal.  
Clinicians reported that the position in which patients are examined can cause discomfort.  
Patients and clinicians have reported that anoscopy can be invasive and invades patient’s 
privacy and dignity. Anoscopy is gold standard for detecting AIN according to clinicians 
and is superior to sigmoidoscopy.   
4.4 Education, Knowledge and Training in Anal cancer screening 
In this section, I will discuss the knowledge and education of patients and clinicians with 
regards to the information around anal cancer screening.  Patients have described their 
knowledge as limited as there is very little information available but the influence of the 
media, magazines and being an expert patient on health issues has had an impact on 
educating oneself on anal screening.  Clinicians also agree that there is very little 
information available for both clinicians and patients, that studies are now providing 
evidence and information like the Study for the Prevention of Anal Cancer (SPANC) study.  
British HIV Association (BHIVA) and British Association for Sexual Health and HIV 
(BASHH) have no information available but America has produced information on anal 
screening.  The UK has no information available except information adapted from America, 
Australia and other and HIV magazines like NAM.  There is also little training available for 
clinicians in the UK with the only accredited course offered in the US. 
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 Education and Knowledge  
Patients who started the anal screening programme in some sexual health clinics in the 
UK had limited information available in the health services but obtained information 
through other source like they would see it in magazines for instance or through 
conversations with other HIV positive people. 
Patient-information 
“I believe I was one of the first patients here to go into the screening programme, so I don’t 
think there was information available ...  I’m unaware if there is information available these 
days” (Patient 1). 
 
“I would see it in HIV positive magazines or in the treatment updates and things like that” 
(Patient 2)  
 
The first time, well I seem to recall probably about 10 years ago that it was going to the 
press that anal cancer or problems … I seem to recall seeing that in various or different 
articles I saw, or through conversation, or whatever, because people with HIV tend to talk 
to each other.” (Patient 3) 
 
Patients also believe that information is important to them especially if they are faced with 
anal cancer which is a life-threatening disease.    
 
“There needs to be a safety net, but the safety net is information, and honest information, 
because if they are facing death” (Patient 9) 
 
Patients also mentioned that reading about anal cancer and the influence of the media has 
encouraged them on educating themselves.  Knowledge on areas that impact one’s own 
health like HIV and anal cancer, makes one an expert patient.  Patient 1 describes himself 
as an expert Patient and says:   
 
“So, I think I’m a fairly, expert patient in many ways and I have stayed on top  
of reading on what’s happening in the areas I have interest in, particularly in those areas 
that might be impacting my own health problems.” 
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Clinician-Information 
Clinicians that are undertaking anal cancer screening in the UK do not have much 
information for the patients and for their practice, and neither is it outlined in any national 
guidelines in the UK.   In this way patients are less informed.   
 
“...the British HIV association for example:  there is no information available over there on 
anal screening or cancer screening … in the States there is a website dedicated where 
patients can actually get this information about what anal screening is about, where they 
can get anal …. If you look at BASHH there is absolutely nothing about that” (Clinician 5).   
There are only a few anal cancer screening services available in sexual health clinics in 
the UK and not all patients living with HIV can be screened for anal cancer. This 
information is not disseminated to people living with HIV.    
“There is pretty much very little out there and so I think patients are less informed and in 
the dark in some ways.   Partly because there aren't many services available” (Clinician 6) 
“There's not that much information really.   We've got a website attached to our project … 
around the globe you've got the SPANC study, the stuff that's come out of 
BASHH.   There's quite a lot of information … in America... if I googled it as a patient, I 
don't think the top four or five hits would get you pertinent information as to where we are 
with anal screening and especially where the UK stands in that mass of information” 
(Clinician 2) 
 
Clinicians have experienced uncertainty with regards to courses to inform their medical 
practice but greater uncertainty with what will be available for patients about anal 
screening.   
 
“I've not seen anything UK wide.   I guess from, I mean there's, I believe there's possibly 
going to be a UK course…. this is going to be the first time in the UK ...  may be the 
information medically wise will be better.   I don't know what will be for the patients though” 
(Clinician 2) 
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Clinicians have reported that there is very limited information in the National AIDS Manual, 
and there is a roll for having information leaflets in clinics to prepare patients about AIN, its 
natural history and the anoscopy procedure. 
 
“There have been features in some of the HIV literature, sort of NAM ....  there's a role for 
having nice quality information leaflets available for patients in all clinics…best thing we 
can do is to prepare them well with information leaflet ahead of time ... which is about AIN 
and its natural history … they get a separate piece of paper that tells them about what to 
expect from the procedure itself” (Clinician 3). 
 
Clinicians have developed information leaflets for patients but have perceived verbal face 
to face information is important as well. 
 
“There is a patient information leaflet.   …. but what has happened at our service is, people 
get phoned to come to the next appointment... I'm taking more time verbally with 
patients.  That doesn't seem to be a problem actually” (Clinician 4).  
 Training 
Training in essence is about the skill required of clinicians to undertake anal screening.  
This skill entails the ability to take anal cytology, DARE, perform HRA and take a biopsy 
from the anal canal for histology assessment.  Clinicians have accessed training locally or 
internationally (e.g. accredited course in the USA).  Some clinicians have mentioned that 
having a gynaecology background has helped them pick up the skill quickly.    
 
Clinicians have trained in America and some clinicians have trained with other 
experienced clinicians in the UK.  Clinicians with a gynaecology background have helped 
clinicians pick the skill of undertaking HRA quicker. 
 
“I assimilated that procedure from America, came back to the UK and I was trained over 
about six months or three to six months with …. also, what the doctor taught me in London 
… he said that evidently my colposcopy background and my laparoscopic background 
from training to be a gynaecologist had helped me because I picked things up quite 
quickly.” (Clinician 2) 
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There is no UK based training that’s accredited. The only accredited course as mentioned 
by participants is in America.  
 
“So, I decided to learn about anoscopy as a prelude to setting up a clinical study … so I 
went to and I spent a week in San Francisco in 1999 learning anoscopy … so you just 
came back and did it you know that's what I did and of course it was kind of sink or swim” 
(Clinician 3) 
 
“I was very lucky to go to San Francisco and which is run by the International Anal 
Neoplasia Society and is an accredited course, two-day course which was involved with a 
bit of colposcopy as well” (Clinician 1) 
 
Whilst there is no UK based accredited course for ansocopy, trained clinicians provide 
local training and the vision for the future for clinicians is to set up clinics across England 
and Wales.   
 
“We've trained people who have started up clinics in Manchester and West London and I 
am supporting people in North London setting up a clinic …where HRA will be carried out 
so the gospel is being dispensed and is being promulgated as one of our goals … we are 
training people, so they can set up HRA clinics in other hospitals across England… there's 
a need to ripple out into Scotland and …” (Clinician 6). 
 
Clinicians in their experience of undertaking HRA mention the length to time to be 
proficient at HRA is up to 5 years.   
 
“I can certainly say that it takes a good couple of years to become really proficient at it.” 
(Clinician 3) 
 
 “It can take up to five years to be a completely brilliant trained up anoscopist...I'm going to 
you know trundle on gently for five years”. 
 (Clinician 2) 
 
Some clinicians that have been undertaking anal screening still do not consider 
themselves as an expert. 
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“I’ve been doing anoscopy for a few years only.   I still do not consider myself an expert.   I 
am not going to be any sort of expert until I’ve had minimum five or ten years of 
training….” (Clinician 7) 
 
Clinicians mention that there is published data to show that training to be an anoscopist 
can take a few years to acquire skills. 
 
“There are published data out there showing that people learn over a period of years in 
terms of acquiring these skills” (Clinician 6) 
 
Both patients and clinicians have reported that there is very limited information on anal 
cancer screening in the UK.  The media, HIV magazines and being an expert patient has 
helped patients to gain knowledge and educate themselves on anal cancer.  Clinicians 
believe that there is a role to develop information leaflets for patients and highlighted that 
information inadequate even in the National AIDS manual, but there is also value in 
provided information face to face.  Clinicians have trained locally with other experienced 
clinicians undertaking HRA.  Some clinicians have undertaken an accredited course in San 
Francisco and have reported that it can take up to five years to be fully trained in HRA.   
 
4.5 Social and Sexual Activity 
Patients who have had anal screening and have diagnosed with warts or AIN have 
experienced varied changes to their social and sexual activity. I asked the following 
question:  Having been diagnosed with AIN, does this in any way affect your sexual activity 
or social life?  The responses are varied as some patients’ experience no change in sexual 
activity while as other patients stopped having sex and socialising.  
 
“In answer to the last question, it hasn't affected my social life but it has affected my sexual 
activity. I used to regularly have receptive anal sex (Albeit only ever with a condom) 
but after being diagnosed and treated for AIN I no longer do this. Mainly because the 
treatment makes me sore and I'm afraid of damaging myself.” (Patient 2) 
 
Patients having a diagnosis of AIN increased their protection in sex.   
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“No not really there was no difference with sexual activity, I was just extra careful.  I used 
condoms.  My social life was not affected.” (Patient 5) 
 
However, some patients associate sexual activity with warts and cancer.  Some patients 
experience anoreceptive sex as painful while others perceive anal cancer to be self-
inflicted by engaging in sexual activity.  Some patient’s social life was affected and 
stopped dating.  
 
“No when I had the wart, I did not have any sex, because I think it can be contagious.  I 
stopped dating and I did not have a regular partner.  Also, I was working and studying so I 
had no time for socialising.  I am very nervous to have receptive anal sex because it 
hurts.” (Patient 13) 
 
“It’s like smoking cigarettes; you get lung cancer and die.  If you engaged in sexual activity, 
then you get genital warts and get cancer so it’s kind of like self-inflicted, no I don’t have 
sex” (Patient 14).  
 
Sexual activity was only mildly affected by patients having warts or diagnosis of AIN, but, 
remarkably, some patients reported not having sexual intercourse and stopped socialising.  
Interestingly some patients associated anal cancer as a self-inflicted behaviour caused by 
sexual activity.  The diagnosis of AIN or warts made patients aware that using condoms for 
sexual activity is important and some patients who had treatment for AIN or warts reported 
they stopped having sex as it was painful.  
4.6 Anal Cancer Screening Guidelines and Practices in the UK 
This section will discuss the key findings of my study on guidelines and anal cancer 
screening practices in the UK.   
 Guidelines 
Guidelines are important to guide clinical decisions.  Clinical guidelines recommendations 
on how healthcare professionals should care for people with specific conditions. They can 
cover any aspect of a condition and may include recommendations about providing 
information and advice, prevention, diagnosis, treatment and longer-term management 
(NICE, 2015).  A clinical guideline, clinical protocol or clinical practice guideline is a 
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document with the aim of guiding decisions and criteria regarding diagnosis, management 
and treatment in specific areas of healthcare (IOM, 2011).   
Patients-Guidelines 
Patients are aware that there are established cervical screening guidelines and a cervical 
screening programme for women in the UK.  Patients believe there should be a national 
anal cancer screening programme for high risk men in the UK as it is for women.   
 
“… Women are routinely screened for cancer of the cervix and it’s the same HPV strain 
that puts them at risk. If they have a national screening programme for women why not 
have a national screening programme for high risk men.” (Patient 2) 
 
“Women have the right in a way to have had their programme and I think the fact that it 
has been rolled out across the country, we are talking about reducing the age at which that 
screening programme starts so we can catch a few more people.  I think that screening 
programme has already been shown to be worthwhile.” (Patient 1) 
Clinician-Guidelines 
Clinicians have knowledge that there are no national guidelines in the UK on anal cancer 
screening but they are aware of the guidelines in the USA for people living with HIV.   
“There are no national guidelines as to who to screen is a setback.   Anal cancer screening 
is not recommended in any national guidelines… In the United States, particularly in New 
York, they recommended anal cytology screening of HIV positive individuals, in gay men 
and those with some other criteria… NICE have not recommended it.   BHIVA have not 
recommended it.” (Clinician 8) 
Clinicians see patients with multi focal disease as there is no gold standard for treatment 
or guidelines and manage this within their clinics.  This is a disease process which 
involves the perianal skin, the anal canal including the anal canal transitional zone and 
there is a strong clinical association with cervical (CIN), vulval (VIN) intraepithelial 
neoplasia (Scholefield et al, 2011).   
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“If there are multi-centric, multifocal lesions, if there are more sort of proximal lesions, 
perianal lesions; it is about how to best manage it as there are no gold standards, there 
are no national guidelines.” (Clinician 6) 
Clinicians therefore suggest a way forward with screening or reason for screening in the 
absence of guideline is to develop techniques for anal cancer screening and that there 
should be robust evidence to develop guidelines.  Most clinicians have developed anal 
cancer screening guidelines, training and competencies for their sexual health clinics 
based on the colposcopy guidelines in the absence of national anal cancer screening 
guidelines in the UK. 
 
“there are no guidelines in the UK and the … we’re screening with cytology, HPV and 
anoscopy is to see whether we can develop a screening technique without using anoscopy 
if you have evidence, that's robust then I think it would be very easy, it would be much 
easier to formulate guidelines, form a consensus.” (Clinician 7) 
 “…my thought was that anoscopy was very similar to colposcopy, so I managed to get 
hold of the national training guidelines for colposcopy nursing in the UK and did my own 
guidelines and my own workbook and based that all around what the UK colposcopy 
guidelines are, and I used that as a template really” (Clinician 1) 
 Anal Cancer Screening Practices in Sexual Health Clinics in the UK 
Anal cancer screening is unevenly distributed geographically across the UK, which is 
presented in the preceding section.  Anal cancer screening is offered mainly in the London 
region and patients as well as clinicians have reported that this is not offered throughout 
the UK.   
Patients-Anal cancer screening practices in UK 
Patients are well informed that anal cancer screening is mostly offered in the London 
region and not all patients can access screening due to lack of specialists, treatment 
centres and equipment 
 
“… I’m thinking of all the people around the country that aren’t able to get it and maybe are 
at risk.” (Patient 11) 
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“I would like to see it rolled out over the whole of the UK really…HIV specialists in 
provincial HIV treatment centres…don’t have any facilities at their hospital to check.  They 
must realise that in London...people with HIV are being screened … Most provincial 
treatment centres just do not offer this. I think it was London, Manchester and maybe 
Edinburgh was the only medical centres that were doing this ….” (Patient 2) 
Clinicians-Anal cancer screening practices in the UK 
Clinicians see patients from all over the country as not many sexual health clinics offer 
anal screening and patients do not want anyone to know of their HIV status. 
 
“I have patients who attend Manchester sexual health who live as far as nearly on the 
border of Scotland who come to Manchester because they don't want anyone to know 
about their HIV status.” 
 (Clinician 2)   
 Relationships with Health Care Professionals  
It is important for clinicians to work in partnership with patients and share with them the 
information they will need to make decisions about their care.  According to Cumming and 
Noble (2010), patients may experience stress about their conditions therefore it is 
important to treat a patient's physical ailments as well as his or her emotional needs.  
Patients have mentioned the most fundamental principles of healthcare professionals 
(clinicians) like trust, compassion, being sensitive, supportive, and professional are 
important to them.    
 
“I trust the doctor totally and I know what they're doing and as long as you keep up with 
your appointments and they monitor what is happening down there then I am absolutely 
fine with what the doctor is doing to me because I totally put my trust in doctor.” (Patient 
12) 
 
“Very nice! They very compassionate, very caring …But here they are more professional, 
they counsel they give and offer one to one bespoke service …. Medical staff and patients 
and here one feel more spoiled. …the fact that the medical staffs here treat you as 
valued.”  (Patient 11) 
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Patients perceive healthcare professionals as being sensitive toward them and were 
caring plus supportive during their anal cancer screening appointments.   
 
“I think everybody is being very sensitive” (Patient 9) 
 
“It was part of a very caring package and care was being given by a set of very caring 
people in the clinic who were very supportive, I felt, in all manner of ways” (Patient 5) 
 
“They help me and sometimes its Psychological help. Because of course, people with HIV 
they have many psychological problems, because they need to accept that they have HIV. 
And they help even when they call you with your first name, its Personal.  Here they call by 
name and its more like warmth, its warm, it’s more polite.” (Patient 7).   
 
 Multidisciplinary Team Approach in anal cancer screening 
A multidisciplinary team (MDT) approach is essential for the management of anal cancer 
screening. Clinicians have suggested MDT centres for instance, teams should consist of 
clinicians, surgeons, histopathologists, cytopathologists, gynaecologists, HIV consultants 
and administrative person to coordinate the anal cancer screening pathway for patients.   
 
Clinicians believe that there should be MDT centres which is attached to a tertiary referral 
centre across the regions in the UK. 
 
“I think possibly the way forward of this being managed is that you would have these MDT 
centres attached to a tertiary referral centre with a gynae/oncology and a colorectal 
specialist maybe… you've got Brighton near London but maybe London, Birmingham, 
Manchester, somewhere in Scotland and you've then got a spread up and down country 
that patients can access.” (Clinician 2) 
 
According to clinicians who participated in my study mentioned that MDT teams should 
consist of histopathologists, cytopathologists, surgeons, gynaecologists, HIV consultant 
and an administrative person.   
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“The whole team who is involved in this, so we have the histopathologist, cytopathologist 
who is involved with reading specifically anal smears.   We have the surgeons as… part of 
the colorectal surgery network…a gynaecologist, HIV consultant, an admin person ….” 
(Clinician 5) 
 Referrals into Anoscopy Clinics in the UK 
Patients at the outpatient’s clinic were mainly informed about anal screening by the nurses 
at the NHS trust.  Some patients read about AIN screening and treatment clinical trials in 
AIDs magazine and self-refer for anal cancer screening.   Clinicians see patients from all 
over the country and from other clinician referrals while most patients self-refer for 
screening. 
Patient-Referrals 
Patients are informed of anal smear by their clinicians which are part of their routine HIV 
outpatient clinic visit. 
 
 “The nurses, they said it has become routine now. So, they are offering the other smear, 
the normal smear, and then they offer you this one as well… but it has become routine 
now. (Patient 6) 
 
Some patients were aware of anal cancer screening through AIDS update dedicated for 
people living with HIV and entered a treatment clinical trial many years ago.   
 
“I probably became aware of the importance of doing that sort of screening from reading 
the AIDS update which had some interesting articles about AIN. Well I suppose there's a 
debate about whether how you split it to have a screening as opposed as to treatment and 
that kind of treatment with clinical trials.”   (Patient 14) 
Clinician referrals 
Clinicians receive referrals for screening from all over the UK and it is evident that patients 
attend for anal cancer screening from other regions. 
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“I also see a lot of people from all over the country, certainly from and predominantly from 
different parts of London but I get referrals from people come to see me from quite far.”  
(Clinician 3) 
 
One clinic which is a tertiary referral centre is long established and sees patients from all 
over the UK, clinicians from other hospitals or by doctors from their own sexual health 
clinic. 
 
“The service … is long established and we get referrals from all over UK …. this is a 
tertiary referral clinic, so all our patients are referred by other clinicians from other 
hospitals or internally by other doctors and so therefore we offer all cytology and HRA.” 
(Clinician 6) 
 
Patients also self-refer or get referred by their HIV clinician 
“They’re self-referred or referred from their regular doctor and they may or may not have 
been symptomatic with warts.   They may have a previous history of warts or may not have 
a previous history of warts and so we will see them.   (Clinician 7) 
 
 Multifocal Disease in Anal Cancer Screening Sexual Health Clinics 
In the presence of multi focal disease in patients, anal screening is offered in one sexual 
clinic in the UK.   Clinicians have reported seeing patients with multifocal disease in their 
clinics.   
 
“We also see women who’ve got a history of vulval cancer or vulval disease, vulval HPV or 
VIN.”  (Clinician 7) 
However, only one tertiary referral centre sees patients with multifocal disease and treats 
these patients. 
 
Obviously, women with cervical CIN, they might have a cervical lesion and quite likely to 
have an anal lesion.  I ask them about previous PAIN, CIN, and AIN and if they say that 
they've had something I will ask them when it was treated and where they're up to with 
their smears and things, that's also my gynaecology background.   I've had two or three 
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women - perianal wise I assess it and I biopsy it and some of the ... well one cancer that I 
found they also had a suspicious lesion perianally.  Two years ago, we teamed up with  
Cancer networks in London and we now have an arrangement whereby all patients with 
multifocal anal genital neoplasia in women are referred to for assessment with HRA and 
offered treatment.   So, the treatment spans over anal canal disease, perianal disease, 
vulval disease, vaginal disease and except for cervical disease.” (Clinician 6) 
 
 Evidence-Base for Anal Cancer Screening in the UK 
Evidence can help support patient care once a diagnosis is made.  Evidence-based 
practice can generate questions about treatment, diagnostic tests, aetiology and prognosis 
about AIN disease.  Patients suggest more evidence is needed for prevention of 
progression of AIN or psychologically.  Clinicians are being proactive in doing a trial to 
contribute to evidence in the UK while there are many studies produced in Europe.   
Patients-Evidence-base for anal cancer screening in the UK 
Patients believe more evidence is needed in the NHS on anal cancer screening as the 
sexual health clinics are part of the NHS. 
 
“I think the NHS needs evidence and once we have more evidence that it’s worthwhile, 
whether preventing progression or if it’s worthwhile in psychological terms, those are 
maybe two end points that could be explored.” (Patient 1) 
Clinician-Evidence base for anal cancer screening in the UK 
Clinicians believe that the LOPAC trial to be undertaken in the UK will to contribute to 
evidence. 
 
We're going to do a big research soon called 'LOPAC' trial which stands for laser ablation 
versus observation for prevention of anal cancer and that is to answer precisely the 
point.   Is treatment going to stop cancer development in patients with high grade disease 
and one of the problems of screening is that the screening agenda has been hampered by 
the lack of evidence in terms of treatment and in terms of prevention of cancer so we try to 
think we have to provide some data to support that.” (Clinician 6) 
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Clinicians have also mentioned that the US and Europe are contributing to evidence by 
producing lots of studies while the UK haven’t done much to date in terms of studies to 
contribute to the evidence.  
 
“The States and Europe are producing a lot of studies, but we haven’t done much here.” 
(Clinician 2)   
 Prevention and Funding of Anal Cancer Screening 
Patients’ perception on anal cancer screening is that they feel it is better to prevent 
disease than treat disease.  Clinicians state that anal cancer is increasing especially in the 
HIV positive MSM and that it would be cost effective to screen these high-risk groups 
instead of a screening programme targeted at everyone.  In the UK screening is 
considered and funded by clinical commissioning groups but these decisions are likely to 
have capped funding according to the clinicians. 
Patients-Prevention and funding for anal cancer screening 
Patients believe that it cheaper to prevent disease than treat someone with the disease.  
Patients mention screening will help prevent a person from becoming ill and it will be 
cheaper to screen than treat illness.   
 
“So, I think it’s becoming clearer when you look at costs based on the burden of ill health 
care, if you can prevent things happening in the first place you might actually save a bit to 
actually do it, but it’s often cheaper overall than having someone become ill than whatever 
it is you are screening for.” 
 (Patient 1) 
 
“Yes, prevention is better than cure no matter what way we explore it.  That seems to be 
proven from personal reassurance, reduction of anxiety and then 
from the health care provider view we have less burden of illness regarding costs and 
other things.  Whichever way we think of it I think it’s personally a winner.” (Patient 2) 
 
“If it is something that could kill me, I would prefer to know about it beforehand rather than 
afterwards.  Early prevention seems to be a good thing really.” (Patient 5) 
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Patients want to do their best to prevent a problem and name a celebrity who ended up 
having cervical cancer as she did not follow up her appointment, which meant she did not 
take responsibility for her own health and the hospital did not follow-up on her too.  
 
“I just want to do my best to prevent a problem, rather than solve a problem, but my 
understanding is that the small percentage of the population thinks that way.  A large part 
of the population waits until a problem happens.  It seems to me that if a clinic can get 
people to think along the lines of preventing a problem rather than waiting for it to happen, 
so it’s like for example, what’s her name, Jade Goody, who died from cervical cancer, well 
I think 2 things happened.  I think she didn’t follow-up on an appointment and I also think 
that the hospital didn’t follow up on her, so it was a double failure.  It was a failure for her 
to take responsibility for herself and it was a failure of the clinic to follow up efficiently and 
aggressively.”  (Patient 3) 
Clinicians-Prevention and funding for anal cancer screening in the UK 
Clinicians believe that it will be cost effective to screen people living with HIV for anal 
cancer.  
 
“Anal cancer is increasing in MSM HIV patients and in that particular group of patients the 
rates are extremely high. So, it might not be cost effective as a  
national programme for everyone to have anal cancer screening and I would agree with 
that because it’s not cost effective but for a particular group of patients such as HIV 
positive patients, I think it is cost effective.”  (Clinician 5) 
 
Clinicians have stated that anoscopy does not have a financial incentive as currently they 
are being paid by a locally agreed tariff and with the restructure of the NHS; Clinical 
Commissioning Groups will be agreeing a financial cap. Clinicians believe anoscopy 
should be based on clinical benefits and see if costs can be reduced so more patients are 
seen.   
 
“There was a not necessarily financial incentive but we were paid recently per patient seen 
in anoscopy with a locally agreed tariff...we were seeing with the restructure of the NHS 
and move to Clinical Commissioning Group… hence that may potentially limit the number 
of patients that we should be screening and seeing in anoscopy who I think it should be 
149 
 
done on clinical benefit, not on financial capping and… to see if there is any way we can 
reduce costs unnecessary costs so we can see potentially more patients.” (Clinician 8) 
 Recommendations for Anal Screening in the UK 
Patients suggested screening to be rolled out throughout the UK as they recognise anal 
screening is limited to the London region mostly.  Clinicians have mentioned anal 
screening is a new field and this should be part of the London cancer care pathways and 
anal cancer group.   
Patient-Recommendations 
Patients have recommended that anal cancer screening should be rolled out across the 
UK especially within their health area, and where they attend for their HIV outpatient 
appointments. 
 
“I would like to see it rolled out over the whole of the UK really, so that in all HIV treatment 
centres wherever they could send you somewhere within their health area anyway that 
could do what we are doing here.” (Patient 2) 
 
Patients have mentioned that a TV celebrity star had anal cancer many years ago and 
died.  The impact of her messages about anal cancer and its complications has been 
widely documented and reached people.   
 
“I would recommend it, but I would also say, ‘look I’m sure you don’t want to do this, but 
you probably should’.  So like back like, I don’t know how many  
years ago, a famous actress died of anal cancer and she made a documentary about its 
‘Farah Fawcett’ and she documented it and I admire her bravery, not only for the cancer 
but also about a cancer that has other issues associated with it, it’s not like a skin 
melanoma.” (Patient 3) 
Clinician-Recommendations 
Clinicians are aware anal screening is a new field which is changing quite rapidly.  They 
will be able to shape management, protocols, develop national guidelines for anoscopy as 
data is being published. Clinicians would like to share this experience with other clinicians 
around the world which is a positive step to preventing anal cancers.   
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“It’s a new field…you’re working in a field that I think is changing quite quickly.  New data 
is being published…by doing anoscopy, being able to shape management, protocol, 
develop national guidelines…share your experience with other clinicians around the 
world… will be shown to be a positive step in preventing anal cancers.” (Clinician 8) 
 
Clinicians in the North East of London have introduced anoscopy and management of AIN 
as part of a cancer care pathway.  They hope to pass this on to other cancer networks.  
 
“Well we have now introduced high resolution anoscopy and management of AIN-3 as part 
of the cancer pathway so in terms of London cancer networks, anal cancer pathway is very 
much part of what we do now…This is for north east London at the moment, but we will 
want this to be emulated in other networks and London cancer pathway for London…for 
other parts of the country too in future I hope.”  (Clinician 6)   
 
Clinicians suggested an anal cancer group where data are pooled together to build a 
business case for commissioners to consider funding.   
 
“We need to sort of have an anoscopy anal cancer group and centralise all that data and 
say that this is what has been found collectively and then build a business case …. 
convince commissioners that this is a worthwhile service to commission.  (Clinician 7) 
 
 Benefits of Anal Screening Practices in the UK 
Patients perceive the benefits of anal screening valuable as they are being screened and 
treated to prevent further progression of AIN and at the same time feel in control of their 
health.  Patients also felt that they would have peace of mind as they are monitored for 
cancer.  Clinicians feel that screening does pick up early disease and they can offer 
surveillance and health promotion.  Clinicians believe that they are being proactive by 
providing preventative medicine.   
Patients-Benefits of anal cancer screening in the UK 
Patients mentioned that a screening programme will be worthwhile if they are screened 
and treated to prevent disease progression and people will feel in control and in charge of 
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their health if they are in a cancer screening program which offers monitoring and 
surveillance of AIN.   
 
“I would hope the screening programme will show its worthwhile both that if you are 
screened and treated it will help prevent further progression, but also that while people are 
in it they do feel more in control and in charge of their own health.” (Patient 1) 
 
The benefit of anal screening is that patients will have peace of mind that someone (as in 
clinicians), are aware of cancer risk by screening.   
 
“The benefit is the peace of mind that somebody is keeping aware of the cancer risk.” 
(Patient 11) 
Clinicians-Benefits of anal cancer screening in the UK 
According to clinicians, the advantages of anal cancer screening are that disease is picked 
up early and surveillance offered with health promotion. 
 
“So, I think the advantages are that it does pick up early disease and, if anything, you can 
at least offer surveillance.   You can offer some health promotion.”  (Clinician 7) 
 
Clinicians also believe that offering preventative measures by offering anal cancer 
screening is being proactive.   
 
“I think we’re being proactive versus reactive so offering preventative medicine.” (Clinician 
8) 
 
Patients have reported that women have a national cervical screening program and 
believe that the UK should have the same guidelines for anal cancer screening for high 
risk men.  Clinicians have reported that there are no national guidelines for anal cancer 
screening in the UK for people living with HIV.  Anal cancer screening practices vary 
across the UK and accessibility and availability of screening centres are limited to the 
London region mainly.  Some contributing factors for this are lack of specialists in HRA, 
treatment centres and equipment.  Patients have mentioned that they trust their clinician; 
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they are sensitive, supportive and compassionate.  Clinicians have suggested MDT 
centres attached to tertiary referral centres across the UK.  Patients are informed about 
anal cancer screening by nurses at the outpatient clinic while, some patients have read 
about anal cancer screening in AIDS magazines and entered clinical trials.  Clinicians 
receive referrals from other clinicians from around the UK or patients self-refer in 
screening centres. Only one tertiary centre offers screening and treatment for multifocal 
disease.  Patients believe that evidence is needed for the prevention and progression of 
AIN and for psychological aspects too.  Clinicians have stated that the UK will be starting a 
clinical trial (LOPAC trial) to contribute to evidence needed for anal cancer screening, 
however the US and Europe are contributing to evidence needed e.g. the natural history of 
AIN. 
 
Patients believe that it is better to prevent disease by screening than treat disease and 
clinicians have suggested that high-risk groups should be targeted for anal cancer 
screening.  Funding for anal cancer screening in sexual health clinics is approved by 
clinical commissioning groups and there is a cap on how many patients can be screened.  
Patients suggested that anal cancer screening should be rolled out throughout UK as 
accessibility and availability of screening centres are currently limited.  Clinicians have 
reported that anal cancer screening is a new field in the UK and that it should be part of 
the London cancer care pathways and anal cancer group.  Patients reported that the 
benefits of anal cancer screening will be worthwhile if they are screened and treated to 
prevent progression of AIN so that they can feel in control of their health.  Clinicians have 
stated that anal cancer screening does pick up early disease and they can offer 
surveillance and health promotion to patients at risk of AIN and anal cancer. 
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5 Implications for practice  
The purpose of this study was to a) explore the perceptions and experiences of patients, 
and clinicians on anal cancer screening and b) generate findings to help inform clinical 
practice for anal screening in sexual health clinics in the UK.   This was guided by asking 
the following question: what are the perceptions and experiences of patients and clinicians 
in anal cytology screening and high resolution anoscopy in the UK? 
 
This is the first study in the UK to provide a detailed exploration of the perceptions and 
experiences of both patients and clinicians in anal cancer screening.  The UK National 
Screening Program (UKNSC, 2012) Criterion 15 states that ‘the benefit from the screening 
programme should outweigh the physical and psychological harm caused by the test, 
diagnostic procedures and treatment’.  No evidence was identified and therefore there is 
no update to the conclusions of the literature review done by Czoski-Murray et al (2010).  
The literature review states that the screening process does not appear to present any 
physical harm; however, any psychological effects of anal cytology screening or pap 
smears have not been evaluated in the studies included in this review. Studies by Landstra 
et al (2013) and Tinmouth (2011) have researched the psychological aspects of anal 
cancer screening since the review by Czoski-Murray et al (2010). A recent study by Russo 
(2018) aimed to investigate gay, bisexual and MSM’s experience, understanding and 
emotional response to screening techniques for anal cancer to determine how best to 
minimise psychological distress in future programs.  My study sets to explore the 
perceptions and experiences of patients and clinicians in both anal cytology screening and 
high resolution anoscopy in patients living with HIV undergoing screening and clinicians 
undertaking anal cancer screening in sexual health clinics. My study provides insights into 
the psychological aspects of anal cancer screening, perceptions and experiences during 
anal screening procedures, knowledge and education on anal cancer screening, 
guidelines and practices across sexual health clinics in the UK.   
 
This section will discuss my findings under the main themes identified in my study as 
follows:  
• Psychological effects of anal screening 
• Anal Cancer Screening Procedures 
• Education, knowledge and Training 
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• Social and sexual activity 
• Guidelines and Practices 
5.1 Psychological Effects of Anal Screening  
The psychological effects of anal cancer screening are not widely researched.  Emotional 
responses worry, anxiety, fear, embarrassment, shame, stigma and reassurance are 
presented in my study.   Although some authors according to Vrinten et al (2017) suggest 
that ‘cancer fear’ and ‘cancer worry’ are conceptually different as these distinctions are 
poorly understood. For example, ‘cancer’ may be associated with perceptions of treatment, 
incapacitation, and death, and these could be considered separate fears relating to 
cancer.  I will discuss how worry, anxiety and fear of anal cancer are linked or interrelated 
emotional responses.  Distinguishing between the various worries, that cancer can evoke 
According to Murphy et al (2018), may help inform efforts to allay undue worries in those 
people who are deterred by these worries, and from engaging with cancer prevention, and 
early detection.  In my study both patients and clinicians highlighted how these emotional 
responses has psychological effects on them such as worry, fear, and anxiety for instance, 
particularly in response to anal cancer screening available in sexual health clinics in the 
UK.  Balasooriya-Smeekens (2015) mentions how fear of ‘getting cancer’ may facilitate 
cancer screening participation to, obtain reassurance, while fear about cancer treatments 
may be a barrier to screening to avoid being diagnosed.  Below I will present each 
emotional response and discuss how these emotions are related to worry about anal 
cancer screening.   
 
Patients’ perception of worry on anal cancer or the perceived notion of getting cancer is a 
far greater than having HIV.  HIV is less of a worry today for people living with HIV as they 
live longer with highly active antiretroviral therapy (HAART) and less people are 
progressing to AIDS (Dandapani et al, 2010).  However, because of an ageing HIV 
population and the advent of HAART for people living HIV, non-AIDS defining cancers 
such as anal cancer is on the rise (Oette et al, 2016).  Patients who have had a family 
history of cancer have contributed to their worry and the realisation that cancer is difficult 
to treat in the anal area.  The anatomy of the anal canal makes it difficult to treat disease 
and there is no optimal treatment available.  According to Dyson and Draganov (2009) little 
is known about the aetiology, prognosis, and optimal treatment for squamous cell 
carcinoma of the anal canal.  While Palefsky (2012) mentions that the anal canal has 
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uneven topography; obscuring lesions due to haemorrhoids, folds, stool or mucus; or 
lesions being located at the base of folds and anal glands, therefore is a challenging area 
to examine and treat.  Patients in my study have identified these factors and are willing to 
have anal screening purely because developing anal cancer is their worry.  Patients have 
perceived this worry as a scary emotional experience and therefore had anal cancer 
screening.   This is similar to the findings in the study by Truesdale and Goldstone (2010), 
they mention that patients who have had greater worry about anal cancer or higher 
perceived likelihood of getting anal cancer were willing to have anal cancer screening.   
 
Clinicians in my study worry for several reasons.  This is attributed to the discrepancy 
between anal cytology and targeted biopsy results.  Clinicians have reported that an anal 
pap smear can show dysplasia yet when biopsies are done there is no evidence of high-
grade disease which correlated with the study done by Bean et al (2010). These authors 
explained that the sensitivity and specificity of a single anal-rectal cytology specimen is 
comparable with that of a single cervical cytology test, but cytological interpretations do not 
always correlate with lesion severity.   Clearly the differences in anal pap results and 
targeted biopsy results create a worry for the clinicians as they feel they may be missing 
some disease or HSIL therefore HRA is repeated. Clinicians reported that bringing patients 
back for repeated anoscopies can create greater worry in these patients although they 
have treatment interventions in place for treating AIN.  In other words, in some patients’ 
high-grade lesions in the anal canal do not respond to the treatments available.  Another 
worry that clinicians have reported is that they have had patients who subsequently had 
anal cancer although there are treatments like laser ablation available to treat high-grade 
AIN.  According to Goldstone et al (2005 and 2007), screening and treatment modalities 
are highly efficacious but repeat treatments are often required due to HSIL’s relatively high 
recurrence rate and this is due to high grade lesion persistence.  Clinicians mention that 
stubborn lesions keep coming back and these patients go on to develop anal cancer.   
 
Truesdale and Goldstone (2010) suggests the need for multiple treatments to fully 
eradicate disease highlights the critical need for follow up and screening in patients with 
HSIL.  Clinicians have reported that patients stopped coming in for anal cancer screening 
as they worry about of having anal cancer. This meant that clinicians provided support to 
patients during their routine HIV outpatient appointments; call them on their mobile or 
home phone and talk to them to alleviate any fears and worries about anal cancer.  This 
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can be time consuming for the clinician as there is a time constraint for each consultation 
with a patient.  Providing this kind of support is not always feasible therefore clinicians 
reassured patients by giving them information leaflets on AIN and anal cancer to be able to 
better understand anal cancer screening and their results at home in their own time. 
Landstra et al (2013) show in the results of their study that specific worry about anal 
cancer increases throughout the medical process and suggest that receiving some 
threatening information and then reassuring information may produce greater optimism for 
screening than never receiving threatening information.  Similarly, Truesdale and 
Goldstone (2010) in their study mentions that the severity of diagnosis was related to more 
compliance with screening.   My study highlights that patients with a diagnosis of AIN 
perceive this diagnosis to be anal cancer which affected them psychologically which in turn 
affected their follow up screening.  Patients will return for anal screening with the 
appropriate information relating to their disease and face to face discussions with their 
clinician.   
 
Anal screening has led to patients experiencing anxiety of some degree. Patients have 
described their feelings of anxiety as they think they may have anal cancer and according 
to Wardle et al (2003) patients most anxious are those with a perceived risk of anal 
cancer.  Some patients have reported that they felt anxious all the time while others did not 
want to leave their home and almost became agoraphobic.  Although patients in my study 
have been given patient information leaflets on anal cancer screening and explanation of 
results before and after anal cancer screening, patients experienced anxiety about not 
understanding the result.  Patients who had been told they had a low-grade dysplasia 
result, felt that they had anal cancer.   In a recent study by Russo et al (2017), abnormal 
screening results affected participants’ sense of well-being and were associated with 
anxiety and concern about developing anal cancer.  This anxiety has also been 
demonstrated in studies like breast and cervical screening where anxiety increases with 
abnormal results from screening (Brett et al, 2005, Swarewski, 2011).  Patients in my 
study came back to the clinic for follow up appointments for results of their tests and at this 
point clinicians have reported that a face to face consultation with patients has helped 
alleviate some anxiety about their screening results.  In the study by Brett et al (2005) on 
breast screening women do not appear anxious after being given a clear mammogram 
results and were placed on normal recall for breast screening, but women who have had 
further investigations following routine mammogram experienced significant anxiety in the 
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short term and possibly in the long term.  Conversely, Nelson et al (2009) in their review of 
literature on breast cancer screening studies have shown conflicting results about anxiety 
where women had persistent anxiety despite eventual negative results and some women 
showed only transient anxiety.  These studies highlight anxiety as experienced in most 
cancer screening, that education and understanding results is key to reducing anxiety for 
patients. This emotion of anxiety in my study is attributed to the lack of understanding 
results in anal cancer screening. 
 
Clinicians in my study alluded to the fact that patients receiving news of their cytology puts 
them in a state of anxiety while some patients felt anxious all the time after receiving a 
positive result which is different to the opinions presented in the study by Landstra et al 
(2013).  Landstra et al (2013) provides an argument, although the possibility has not been 
investigated that HIV-infected populations may differ from other groups, in that they are 
familiar with regular medical testing for their HIV, may therefore not be upset by waiting for 
test results or receiving ‘bad news’.  However, studies in breast and prostate screening 
have shown increased anxiety with worry where this anxiety is associated with increased 
medical follow up and patients go for repeated follow appointments to clinics, or where 
patients are encouraged to do self-examinations and information seeking from the internet 
(Brett et al, 2005; McNaughton et al, 2004; Hay et al, 2005).   My study show that anxiety 
exists with anal cancer screening and related to results patients receive after screening.   
 
Another emotional response in my study is fear.  Some patients have reported that their 
family members have died of cancer (e.g. testicular cancer for instance) and this made 
them afraid therefore stayed in the anal screening program at the clinic.  Clearly there is a 
parallel between family history and the perceived risk for these patients as they are aware 
that they have a great chance of developing cancer. According Bobridge et al (2014), in 
colorectal cancer screening, the cancer risk perception and screening decision making 
have been shown to influence future screening intentions and uptake. Hay et al (2005) 
concluded that cancer worry increases the likelihood of patients screening for cancer but 
fear of positive results or the test itself may deter screening.  Fear of knowing about anal 
cancer or to have a diagnosis of anal dysplasia encouraged patients to come in for 
screening in my study.  These patients fear getting anal cancer.  On the contrary, the study 
by Koskan et al (2016) demonstrated that fear is a barrier to anal screening where the fear 
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of knowing about having anal cancer and confront the diagnosis served as a barrier to 
screening.   
 
Clinicians believe patients are scared if find anything associated with cancer and felt that a 
proportion of the patients do not attend first anal screening appointments because find this 
experience scary and daunting.  A similar finding to my study was from Scott et al (2008) 
where their study highlighted that barriers to screening for patients were fear of a cancer 
diagnosis and difficulties of these patients with maintaining clinic appointments.  However, 
clinicians in my study believe reassuring patients that an abnormal screen does not mean 
they have cancer can limit that worry.  Wilkinson et al (2000) mention that they provided 
patients with written information about what an abnormal Pap smear meant, and this led to 
less anxiety and fewer patients think they have cancer.  Some clinicians also felt they are 
afraid of missing a diagnosis or a lesion during HRA, but they are not afraid of performing 
HRA or taking a biopsy.  This is because clinicians are aware that other lesions or 
metachronous lesions may be present in the anal canal and a high possibility of missing 
that lesion. These metachronous lesions present during first HRA examination or 
according to Brambilla et al (2013) it occurs within the first three years after the primary 
lesion is identified.   Truesdale and Goldstone (2010) have demonstrated in their study the 
development of metachronous lesions is a great driver for recurrence rates of HSIL 
following treatment. The other factors may be due to the anatomy of the anal canal and 
multiple folds that may obstruct or make visualisation of lesions possible and clinicians are 
afraid that they may miss a lesion. Palefsky (2012) mention that HRA can be challenging 
which includes uneven topography of anal canal, obscuring of lesions due to 
haemorrhoids, folds, stool or mucus or lesions being located at the base of folds and anal 
glands when examining the anal canal.   
 
In my study embarrassment is highlighted as an emotional response to anal cancer 
screening.  Patients have reported they felt embarrassed, that it is ‘bizarre’ or mention 
“freaks” them out to know a part of their body is exposed and faeces may come past or 
bowels about evacuate during HRA.  Some patients felt that HRA is an intimate procedure 
and were worried about being dirty. Patients felt the need to be clean and prepare for the 
procedure.  In relation to anal screening Ong et al (2015) highlighted that patients were 
worried about not being clean for the examination in their study.  This too is strongly 
evident in my study and responses to embarrassment of anal examination when being 
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screened.  Women in cervical screening often described their embarrassment using terms 
like ‘unclean’ and ‘dirty’ (Szarewski, 2011). To overcome this embarrassment Ong et al 
(2015) suggests one strategy to increase digital anorectal examination (DARE) for 
instance, is allow patients time to prepare physically and psychologically for the 
examination, while Ferris et al (2013) suggests that embarrassment can also be minimised 
by empathetic discussions before the procedure. Landstra et al (2012) in their study states 
that anal cancer screening is similar to other cancer screening like prostate and cervical 
cancer screening; both are associated with private parts of the body and are related to 
sexuality. The examination is embarrassing for patients because it is a body part that is 
connected to sex and to something private.  According to Sörensdotter & Siwe (2016) 
genitals are perceived as a special body part connected to sexuality and intimacy and they 
discuss how gender, cultural norms and sexuality affect examinations. In cervical 
screening women identified barriers to screening due to embarrassment with regards to 
the examination which affected attendance to screening (Szarewski, 2011).  However, the 
study by Waller et al (2009) endorsed the most frequent barrier to cervical screening 
remains as embarrassment for those intending to go when due for a test. Longabaugh 
(2017) who is a patient and author had active bleeding into the toilet; the itching became 
unbearable, and she eventually consulted with her physician, although she felt awkward 
and embarrassed. This was due to her being self-conscious with her physician and the 
nature of the examination which is intimate involving private body parts.  My study 
highlights how many factors can contribute to embarrassment in anal screening i.e. not 
being clean, feeling exposed, being symptomatic which can be barriers to screening.  
However, patients in my study were not deterred from anal cancer screening and stayed in 
the screening program inspite of feeling embarrassed.  Clinicians have reported that 
patients were embarrassed and afraid of having AIN, as this disease is acquired in the 
same way as HIV (i.e. sexual practices like anoreceptive sex for example), and their 
patients did not want to be reminded of it. The association of AIN and HIV meant that in 
clinicians experience their patients were embarrassed with sexual activity and the link with 
anoreceptive sex.  These findings are similar to the study by Martin and Bower (2103), 
who states that aside from smoking, one of the independent risk factors for developing AIN 
or anal squamous intraepithelial lesions is a history of anal intercourse.   
 
Shame is another emotional response in my study.  Patients have reported that while HIV 
comes with stigma, the shame they experience with the diagnosis of AIN is like having 
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HIV.  Patients feel ashamed because of the questions that arise about their sexual 
practices. The issues that arose in my study for these patients are about how they 
acquired AIN and questioned themselves about what they did to acquire this diagnosis 
other than having a positive diagnosis for HIV.  Datta et al (2017) mention that staff should 
be sensitive to men’s fears about being judged negatively especially those not used to 
being open about their sexuality and sexual practices.   Clinicians have reported that HIV-
positive women who have had anal receptive sex for cultural reasons for instance, see this 
as a shameful act.  Clinicians who offer anal screening to women in their clinics have 
mentioned that women feel ashamed of their diagnosis of AIN.  Women feel ashamed as 
their understanding of acquiring AIN is low regarding anal cancer risks; therefore, the onus 
of acquiring AIN is on receptive anal intercourse and the association with HPV.  The only 
heterosexual female in my study felt ashamed and associated anal disease with men who 
have sex with men, and could not believe she had HSIL after screening, as she never had 
anoreceptive sex in her life.   According to Kojic et al (2011), many women fail to recognise 
that anal HPV infection can develop irrespective of anal sexual practices.  While clinicians 
are aware that women are not interested in screening or feel that they are not risk, 
therefore decline anal cancer screening, they need to understand that they are still at risk 
due to the association of cervical HPV and progressive neoplasia in the anal canal.  This is 
reported in a study by Turner et al (2015) that anal HPV may be associated with cervical 
HPV due to the anatomical proximity of the anus and genital tract, permitting tracking and 
infection between both sites; autoinoculation of genital HPV into the perianus and anal 
canal during front to back wiping, after urination and/or defecation.  Other factors like 
insertion of fingers or sex toys into the anal canal can also result in anal HPV infection in 
women who do not have receptive anal intercourse (Blankenship et al, 2016).  A study on  
women’s knowledge and attitudes towards anal pap testing demonstrated that other than 
anal sex, the risk factors of anal cancer were poorly recognised by these women (Ferris et 
al, 2013).  
Stigma is an emotional response experienced both by patients and clinicians in my study.  
The perception of stigma patients highlighted is that HIV has related stigma and so they 
have a notion that AIN will have the same stigma attached to it as HIV.  Bucher (2015) 
states that the stigma surrounding anal cancer is similar to that of HIV where both who 
have these diseases are open to judgemental assumptions about their sexual activity, self-
respect, even morality by others. This is clearly an assumption of societal stigma where 
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the idea of promiscuity is identified; unprotected sexual activity and spread of sexually 
transmitted infections are reported by patients in my study.  Interestingly this is discussed 
in a study by Newman et al (2008) where the participants stated that the health risks 
associated with unprotected receptive anal intercourse have been evident since early in 
the HIV epidemic and is openly discussed in the gay community.  This study concludes 
unprotected anal intercourse is not socially acceptable in the gay community due to its 
implication in spreading HIV infection, syphilis and other diseases.  Patients in my study 
have reported that this stigma is affixed to them as person by society just because they 
have a chronic condition HIV which is related to sexual activity (receptive anal sex, 
multiple partners, and people from ethnic minority groups which include gay men or being 
promiscuous).  The most compelling findings of the study by Truesdale & Goldstone 
(2010) identified factors contributing to stigma associated with emotional upsets were 
feelings of promiscuity, severity of diagnosis, and physical symptoms.  Salati and Kadi 
(2012) states that promiscuous sexual behaviour increases the risk of HPV and HIV 
infection thereby increasing the risk of anal cancer; that receptive anal intercourse also 
increases the risk of anal cancer in men and women. In cervical screening, Asian women 
who were offered the HPV vaccine for example cited that HPV is sex-related with the 
possibility of increasing promiscuity (Marlow et al, 2009).  Patients have mentioned that it 
is taboo to discuss anoreceptive sex and it is associated with men who have sex with men.  
Longabaugh (2017) mentions from her personal perspective as a patient who was 
diagnosed with anal cancer, that there is a stigma attached to anal cancer, and the stigma 
can be paralysing where the isolation is notable.  She also describes anal cancer as an 
overwhelming, stigmatised and discriminatory (‘squeamish’) type of diagnosis where 
patients can and often relegated to silence.  In a study by Goldman et al (2009) with 
regards to colorectal screening and risks, almost all participants who cited sex as 
implicated in colorectal cancer referred to anal sex, usually between men, but sometimes 
between men and women; many participants who believed in sex-related causes, used 
words that demonstrated their discomfort in discussing the topic and this was particularly 
true among women who believed that colorectal cancer risk was greatest with homosexual 
behaviour. 
 
Clinicians have highlighted self-stigma in their practice of anal screening in my study due 
to lack of experience in anal screening in the UK. Clinicians are aware of the stereotypes 
that describe a stigmatised group like those living with HIV and at risk of anal cancers to 
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experience this self-stigma.  These clinicians who internalise these negative beliefs can 
have low self-esteem and can adversely affect the ability to perform anal cancer screening 
or their ability to undertake HRA. Corrigan et al (2009) mentions that because people have 
self-stigma, they suffer from low self-esteem and low self-efficacy and avoid using 
evidence-based practices to achieve their goals. Clinicians in my study did not have low 
self-esteem but discuss low self-efficacy as they lack experience in HRA and anal cancer 
screening, as it is still new in the UK but rely on evidence for anal cancer screening from 
countries with established anal cancer screening guidelines and practices.  Clinicians in 
my study have realised that self-stigma is not acceptable behaviour as professionals and 
has led them to improve their practice through understanding sexual practices, the need 
for training, the need to screen high-risk groups of people and evidence produced by other 
countries like the US. Therefore, clinicians have mentioned that they are aware they can 
seek help from the wider community (other practicing clinicians, International Neoplasia 
Society or cancer networks) who undertake or perform anal screening.  This can help 
alleviate feelings of inadequacy and provide an effective anal screening service to people 
living with HIV in their clinics. Bucher (2015) states that there is the IANS professional 
body devoted to the prevention and treatment of AIN and anal cancer; its mission is to 
provide a forum for individuals with a broad spectrum of backgrounds, viewpoints and 
geographic origins, an exchange of ideas and dissemination of knowledge regarding the 
pathogenesis, diagnosis, treatment and prevention of anal neoplasia.  Clinicians 
undertaking anal screening in the UK are aware of IANS where most clinicians are 
members and can access up to date information and support from this scientific society.  
Whilst IANS provides a forum for clinicians on AIN, this is a dedicated site for learning, 
conferences, publications and webinars where clinicians can present difficult cases or 
challenges in their practice.  Within this IANS has a link to the HPV organisation to support 
patients with HPV related cancers, information leaflets, mentors and buddies and clinicians 
can refer patients to or clinicians to use a reference when seeing patients.  In the UK the 
cancer network and web page provide information on anal cancers (CRUK, 2016).   
 
Another emotional response is reassurance.  Patients felt reassured to be part of a 
screening program and this is available to them at their HIV outpatient clinic.  They also 
felt reassured that treatment is available for AIN. This finding is similar to prostate cancer 
screening where screening may have some reassurance value for men, and that added 
reassurance afforded by screening (Scott et al, 2002).  Clinicians on the other hand give 
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information leaflets to their patients on anoscopy which informs them on how to prepare for 
the procedure which creates a degree of reassurance for them.  Landstra et al (2013) 
mentions that a person’s knowledge about screening can influence their psychological 
response to screening which is highlighted by clinicians, where information provided to 
patients gives them a degree of reassurance.  My findings concur with the findings of 
Colon-Lopez et al (2016) that developing comprehensive cancer screening programs for 
people living with HIV to achieve earlier diagnosis and promptly initiate treatment.  
 
The emotional responses presented above highlights worry, anxiety and fear are 
interrelated.  Patients worry they may have cancer, worry about cancer results in anxiety 
and worry about anal cancer makes them fearful.  These emotions are real or perceived 
and are all related to anal cancer.  Embarrassment makes patients self-conscious about 
screening as they have to expose private and intimate body parts for examination during 
HRA.  Patients have highlighted that feel humiliated as there is a connection with HIV, AIN 
and sexual activity.  Some participants felt that having anoreceptive sex is a shameful act 
and like HIV, this is a taboo subject.  Stigma was experienced both by patients and 
clinicians.  Patients experienced societal stigma due being HIV-positive, being gay and 
having anoreceptive sex.  Clinicians experience self-stigma because of lack of training in 
HRA in the UK.  Patients felt reassured to be part of an anal cancer screening program in 
their sexual health clinics, that treatment was available to treat AIN.  Clinicians believe that 
information given to patients create a degree of reassurance as knowledge can influence 
their psychological response to anal cancer screening  
5.2 Anal Cancer Screening Procedures 
Anal screening procedures in my study included anal cytology, DARE, HRA and anal canal 
biopsies.  Patients and clinicians have discussed and expressed their experiences and 
perceptions on acceptability and tolerability, pain during HRA, bleeding after biopsy, 
discomfort and anal screening as an invasive procedure.    
 
Most patients found anal screening acceptable however tolerability in my study was 
variable in terms of their experiences and perceptions.  However, clinicians’ have reported 
that women who have anal screening find it an acceptable procedure but did not tolerate it 
well while men who have sex with men accept and tolerate screening well.  The reasons 
for women not tolerating the anoscopy procedure is due to anal tone and women who do 
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not have anal-receptive sex find it difficult when the anoscope is inserted into the anal 
canal, but these women want to contribute to evidence needed in the UK.  This is 
supported by some studies as discussed in the preceding discussions.    
 
Blankenship et al (2016) explains that a significant factor influencing anal cytology 
acceptability was high levels of familiarity and belief in the utility of anal cytology in 
detecting anal intraepithelial neoplasia.  Botes et al (2011) suggests that participants who 
take self-collected anal swabs, 81% of men reported this procedure as highly acceptable. 
Acceptability of screening is also associated with pain, discomfort and embarrassment. 
Davis et al (2013) in their study of tolerability of anal dysplasia screening demonstrated 
that screening procedures for HGAIN are generally well tolerated by patients with minimal 
to no discomfort; no single screening procedure caused enough discomfort to decrease 
patient compliance with anal screening.  My study highlights that HRA was very well 
tolerated although it is by far the most complicated procedure performed.  Moreover, 
clinicians taking a biopsy did not add to perceived discomfort for these patients, as the 
biopsies were performed within the anal canal and above dentate line or pectinate line (i.e. 
is a line that divides the upper two thirds and lower third of the anal canal), where there is 
no pain sensation and is carried out by an experienced clinician.  Data produced by 
Hillman et al (2011) on participants’ perspective of high resolution anoscopy found most 
participants found HRA acceptable, with a few complications as acceptability was strongly 
correlated with pain and bleeding during and after the procedure.   
 
Clinicians have reported that tolerability of anal cancer screening was variable for patients.  
This tolerability is due to some patients who have receptive anal sex, and due to reduced 
anal tone where internal and external sphincter muscle is more relaxed, it is easier to 
tolerate the anoscope.  Women don’t find anal screening very tolerable mainly because 
the anal tone is tight.  Clinicians have described in their experience of undertaking anal 
screening is different for men who have sex with men and women.  On the other hand,  
clinicians have explained that although women do not tolerate anoscopy procedure, they 
accept it is a screening process and are excited about contributing to evidence needed in 
their clinics.  These surveys are included in the study by Vera et al (2014) undertaken in 
the UK.  My study does highlight that clinicians found when they undertook patient 
satisfaction surveys at their clinics, that several patients found anoscopy acceptable 
although invasive procedure.  Some other reasons as alluded to by Davis et al (2013) for 
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tolerability of screening procedures may be the result of anoscopy performed after non-
lubricated cytology and HPV sampling followed by DARE which have progressively 
irritated the anal canal and perianal skin.   
 
Patients have reported that anal exams are invasive in every sense; it is not something 
they look forward to where they must undress, and a clinician must examine their rectum. 
Newman et al (2008) mentioned in their study that men have poor knowledge about their 
perianal genital area and the apprehension of having an anal pap meant that this would 
publicise a body part that is so private, that the anus is a body part that is never discussed, 
seldom seen and neglected.  Several participants in the study by Newman et al (2008) 
also equate the intra-anal space to a women’s vagina which is unseen, unknown and 
present.   My study has highlighted that anal examinations (includes anal Pap smear, 
DARE and HRA) where patients must undress, and an intimate examination of the anal 
canal is done, is invasive as reported by patients.  Clinicians on the other hand explain that 
anoscopy is invasive in every sense, is not most dignified but is a ‘gold standard’ for 
screening.  The study by Koskan et al (2016) have reported that men who have sex with 
men found that anal pap smears not overly invasive or painful but described how the test 
was mildly uncomfortable.  One of the strengths of my study explored invasiveness with 
both patients and clinicians experience in anal screening procedures. 
 
Patients in my study have experienced pain during anal pap collection, insertion of  
anoscope, and when biopsy taken.  Patients’ that have anticipated experiencing pain prior 
to HRA procedure, did actually experience pain during HRA.  Clinicians have also noted 
that patients have marked pain when biopsies are taken for instance, and these patients 
can find it unpleasant during HRA.  In breast screening, pain, is associated with menstrual 
cycle, anxiety and anticipation of pain during mammography (Armstrong et al, 2007).  In 
my study pain is perceived and experienced during HRA and correlates with this study 
only in relation to the anticipation of pain.  Nelson et al (2009) describes patient negative 
experiences such as pain during procedures, anxiety and other psychological responses 
are common.  These experiences seem to be transient and do not adversely influence 
future screening.  The study by Davies et al (2010) suggest HRA which is by far the most 
complicated procedure performed, it was well tolerated and the fact that the biopsy did not 
add to perceived discomfort, meant that all biopsies were performed within the anal canal 
and above the dentate line where there is no pain sensation.   
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Patients may experience or can have bleeding during HRA guided biopsies. Patients have 
reported bleeding for up to 3 days and it worries them when they see blood in the toilet 
pan or tissue paper.  But they have the knowledge and understanding that the bleeding will 
stop.  Bleeding can occur after a biopsy is taken from the anal canal as a small piece of 
tissue is cut out measuring about 3mm for histological sampling to detect AIN.  Clinicians 
have seen patients bleed for a week or two after having a biopsy sample taken during 
HRA and have not experienced any adverse events but all they needed was reassurance.  
In the study by Botes et al (2011), 17% of participants reported some level of bleeding 
after screening procedures (i.e. HRA guided biopsy); while Hillman et al (2011) reported 
only 11.4% of participants have slight bleeding for less than a week.  In my study, there 
were no significant reports of prolonged bleeding and patients were aware they could to 
seek help with the clinicians if bleeding persisted. 
 
Patients have experienced discomfort with anal cytology, where a Dacron cotton swab is 
used to obtain an anal Pap sample and patients have described this procedure as ‘rough’ 
and uncomfortable.  It is clear, that the feeling or sensation of the swab inserted into the 
anal canal for cytology sample collection caused discomfort for patients in my study.  In 
the study by Davies et al (2013) the higher mean discomfort was experienced by 
participants when the sample was collected with an HPV brush, followed by an HPV swab,  
and then anal cytology swab where the perceived sensation between first swab and 
second brush was reported as increased discomfort.  In my study patients have described 
their experience in HRA procedures as uncomfortable while clinicians perceive screening 
procedure as foreign to most patients, and women find this procedure very uncomfortable.  
According to the study by Davies et al (2013), HRA was found to have the highest 
negative rating where patients have cited this is a procedure that will keep them from 
returning to be screened and it appears that discomfort increases as more procedures are 
performed in succession therefore, proposed future research to try and diminish discomfort 
further with a goal of keeping even fewer patients objecting to the procedures. Although 
screening my study included anal cytology, followed by DARE, HRA and biopsy, none of 
the patients stopped screening due to discomfort as it was well tolerated.   
 
The position in which a patient is examined is important during HRA procedures are 
highlighted in my study.  Patients suggested a positional change for their comfort ‘like 
facing forwards’ (prone position) for instance.  Hillman et al (2011) suggested that new 
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methods to improve participant experience are required although they have demonstrated 
HRA to be an acceptable procedure. My study concluded that discomfort has taken into 
consideration that some patients prefer a change in position to minimise their discomfort.  
The most important aspect of examining a patient during HRA is the position in which a 
patient lies on the examination couch.  Clinicians in my study examine patients in the left 
lateral or lithotomy position.   A study done in the UK by De-Masi et al (2018) reported that 
patients are examined in the outpatient (office) setting in the dorsal lithotomy position with 
an adjustable bed.  A commonly used position for HRA is the left lateral position, the 
position I examine patients in, but lithotomy and prone positions have been cited in some 
studies.  In the left lateral and prone positions, the patient should be as close to the bottom 
edge of the table as possible to facilitate focusing the colposcope.  Normally, during HRA 
the patient is in the left lateral position, in the foetal position, with the buttocks at the edge 
of the table (Albuquerque, 2015).  The prone position is used if an overhead colposcope is 
available which means patients bend forward over the table (Watt, 2005).  All patients in 
my study are examined in the left lateral position as I use a colposcope which is mobile 
with wheels to adjust positioning and focusing for HRA procedures.  Clinicians should 
consider the equipment they have to examine patients and patient’s choice.  Sometimes,  
the type of colposcope a clinician use may only allow them to examine a patient in the 
left/right lateral position as it is a mobile colposcope, whereas other clinicians may have an 
overhead colposcopes which they can use to examine patients in a prone position.   
 
Clinicians in my study have compared high resolution anoscopy to sigmoidoscopy and 
mentioned that lesions are better located in the anal canal using the colposcope during 
HRA. HRA is very different from flexible sigmoidoscopy and cannot adequately examine 
the anal canal for the problems being detected by HRA. Patients must have anaesthetic 
for a sigmoidoscopy procedure whereas in HRA only local anaesthetic can be used.  
Clinicians have reported that a sigmoidoscope is inserted too far into rectum and they are 
interested only in 5cm of the anal canal.  The sigmoidoscope does not allow for 
visualisation of the distal anal canal.   Anoscopy allows them to apply acetic acid into anal 
canal to see lesions, whereas this cannot be done with the sigmoidoscope.  They also 
mention that steady equipment is needed, like the anoscope, which is easily applied and 
steadied in anal canal.  Clinicians have highlighted the superiority of HRA to detect AIN as 
it is best visualised with an anoscope rather than the sigmoidoscope.  Alonso-Coello and 
Castillego (2003) in their study stated that the most accurate method for examining the 
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anal canal and distal rectum is anoscopy since it detects more lesions in the anorectal 
region than does a flexible sigmoidoscopy and visualisation are best achieved with the 
anoscope. Two prospective studies by Kelly et al (1986) and Korkis & McDougall (1995) 
found that anoscopy detects a higher percentage (99% versus 78%) of lesions in the 
anorectal region than does flexible sigmoidoscopy as it is a procedure for evaluating rectal 
disease.  It is however very reassuring, that my study concurs with other studies (Jay, 
2017; Alberquerque, 2015; Palefsky, 2012; Gimenez, 2011) to recognise that anoscopy is 
a gold standard in detecting anal canal disease or AIN.  Gosens et al (2017) reiterates that 
high-resolution anoscopy is the gold standard for screening.  Newman et al (2008) 
mentions that most experts suggest direct visualization of the anal canal by using a bright 
light and external magnifier called a colposcope, which is a better way to locate areas for 
biopsy.  The standard for AIN detection is high-resolution anoscopy in combination with 
biopsies and histopathological analysis of suspect lesions De Vries (2015). 
 
My study can conclude that screening procedures for the diagnosis of AIN including anal 
Pap smear, HRA/anoscopy and biopsy are acceptable while tolerability is variable due to  
factors like anal tone and anal receptive intercourse.  There is a degree of discomfort, 
bleeding and pain but this is not a major issue which seem to be transient and do not 
adversely affect patients.  However, it must be noted that anal screening is an invasive 
procedure which is not highlighted in many studies.  The gold standard in anal screening is 
high resolution anoscopy as reported by clinicians.   
 
5.3 Education, Knowledge and Training in Anal Screening 
It is vitally important that the necessary information is available for patients and clinicians, 
so they are knowledgeable on anal cancer and screening.  Training that clinicians receive 
to be able to undertake or perform HRA warrants good knowledge and education to be 
able to deliver a robust screening program for people living with HIV.  It is important to 
note that the limited information available in the UK on anal cancer screening, knowledge 
and education are identified in my study.  Most the knowledge that patients and clinicians 
acquired was through magazines, the press and articles on anal cancer screening.   
 
Patients have highlighted that there very little information available on anal cancer 
screening except in HIV magazines or in treatment updates.  Patients have also 
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mentioned that knowledge and information were mainly given to them by their clinicians 
(see appendix 15).  Landstra et al (2012) states that raising awareness may increase 
concern and there is a perceived vulnerability of participants, therefore it is vital to increase 
motivation to have anal screening because education is particularly important for high-risk 
groups.  Patients in my study have reported that they take care of their own health have 
self-knowledge and do their own research on anal cancer and screening.  They also feel 
that the influence of the media plays an important role in educating one’s self.  Some 
patients perceive ‘being in charge’ of their own health and having knowledge of HIV and 
anal cancer means that they are the ‘expert patient’.  Patients also reported that 
information on anal cancer is important especially if faced with a life-threatening disease 
as that information is a ‘safety net’ and they having different needs in terms of knowledge 
and education on anal cancer screening.  Some patients believe that they are expert 
patients as they are well read or do research while others feel information provided to 
them is a safety net.  According to Bower and Gilbody (2005) different support may be 
needed by different people therefore where possible it would be helpful to have a variety of 
support options available such as written information, support staff available by phone or 
email, patient support groups or have access to a psychologist or social worker.  In view of 
the limited information available to patients, access to written information in the form of 
leaflets with links to websites about anal cancer and screening, access support by phone 
or email if they wished to contact clinicians and the availability of a psychologist for 
counselling is useful for them.  Newman et al (2008) highlighted that the participants in 
their study offered a variety of suggestions like advertising in a wide variety of venues 
would increase HPV infection and anal cancer screening; pamphlets in the doctors’ offices; 
and in healthcare settings using posters, outreach workers, media and press Longabaugh 
(2017) acknowledges that the quandary or perplexity for patients with rare cancers are the 
lack of resources, which reinforces the challenges patients experience with information, 
and education in my study.  Furthermore, it is important to note patients faced with cancers 
like breast, cervical, and prostate cancer for instance, resources are easily available unlike 
anal cancer, and there is very little information.  According to Longabaugh (2017), 
education, support groups, websites, study availability and resources to help for breast, 
cervical prostate even colorectal cancers are readily available. Currently anal cancer is not 
widely advertised in healthcare settings except in clinics offering anal cancer screening in 
the UK.  For example, clinicians undertaking anal cancer screening inform patients face to 
face, give them information leaflets, refer to screening centres via clinicians’ and in 
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patients’ case, they inform their friends and colleagues about anal cancer screening.  
BASHH and BHIVA don’t have information on anal cancer screening but in the USA, there 
is a dedicated website available for patients (https://www.analcancerfoundation.org/).  
Clinicians have also highlighted that patients are not informed due to the lack of screening 
services available in the UK.  Individual clinics have developed their own patient 
information leaflets 
 
The results of my study demonstrate that education, knowledge and information on anal 
cancer screening is limited to the media, press, magazines and those clinicians offering 
screening at their sexual health clinics in the UK. Vera et al (2014) completed a national 
survey in the UK and concluded that the increasing risk of HPV-associated anal cancers in 
high risk groups, (i.e. those with HIV infection). A study by Colon-Lopez et al (2016) 
highlights that healthcare professionals (clinicians) that were interviewed in their study, 
reported that they were not aware of any resources or programs providing anal cancer 
prevention services for people living with HIV.  Longabaugh (2017) suggests that it is  
imperative for the medical community to be educated on anal cancer screening and 
prevention and those immunisations for HPV are key to reducing the incidence of anal 
cancer for future generations.  My study also demonstrates that HRA is a skill that takes a 
long time to acquire and clinicians have mentioned that it is a steep learning curve.  
Palefsky (2012) states that a long learning curve is typically required before becoming fully 
competent in this technique of HRA while, Richel et al (2014) mentions that HRA is a 
complicated procedure which should never be underestimated as it requires extensive 
training and experience.  Even though there is a small group of clinicians in the UK who 
are motivated to undertake anal screening, there are difficulties as the only accredited 
HRA course is through IANS in the US (IANS, 2016), although the UK held its first course 
in 2014 (HUHFT, 2014) and Europe 2016 (anoscopycourse.eu, 2016).   
 
5.4 Social and Sexual Activity 
Most patients have reported that having AIN has not affected their social life but has 
affected their sexual activity, mainly because treatment makes them sore.  Some patients 
have reported their social life was not affected and that sexual activity did not change as 
they used condoms.  It is evident that some patients adopted safe sex practices, like using 
a condom to resume normal sexual activity for reasons of companionship or even to 
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satisfy their sexual desires.  This is vital for patients to improve quality of life and for 
patients’ sexual health well-being.   According to Koole et al (2007), assessing health 
related quality of life in addition to sexual functioning is important because sexual well-
being is a crucial part of overall quality of life.  Other patients reported having anal warts 
stopped them from dating as they are aware that having HPV are contagious from skin to 
skin contact or can be passed on through sexual activity.    Some patients have mentioned 
that they did not have time for socialising as they were busy studying or working.  This is a 
form of escapism where patients would rather be busy with work or study to avoid sexual 
activity with the effort of not dealing with a stressor like HPV which is linked to anal cancer.  
Some patients associated sexual activity with AIN and smoking with lung cancer for 
instance and describe this as self-inflicted behaviour.  The reference to self-inflicted 
behaviour means if patients have unprotected sexual intercourse then they will be more 
likely acquire sexual infections including HPV and eventually get anal cancer.  Sexual risk 
behaviours and engaging in sexual intercourse with multiple concurrent (or lifetime) 
partners, have been shown to be associated with an increased risk of acquiring 
genital HPV infection thus, likely explaining the association of these behaviours with 
cancer risk (D’Souza, 2008).  According to Brown et al (2009), despite diverging 
theoretical perspectives, a common thread across theories is that self-inflicted injury is 
related to severe emotion which emphasizes the importance of self-invalidation and shame 
in the development and maintenance of self-inflicted injury and this is to escape or avoid 
aversive emotions.  This could also be linked to patients living with HIV and the inability to 
cope in healthy ways with psychological pain of then having unprotected sex and getting 
HPV which then leads to anal cancer.  Patients in my study have highlighted that sexual 
activity, sexual practices and sexually transmitted diseases are risk factors for acquiring 
anal intraepithelial neoplasia which are associated with anal cancers.  Goldstone et al 
(2011) states that the risk factors for new or persistent anal HPV infections include anal 
intercourse, having multiple sexual partners, and smoking.  Uronis and Bendell (2007) 
mention the association between anal cancer and sexual practices including anoreceptive 
intercourse and MSM is clear, but the association between anal cancer and HIV infection 
has been difficult to separate from cofounders as HIV positive patients are more likely to 
be infected with HPV and often with more than one subtype of HPV.  Similarly, according 
to Szwareski (2011) shock, embarrassment and shame were common responses in 
cervical screening with women using terms like ‘unclean’, ‘dirty’, ‘cheap’ and ‘nasty’ to 
describe how they felt about their HPV result, affected their attitudes towards sex and 
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relationships.  Patients in my study are aware of the risks of HPV, being HIV positive and 
sexual activity are factors that may contribute to acquiring AIN through having unprotected 
sexual activity.   
5.5 Guidelines and Practices 
This section will report on the perceptions of patients and clinicians on anal cancer 
guidelines and practices in the UK. It must be acknowledged there are no guidelines 
available in the UK for anal cancer screening while BASHH and BHIVA are not committed 
to anal cancer cancer screening.   National population screening programmes are 
implemented in the NHS on the advice of the UK National Screening Committee (UK NSC, 
2013), which makes independent, evidence-based recommendations to ministers in the 
four UK countries.  
 
Patients believe that there should be a national screening programme for high risk men as 
they are aware a national screening programme for cervical cancer screening exists.  
Clinicians have reported that there are no guidelines available for anal screening in the UK 
and they rely on local protocols and best practice, especially for multicentric/multifocal 
disease.  The Institute of Medicine Committee on Standards for Developing Trustworthy 
Clinical Practice Guidelines (IOM, 2011) in the US define clinical practice guidelines as 
statements that include recommendations intended to optimise patient care that are 
informed by a systematic review of evidence and assessments of the benefits and harms 
of alternative care options.  The Association of Coloproctology of Great Britain and Ireland 
Colorectal Disease published a position statement by Scholefield et al (2010) on 
guidelines for the management of AIN but screening recommendations are still very 
unclear in the UK.  IANS has published international guidelines and practice standards on 
the detection of anal precursors in 2016 for clinicians around the world who undertake anal 
cancer screening.  Clinicians in the UK use these guidelines and practice standard to 
guide their practice and develop standards for their own sexual health clinics. The New 
York State Department of Health Aids Institute is one of the only few health departments’ 
worldwide recommending anal cytology screening for HIV positive MSM (The New York 
State Department of Health Aids Institute, 2018). 
 
Nearly all anal cancer guidelines avoid any direct recommendations regarding routine 
screening as there are no clinical trials or data on anal screening available.  According to 
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Leeds & Fang (2016) large randomised clinical control trials are necessary to demonstrate 
the increasing consensus among practitioners that anal cancer screening offers a cost-
effective, prevalence lowering of anal cancers and interventions for screening in high-risk 
groups.  These authors further suggest that the SPANC and ANCHOR studies will be 
helpful in determining whether routine screening to build the evidence for a population 
wide recommendation on anal cancer screening.  The study results from SPANC which 
will published in later 2018 will contribute to understanding of the natural history of anal 
HPV and inform the possible development of guidelines for implementing anal cancer 
screening programs in this population (Machalek, 2013). The purpose of the ANCHOR 
study, which started in 2015 is an 8-year study, is to determine whether treating anal HSIL 
is effective in reducing the incidence of anal cancer in HIV-infected men and women 
(anchorstudy.org, 2018). 
 
Patients in my study have reported that people who are living with HIV and at risk of anal 
cancer cannot access screening because most of screening is offered in London region 
and not in other parts of the country.  Patients have also stated that they are aware that 
specialists in provincial HIV treatment centres do not have the facilities to undertake anal 
cancer screening.  These patients have identified centres in London, Manchester and 
possibly Edinburgh are screening people living with HIV.  Clinicians have mentioned 
patients that attend Manchester sexual health clinic live as far away as Scotland and come 
for anal cancer screening to Manchester as they do not want anyone to know their HIV 
status.  This can also be related to the stigma people have about HIV, so these patients 
are migratory and seek medical care for their HIV in other parts of the country or regions.   
According to the StigmaSurveyUK (2015) the reason for this could be attributed to a 
considerable number of people in the UK still hold stigmatising attitudes towards those 
living with HIV.  Anal cancer screening is offered to patients living with HIV mainly in the 
London regions while one clinic offers anal screening on North East England.  According 
to Baylis et al (2017), almost half of all people who receive treatment for HIV in the UK do 
so in London. The rate for new HIV diagnosis in the capital is more than three times higher 
than any other area; the population with HIV is more diverse than anywhere else in the 
country; and there are more people living into older age with HIV in London than anywhere 
else in England.   The trends in epidemiology and behaviour are often seen first in London, 
as are the clinical and wider responses to those trends. Patients have suggested that they 
would like to see anal cancer screening rolled out across the UK. A national survey 
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completed by Vera et al (2014) stated that despite the increasing risk of HPV-associated 
anal cancer in high-risk groups such as those living with HIV, only a minority of sexual 
health clinics are offering anal cancer screening in the UK.  Clinicians have reported that 
they see patients from different parts of London and they are referred from other clinicians 
in the UK due to the limited number of sexual health clinics offering anal cancer screening.   
 
The face of HIV as a chronic disease has changed as a result of advances in HIV 
treatment in the last three decades but a new set of HIV-associated complications have 
emerged, resulting in a novel chronic disease that for many will span several decades of 
life. Treatment does not fully restore immune health therefore, several inflammation-
associated and/or immunodeficiency complications such as cardiovascular disease and 
cancer are increasing (Deeks et al, 2013).  Despite all the complications associated with  
HIV, effective treatments mean that increasing numbers of people with HIV now have 
normal life expectancy. Baylis et al (2017) reported that we are seeing rapid increases in 
the overall the number of older people living for long periods with HIV, alongside co-
morbidities such as hepatitis and mental health needs, plus health and care needs 
associated with ageing including cancers which is non-AIDS defining illness.  As the result 
of HIV being a long-term chronic illness, patients form long term relationships with their 
clinicians as they will have been seeing the same clinicians for many years.  Patients have 
reported that they trust their clinician, as long as they are being monitored and therefore 
put full trust in them.  Patients also describe their clinicians as compassionate and 
professional as they offer counselling as well as a bespoke service for anal screening and 
have described medical staff treat patients a being ‘valued’, and they feel ‘spoilt.’  Patients 
also believe their clinicians are sensitive, caring and very supportive during anal cancer 
screening.  Datta et al (2017) mentions that the personal qualities of clinic staff were key 
features of services, and participants of this study wanted staff to be friendly, professional, 
discreet, knowledgeable and most of all not to be seen to judge their sexual lifestyles.  
Griffin (2006) reported whilst it is evident that having a positive relationship with a care 
professional and that holistic care is provided, the development of such relationships 
implies a long-term caring context for these patients.  Patients can benefit from the 
development of such relationship’s patients can also benefit from anal cancer screening 
through these relationships with the professional especially with the institutional and 
economic pressures of today.  
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Clinicians think the way forward to managing high grade disease and AIN is through 
multidisciplinary team centres (MDT) that are attached to tertiary referral centres like 
London, Birmingham, Manchester, and Scotland so that there is a spread across each 
region in the UK.  Clinicians have also reported that there is only one tertiary centre in the 
UK.  This service in the London region is well established for many years and patients are 
referred to this service by clinicians from other hospitals or from within the tertiary clinic 
where HRA and cytology is offered as part of the screening.  Clinicians have suggested 
MDT centres with gynaecology, oncology, colorectal specialists, histopathologist, 
cytopathologists, and surgeons who are part of colorectal teams as well as an 
administrative person attached to tertiary referral centres.  These recommendations are in 
line with Renehan and O’Dwyer (2011) who suggest that within the United Kingdom, each 
cancer network, or two adjoining networks if population numbers are small, should 
establish a network anal cancer MDT, which meets regularly and to include a team of 
colorectal surgeons, clinical oncologists, radiologists and pathologist, supported by a 
dedicated MDT coordinator, advanced nurse specialist and data manager.  
Multidisciplinary teams should improve coordination, communication, and decision making 
between health-care team members and patients, and hopefully produce more positive 
outcomes (Flessig et al, 2006).  According to Scholefield & Nugent (2011), multi-
disciplinary team working has become established in the last 10 years for colorectal 
cancer, and several sets of local, national, and international Guidelines have been 
developed for the management of colorectal cancer in the UK. In the existing colorectal 
guidelines these authors explain that lymphomas and sarcomas of the anus are even less 
common but have increased in incidence in recent years, particularly among patients with 
HIV.  It is reassuring to note that increasingly, surveillance programmes for patients with 
AIN disease occur in parallel with the anal cancer MDT and detect early invasive 
carcinomas (Scholefield et al, 2011). 
 
Only one clinic in the London region sees patients with multifocal disease which is a 
tertiary centre as there are parallels between AIN, CIN, VIN intraepithelial neoplasia 
(Scholefield, 2011). This tertiary centre has established MDT’s and links with the cancer 
networks for that region. Clinicians have reported that women with a history of vulval 
cancer or vulval disease, vulval HPV or VIN are offered anal cancer screening as they are 
aware there is a risk of developing anal intraepithelial neoplasia. While Scholefield et al 
(2011) mentions a strong correlation with etiological factors in AIN, CIN, VIN, and any 
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perianal disease. My study highlights that patients with multifocal genital neoplasia are 
offered HRA assessment and treatment.  Grulich et al (2012) states that the risk of anal 
cancer is increased in immunosuppression, including those living with HIV and in women 
with a history of HPV associated genital precancerous lesions.  This is significant with the 
only clinic in the UK that offers anal screening including HRA to those patients with 
multifocal disease within a sexual health clinic.  It is interesting to note that Palefsky et al 
(2001) found in their study that HPV infection may act as a reservoir or source of anal HPV 
infection and studies have shown that those who have high-grade lesions in the cervix or 
vulva are more likely to develop anal lesions.  Hillman et al (2015) mentions that rates of 
anal cancer are generally higher in women than in men as women with a history of  
cervical, vaginal and vulval HPV related disease are at a higher risk of anal cancer.     
 
Patients believe that the NHS need more evidence as there is a lack of data like natural 
history of AIN, for anal cancer screening programs as it worthwhile for the prevention of 
anal cancer.  Clinicians are going to start trials like the LOPAC which is going to be the 
biggest trial in the UK and this will contribute to evidence needed for anal cancer 
screening.  In the meanwhile, trials in the US, Australia and Europe are producing studies 
to contribute to the evidence needed.  Salit et al (2010) in their study mention that the 
implementation of anal screening is hampered by the lack of data from randomised 
controlled trials and it is highlighted in my study by patients and clinicians that more 
evidence is needed.  Leeds and Fang (2016) mentions that the SPANC and ANCHOR 
studies will be helpful in determining whether routine screening through to a cancer 
diagnosis will ultimately be necessary to build evidence for a population wide 
recommendation (i.e. HIV negative and HIV positive people to include men and women at 
risk of HPV-related AIN).  According to the data in my study, the current practice in the in 
most sexual health clinics are to screen high risk people (like MSM, patients with multifocal 
disease) and people living with HIV. According to Sackett et al (2000) because evidence-
based practice is a continuing process, it is a dynamic integration of ever evolving clinical 
expertise and external evidence in day to day practice.  The SPANC and ANCHOR studies 
will be helpful in determining whether routine screening through to a cancer diagnosis will 
ultimately be necessary to build the evidence for a population-wide recommendation 
(Leeds & Fang, 2016).  These two studies are important to contribution of evidence-based 
practice for anal screening.   
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Patients in my study have believe that it will be ‘cheaper’ to prevent disease like screen for 
AIN than treat illness (i.e. cancer) especially in terms of costs based on ill health, 
hospitalisation and treatment for cancer.  Patients are aware that in the early days of HIV, 
many patients have been hospitalised with AIDS defining illness which was in their 
perception a financial burden on the NHS as testing for HIV and prevention services were 
not widely available in the 1980’s.  Clinicians on the other hand recognise anal cancer is 
increasing in the MSM living with HIV and agree that it is not cost effective to have a 
national screening program for everyone i.e. the general population but will be cost-
effective for people living with HIV.  Clinicians reported that picking up early disease is 
being proactive in anal cancer screening to detect AIN rather than being reactive to 
patients who go on to develop anal cancer.  According to Goldie et al (2000), anal cancer 
screening programs in the MSM population are considered to be cost-effective.  With the 
restructure of the NHS and funding for services agreed by Clinical Commissioning groups, 
there is going to be a cap on funding thus limiting the number of patients seen in anoscopy 
services for anal cancer screening.  Yet clinicians believe that anoscopy would be 
performed for clinical benefit see how they can reduce unnecessary costs and see more 
patients for anal screening, instead of capping or limiting on the number of patients 
screened in their clinics due to funding.  Lam et al (2011) in their study summarised that 
with HIV infected MSM and where resources permit that anal cancer screening should be 
initiated with HRA, is the most cost-effective strategy for detecting AIN 2/3.  While MSM 
falls under the category of high-risk groups, it is evident that all high-risk groups would 
benefit from anal cancer screening in detecting high grade AIN.  The CRUK (2016) states 
that it is most cost effective to screen people whose doctors think are at higher risk 
especially with an uncommon illness.   Conversely, Czoski-Murray et al. (2010) concluded 
that in the reference case cost-effectiveness model, screening for anal cancer is very 
unlikely to be cost-effective and a key determinant of this finding was the low observed 
incidence of anal cancer in the UK population. According to Ong et al (2016), the cost 
effectiveness of regular anal examinations in HIV clinics to screen for anal cancer in HIV 
positive MSM would improve if there was a reduction of extra costs associated with 
investigations carried out by specialist referrals.  This can be done by upskilling HIV 
physicians to manage common anal conditions and only referring lesions suspicious for 
anal cancer.  A study by Fox et al (2005) mentioned that screening patients for AIN has 
significant cost implications and this has deterred any clinician in the UK from setting up a 
true screening programme.   
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Patients recommended that they would like to see anal cancer screening rolled out 
throughout the UK.  Clinicians suggest anal cancer screening should be part of the cancer 
care pathways or anal cancer groups.  Cancer care pathways, groups and networks can 
influence national agenda on cancer screening and these are normally within a 
geographical area or region.  In this way data would be centralised to a database and it is 
evident the only one tertiary centre in the London region is part of the cancer care 
pathway.  It is hoped that this would be rolled out to other parts of the UK.  Patients feel 
that a screening program will show it is worthwhile if people were screened and treated to 
prevent progression to high grade disease.   Patients also believe that people will be in 
control and in charge of their own health if they are part of a screening program and 
patients will attend for regular follow up appointments for anal screening, and they will be 
more aware if they detect any lumps by self-examination or even highlight to their 
clinicians when they have any symptoms like anal itching or bleeding for instance.  The 
benefit of anal screening according clinicians will mean that patients will have a peace of 
mind that someone is monitoring them or aware of cancer risks.  Reed et al (2010) noted 
in their study that although gay and bisexual men have notably high rates of cancer, it is 
promising that the potential benefits of anal cancer screening are comparable to the 
observed benefits of cervical screening for women as highlighted in the study by Goldie et 
al (2000).  However, the research to date in the UK indicates that the benefits of screening 
to survival rates are not yet fully understood (NSC UK, 2012).  Clinicians reported the 
advantage of anal cancer screening is that disease is picked up earlier and surveillance is 
offered with health promotion, that offering ‘preventative medicine’ is important (i.e. 
clinicians to focus on ways to prevent disease or illness before they develop in a patient’s 
body).  Fox et al (2005), give three reasons as to why a screening program might be 
beneficial as reported by clinicians in my study.  Firstly, patients with high grade AIN would 
be made aware of a potential risk of anal carcinoma and might be more likely to report an 
anal lump at an earlier more treatable stage; secondly, careful follow up would detect 
some early anal carcinomas at a treatable stage; thirdly a cohort is needed to develop 
effective treatments (Fox et al, 2005).  Piketty et al (2003) suggests that it would be 
advisable to screen all HIV positive patients as there are unconfirmed reports that 
heterosexual male injecting drug users have a high prevalence of AIN. 
My study highlights that there are no anal cancer screening programs available in the UK.  
Anal screening practices are different in most clinics and screening offered mainly in 
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London with only one tertiary referral centre offering screening and treatment for patient 
with multifocal disease.  Patients and clinicians have alluded to the fact that preventing 
anal cancer by screening is cheaper or cost effective rather than treating patients who go 
on to develop anal cancer.  Patients feel that being part of anal cancer screening means 
they are in charge of their health while clinicians believe patients will have peace of 
mindwhen a clinician is monitoring cancer risks. 
5.6 Summary of Implications for Practice 
The findings from my study explored the perceptions and experiences of clinicians and 
patients in anal cytology and high resolution anoscopy in sexual health clinics in the UK.  
Anal cancer screening did not have adverse effects on mental health of participants and 
none of the participants needed a psychologist or a referral to a mental health unit.  
However, the emotional responses like worry, anxiety and fear had some psychological 
consequences where patients did not attend for follow-up appointments for instance due to 
cancer worry.  With worry being highlighted by participants, this was alleviated by 
clinicians giving patients information leaflets, web links, informing patients on patient 
support groups and clinicians gave information face to face during clinic appointments.  
Landstra et al (2012) suggested a variety of support options such as written information, 
staff available by phone or email, support groups or access to a psychologist or social 
worker.  Educational campaigns will be beneficial; however, this must be accompanied by 
policy changes in the UK to ensure that it is cost effective and widely available to people 
living with HIV.   
 
 In addition, where patients were at risk of emotional distress during the anal cancer 
screening process, clinicians provided patients with additional support like counselling if 
required, especially those with worry about anal cancer.  The consequences of these 
emotional responses in my study were minimal. Therefore, anal cancer screening can be 
part of patients’ routine HIV outpatient care.  However, further exploration is needed in 
women living with HIV and anal cancer screening in the UK, and the exploration of 
patients’ perceptions and experiences on anal cancer screening in other sexual health 
clinics around the UK.   
 
Whilst there is a lot of uncertainty around anal cancer screening in the absence of 
guidelines and what populations to include in screening, Salit et al (2015) state that there 
180 
 
is uncertainty about which at-risk population to include and there are differing views in the 
cost effectiveness of screening and screening methods.  However, according to Uronis 
and Bendell (2007) the use of Pap smear in high risk patients may lead to an earlier 
diagnosis with dysplasia, whose development of anal cancer and anal cancers that do  
develop may be treated at an earlier stage.  Patients seen in gynaecology or sexual and 
reproductive services in the UK with a diagnosis of CIN or at-risk patients, clinicians can 
advise and inform these patients on anal cancer screening as this is an opportunity to 
screen these patients for AIN. Patients attending these services can be given information 
about AIN and anal cancer screening to educate them on screening.  Blankenship et al 
(2015) alludes to the fact that regular gynaecological encounters represent an opportunity 
for medical providers/clinicians to capture at-risk women and engage them in discussions 
about anal cancer screening. 
 
Another important factor is the availability of clinicians that are knowledgeable and skilled 
in HRA, biopsies and follow up on results.  The UK has very few clinicians providing anal 
cancer screening to people living with HIV although the study by Vera et al (2014) mention 
that more clinicians are looking train to undertake anoscopy and offer anal cancer 
screening.  According to Salit et al (2015) detecting high grade anal canal is limited by the 
availability of experienced anoscopists as there are only 80 documented HRA clinics 
worldwide.   The geographical spread of clinics offering anal cancer screening is mainly in 
the London region, therefore regional centres should be considered throughout the UK.    
 
5.7 Limitations of My Study 
Patients in my study were recruited from a small NHS healthcare Trust, and were people 
living with HIV, is what makes this group of people a homogenous group.  This may limit 
the transferability of results to other individuals not living with HIV e.g. HIV negative MSM.  
Clinicians were only limited to 8 practising anal screening in the UK at the time of my study 
but more clinicians have trained since (this data is not available yet), therefore it will be 
important include or target those clinicians in future studies to help inform and develop a 
screening program to reflect a comprehensive view on anal screening.   
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5.8 Future Recommendations 
Future studies need to explore societal stigma experienced by patients in anal cancer 
while the self-stigma clinicians experience in their practice is a new finding in anal cancer 
screening as highlighted in my study.  There should be some ownership from our UK 
regulatory bodies like the UKNSC, BHIVA, BASH, and NICE to recognise that anal cancer, 
especially in high-risk groups, is increasing and it is urgent we have programs to prevent 
anal cancer. These bodies should consider anal cancer screening in high risk groups and 
indicate this in their guidelines, but also recognise there is lack of evidence and screening 
guidelines in the UK.  They should call on clinicians and centres, as well as patients, to 
see how they can adopt evidence-based approach to anal cancer screening in the UK.  
There are many studies from Europe, US and Australia that can inform the UK on future 
screening, but it must also be noted that the incidence of squamous cell carcinoma of the 
anus is greater in patients with HIV (Uronis & Bendell, 2007).  Clinicians undertaking anal 
cancer screening in the UK should produce data; work with cancer networks in the UK to 
provide robust evidence for screening and for the development of cancer screening 
guidelines.   
 
5.9 Conclusions 
My study is first to report qualitative data from both patients and clinicians in the UK on 
perceptions and experiences on anal cancer screening.  Although the emotional 
responses have been identified and common, my study highlighted what other studies 
have endorsed and more in terms of the psychological effects of anal screening.  My study 
also covered aspects of physical experiences of anal screening procedures, future 
screening for people living with HIV, discrepancies and differences in screening practices 
in sexual health clinics and only few centres offering anal screening in the UK.   
 
My findings support previous publications in that there are no major psychological effects 
of anal cancer screening with the greatest emotional response being ‘worry’ on anal 
cancer.  However other emotional responses like anxiety, fear, embarrassment, shame 
and stigma were highlighted without severe psychological consequences.  With regards to 
stigma, there is the association with sexual practices and HIV and the notion that AIN is 
associated with sexual practices.  This is societal stigma where the attachment of 
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association is promiscuity, unprotected sexual activity and spread of sexual infections, with 
the main perception that anal disease is associated with men who have sex with men. 
Clinicians have experienced self-stigma in their practice due to lack of experience and 
internalise these as negative beliefs.  Patients also feel reassured that they can be part of 
a screening program where treatment is available, plus patients feel reassured when they 
were given information leaflets in AIN and anal cancer screening.  As far as screening 
procedures are concerned, my study shows that anal screening is acceptable, but 
tolerability varies according to sexual practices.  Patients who have receptive anal 
intercourse, their anal tone are relaxed therefore able to tolerate anoscope during HRA 
while those patients who do not have anoreceptive sex are not able to tolerate the 
anoscope. Some patients have experienced pain and bleeding after a biopsy is taken.  
Compliance to anal screening did not decrease due to discomfort.  My study demonstrated 
patients would rather experience a few minutes of discomfort to know their diagnosis.  
Patients and clinicians have mentioned that anoscopy as a procedure is invasive in every 
sense i.e. patients must undress and expose themselves, an intimate part of the body is 
examined, which is the anal canal and this not a dignified procedure for patients.  
Anoscopy is superior to sigmoidoscopy in detecting anal canal lesions.  HRA is a gold 
standard procedure for detecting high grade disease.   
 
All anal cancer guidelines avoid direct recommendations regarding screening and since no 
guidelines are available in the UK, clinicians undertaking anal cancer screening rely on 
local protocols.  Anal cancer screening is offered mainly in the London region, while one 
clinic offers anal screening in the North East of England.  MDT’s should consist of 
gynaecologists, oncology, colorectal specialist, histopathologists, cytopathologists, 
surgeons and administrative person.  A recommendation is that cancer networks should 
establish an anal cancer MDT.   
 
Patients usually self-refer to existing anal cancer screening or clinicians inform patients 
during their HIV outpatient appointment.  Some clinics see patients from all over the UK 
due to limited anal cancer screening services available in the UK.  Only one tertiary 
referral centre in London region see patients with multifocal disease.  The UK needs more 
evidence to determine if anal cancer screening is worthwhile for prevention of anal cancers 
but screening people with HIV or high-risk people, i.e. HIV-negative MSM, are important, 
while clinical trials are in progress, in an attempt to support screening.  In the UK funding is 
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approved by CCG’s.  HRA is the most cost-effective strategy in detecting High grade 
disease.  Lastly, these findings can now inform the UKNSC on the on criterion 15 as the 
screening program does outweigh psychological harm caused by tests and diagnostic 
procedures.  The screening process does not present any physical harm to any patients.   
My results provide a better understanding of the emotional responses during anal cancer 
screening process.  Anal cancer screening should be accompanied by education around 
anal cancer, screening process and what the test results mean.  Collaboration with other 
departments like gynaecology is important to target women with CIN and screen them for 
AIN.  As anal cancer screening is not yet established in the UK, there is an opportunity to 
set up a consistent and evidence-based approach to anal cancer screening to support 
guidelines.   
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Appendix 1:  Bethesda Classification for Anal Dysplasia 
 
Table 1: Comparison of Cytological and Histological Classification of 
Anal Dysplasia 
Bethesda Classification 
(cytology) 
Anal Intraepithelial 
Neoplasia (AIN) 
(histology) 
WHO Terminology   
(cytology) 
• ASC-US 
• ASC-H 
       Atypia – 
      LSIL       AIN I      Mild dysplasia 
      HSIL • AIN II 
• AIN III 
• CIS 
• Moderate 
dysplasia 
• Severe 
dysplasia 
• Carcinoma in 
situ 
    Cancer     Cancer      Cancer 
ASC-US, atypical squamous cells of undetermined significance; ASC-H, 
atypical squamous cells (HSIL cannot be excluded); LSIL, low-grade 
squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial 
lesion; AIN, anal intraepithelial neoplasia; CIS, carcinoma in situ 
  
234 
 
Appendix 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
235 
 
Appendix 2:  Table of Literature Appraisal 
Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data collection Key Findings 
Landstra et al 
(2012), Psycho-
Oncology 
Journal, Australia 
Quantitative The psychological 
impact of anal 
screening cancer 
screening on HIV 
Infected men 
291 HIV 
MSM 
Prospective 
Longitudinal 
survey 
Self-reporting 
questionnaires 
There was no evidence that general anxiety, 
depression or quality of life was significantly 
affected by the process.  Those who had biopsy 
recommended were more about anal cancer; 
rated their anal health worse, were less 
optimistic about their future health than those 
who did not need further investigations.  The 
group receiving high grade histology results 
remained worried  
Tinmouth et al, 
(2010), Diseases 
of the Colon and 
Rectum, Canada 
Quantitative The psychological 
Impact of Being 
Screened for Anal 
Cancer in HIV-
Infected MSM 
104 HIV 
MSM 
Prospective 
Cohort Study 
Questionnaires Anal cancer is not associated with greater 
adverse psychological impact in most men who 
have sex with men.  Younger patients, those 
with more HIV related symptoms had greater 
baseline psychological distress, are at risk for 
increased psychological distress during 
screening. 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia 
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Author, year 
published, 
Journal 
Type of 
Study 
Purpose Sample Design Data Collection Key Findings 
Reed et al (2010), 
American Journal 
of Public Health, 
USA 
 
Quantitative Gay and bisexual 
men's willingness to 
receive anal 
Papanicolaou testing 
306 (236 
gay, 70 
bisexual) 
Cross-
sectional 
study 
 
National Survey Anal cancer screening was highly acceptable 
to gay and bisexual men, although cost was a 
major barrier. Efforts to reduce anal cancer 
disparities should target beliefs about anal 
cancer and barriers to anal Papanicolaou 
testing in this population 
Truesdale & 
Goldstone (2010, 
International 
Journal of Aids, 
USA 
Quantitative The fear factor: 
drivers and barriers to 
follow-up screening 
for human 
papillomavirus-related 
anal cancer in MSM 
195 MSM Cross-
sectional 
study 
Questionnaire 
 
Positive predictors for screening compliance 
include an upsetting experience during the 
HPV diagnosis, physical symptoms driving the 
initial visit and HSIL. Engaging patients in a 
firm, salient approach may facilitate follow-up 
compliance 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia 
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Author, year 
published, 
Journal 
Type of 
Study 
Purpose Sample Design Data Collection Key Findings 
D’ Souza et al 
(2008), USA 
Quantitative Anal cancer 
screening 
behaviours and 
intention of men 
who have sex with 
men 
901 HIV 
infected 
men 
1016  
HIV 
uninfected 
men 
Cross-
sectional 
Analysis 
Interview-
administered and 
audio computer 
assisted self-
interview 
 
This study demonstrates a low rate of anal 
cancer screening and intention to screen 
among MSM.  There are higher rates in HIV 
patients; in locations where perceived 
availability of screening was greater.  MSM rely 
on primary care physicians for anal health care.  
Training and information needs to be targeted 
to this group 
Pitts et al (2007), 
Journal of 
Sexually 
Transmitted 
diseases, USA 
Quantitative What do gay men 
know about human 
papilloma virus?  
Australian gay men’s 
knowledge and 
experience of anal 
cancer screening and 
human papilloma 
virus 
384 MSM Cross-
sectional 
study 
Questionnaire The test for anal dysplasia is still largely 
unknown among Australian gay men and they 
currently have poor sense of personal 
susceptibility to the disease. Health education 
strategies are suggested to improve this 
situation 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia 
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Author, year 
published, 
Journal 
Type of 
Study 
Purpose Sample Design Data 
Collection 
Key Findings 
Ferris et al (2013), 
Journal of Lower 
Genital Tract 
Diseases, USA 
Quantitative Women’s Knowledge 
and Attitudes Toward 
Anal Pap Testing 
370 
women 
Pre-
intervention 
Survey 
Questionnaire Although most women had limited 
knowledge about anal cancer and 
anal Pap tests and few recognized 
known risk factors for anal cancer, 
women were receptive to screening. 
Further implementation of anal Pap 
testing for women may be improved 
by understanding women’s limited 
knowledge 
Blakenship et al, 
(2015), Journal of 
Lower Genital 
Tract Disease, 
USA 
Quantitative Knowledge and 
Acceptability of Anal 
Cytology among Women 
400 
women 
Survey Questionnaire Medical providers should improve 
counselling about anal cytology 
screening among at-risk women, to 
familiarise then with the procedure, 
describe its role in detecting AIN, and 
address expectations around pain to 
increase it acceptability 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia 
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Author, year 
published, Journal 
Type of 
Study 
Purpose Sample Design Data 
Collection 
Key Findings 
Koskan et al, 
(2016), Journal of 
the Moffit Cancer 
Centre, USA 
Qualitative Exploring the Perceptions 
of Anal Cancer Screening 
and Behaviours Among 
Gay and Bisexual Men 
Infected with HIV 
58 MSM 
infected 
with HIV 
open-ended 
questions 
In-depth 
Interviews 
Future intervention work to focus on 
ensuring that health care professionals, 
among HIV/primary care specialists, 
promote screening for anal dysplasia. 
Intervention methods use a community-
based approach to raise awareness 
about the need to screen MSM for anal 
cancer, infected with HIV 
Botes et al, 2011, 
Sexual Health, 
Australia 
Quantitative Participants perspectives 
on self-collected anal 
cytology swabs 
291 MSM 
HIV 
positive 
Cross 
sectional study 
Questionnaire Evaluation of self-collected anal swabs 
for screening.  53% rated the swab easy 
to collect and 81% reported as highly 
acceptable 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia 
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Author, year 
published, Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Hillman et al, 2011, 
Sexual Health, 
Australia 
Quantitative Participants’ perspective 
of high resolution 
anoscopy 
105 HIV 
positive 
MSM 
Evaluation Questionnaire This study suggests that most 
participants found HRA acceptable with 
a few complications.  However, 
acceptability was strongly correlated 
with pain and bleeding during and after 
the procedure. Participants also 
indicated the value of effective 
communication before and after the 
procedure.   This study demonstrated 
that HRA is an acceptable procedure but 
new methods to improve participant 
experience are required.  
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia 
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Joshua et al, 2015, 
Journal of Lower 
Genital Tract 
Disease, USA 
Quantitative Gay and Bisexual Men’s 
Willingness to Use a 
Self-Collected Anal 
Cancer Screening Test 
Sample 1: 
306 
Sample 2: 
428 
Cross-
sectional 
study 
Survey Majority of gay and bisexual men 
were willing to self-administer an anal 
cancer screening test at home.  If anal 
pap tests are shown to be an effective 
means of reducing incidence and 
mortality from invasive anal cancer, 
allowing men the option of home 
testing could improve screening 
uptake.  This study identified 
3npotentially modifiable factors 
associated with willingness to use 
self-test and potential concerns men 
have with using a self-test that could 
be targeted in future public health 
campaigns to increase screening 
rates 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia 
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Moores et al, 2015, 
The Canadian 
Journal of Human 
Sexuality, Canada 
Quantitative Anal cancer screening, 
attitudes, and 
experiences among men 
who have sex with men 
in Ottawa, Ontario 
280 MSM Cross- 
sectional 
study 
Survey This study indicates that a substantial 
percentage of MSM are not aware of 
their increase anal cancer risk nor of 
options for screening and prevention.  
Further research to explore these 
knowledge gaps and determine the 
best way to increase awareness 
among MSM.  This study also 
highlights the need for more 
discussion between MSM and their 
primate care physicians to ensure 
MSM are aware of their risk and of 
available screening and prevention 
options recognising the limited 
evidence base for anal cancer 
screening. 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia 
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data collection Key Findings 
Davis et al, 2013 
Journal of Lower 
Genital Tract 
Disease, USA 
 
Quantitative Tolerability of Anal 
Dysplasia 
Screening 
296 MSM 
(45% HIV 
MSM, 37% 
undergoing 
first time 
screening 
Prospective 
Study 
Questionnaire Screening procedures for anal HPV related 
disease were well tolerated, and no single 
procedure or HPV sampling device reduced 
patient Compliance 
Fenkl et al, 2015, 
Journal of the 
Association of 
Nurses in Aids 
Care, USA 
Quantitative Evaluation of an 
HPV/Anal Cancer 
Screening 
Awareness 
program for HIV-
Infected Men Who 
Have Sex with 
Men 
94 HIV-
infected 
MSM 
Evaluation Questionnaire The most prevalent of all STI’s is HPV an 
under investigated precursor of anal cancer in 
men. This evaluation program was important 
step in developing a comprehensive education 
and awareness program targeted to HIV 
infected MSM.  Members of the healthcare 
team play a vital role in the dissemination of 
research to support initiatives aimed at HPV, 
anal cancer awareness and the need for anal 
cancer screening for all MSM particularly the 
HIV-Infected MSM  
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia 
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Kaufman et al, 
2015), Sexual 
Health, Canada 
Quantitative Acceptability of anal 
cancer screening in 
women living with HIV: 
results from the EVVA 
study 
150 Women 
Living with 
HIV 
Cohort study Questionnaire Most participating WLHIV 
considered screening necessary 
and very acceptable. Pain 
management can be improved and 
potential adverse psychological 
effects of screening should be 
explored. 
Debnath, et al 
(2105), Sexual 
Health, USA 
Quantitative Pain, discomfort, and 
embarrassment during 
high-resolution anoscopy 
among women: a 
potential barrier to care? 
55 HIV 
positive 
Women 
Providers at 
Urban 
Medical 
Centre 
 
Survey  Questionnaire This study demonstrated that 
patients anticipated greater pain 
and discomfort than was actually 
experienced. In contrast, providers 
anticipated that patients would 
experience less pain than reported. 
Consequently, providers need to 
enhance patient education and 
address patient concerns regarding 
anticipated pain and discomfort 
associated with the HRA procedure. 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia, Papanicolaou=Pap, 
WLHIV-Women living with HIV 
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Sowah et al, 2015, 
Journal of the 
International 
Association of 
Providers of Aids 
Care, USA 
Quantitative Anal Cancer Screening 
in an Urban HIV Clinic: 
Provider Perceptions and 
Practice 
26 
Providers 
in an 
academic 
outpatient 
HIV 
practice 
Survey Questionnaire This study was to determine the 
acceptability and perceptions of 
providers on anal Papanicolaou tests 
where one third of the providers 
received screening requests from 
patients.  Female providers had 
higher levels self-rated comfort with 
anal Pap tests compared to male 
providers.  This survey revealed that 
not all providers are comfortable with 
performing anal cancer screening for 
their patients. 
Scott et al, 2008, 
American Journal 
of Sexually 
Transmitted 
Diseases, USA 
Quantitative Routine Anal Cytology 
Screening for Anal 
Squamous Intraepithelial 
Lesions in an Urban HIV 
clinic 
6 
providers 
at HIV 
clinic 
Evaluation Chart Review This study demonstrates that 
providers are able to incorporate anal 
screening as part of routine HIV care 
in an urban clinic with diverse HIV 
risk factors.  Screening is a feasible 
tool regardless of gender and HIV risk 
factors 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia, Papanicolaou=Pap  
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Ong et al, 2015, 
BioMed Central 
Public Health, 
Australia 
Qualitative Why are we not 
screening for anal cancer 
routinely-HIV physicians’ 
perspectives on anal 
cancer and its screening 
in HIV-positive men who 
have sex with men:  A 
qualitative study 
20 HIV 
physicians 
Semi 
structured 
interviews 
In-depth 
telephone 
interviews 
The best method for anal cancer 
screening is an area of uncertainty for 
the Australians HIV physicians.  Most 
of the physicians interviewed were not 
participating in anal cancer screening 
therefore influenced the tone of the 
study and multiple barriers were 
identified.  While HIV physicians 
remain ambivalent regarding the most 
effective way to screen for anal 
cancer, more research is needed to 
address the physicians concern 
before anal screening can be 
implemented into routine HIV care. 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia, Papanicolaou=Pap 
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Ortiz et al, 2013, 
Puerto Rico Health 
Sciences Journal, 
Puerto Rico 
Quantitative Recognising and 
Treating Anal cancer:  
Training Medical 
Students and Physicians 
in Puerto Rico 
34 medical 
students and 
physicians 
Survey Educational 
activity of 
demographic 
survey and a 
pre and post-
test on anal 
cancer 
The educational activity increased 
participants’ knowledge of and cancer, 
most of the participants were interested in 
future and in collaborating in a clinical 
trial.  This study evidences the lack of 
knowledge among medical students, 
residents and faculty members and the 
need for training in anal cancer.  Most 
participants did not know that are national 
screening guidelines for anal cancer 
Patel et al, 2014, 
Cancer Medicine 
Quantitative Environmental scan of 
anal cancer screening 
practices: Worldwide 
survey results 
82 providers 
from 80 
Clinics who 
were health 
care 
professionals 
Survey Online Survey 
via fax or 
email 
This study has demonstrated 
considerable variation in anal cancer 
screening practice. There is no universal 
consensus on optimal strategies for anal 
cancer screening, treatment and follow 
up  
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia, Papanicolaou=Pap 
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Kwong et al, 2011, 
Aids Patient Care 
Quantitative Improving Anal Cancer 
Screening in Ambulatory 
HIV Clinic’s Experience 
from a Quality 
Improvement Initiative 
62 HIV 
patients 
 
Providers: 
89% 
clinicians 
in the 
Infectious 
Disease 
Group 
Practice 
Survey Patients 
completed 
voluntary self-
administered 
questionnaire 
Providers 
completed 
anonymous 
on-line survey 
 
However, the dedicated program 
addressed one of the perceived 
barriers to screening, which was an 
infrastructure for treating patients 
found to have abnormal cytology or 
physical exam findings. By 
addressing a major clinician-
perceived organizational barrier, the 
anal health program provided more 
opportunities for clinicians to discuss 
anal cancer screening, perform their 
own exams, and/or refer patients for a 
focused examination. This 
combination of factors resulted in an 
overall increase in the number of 
patients screened in the clinic. 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia, Papanicolaou=Pap 
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Colon-Lopez et al, 
2016, Puerto Rico 
Health Sciences 
Journal, Puerto 
Rico 
Quantitative Measuring Knowledge of 
Cancer Screening and 
Prevention Strategies in 
HIV Healthcare 
Professionals 
104 
Healthcare 
Professionals 
Cross- 
Sectional 
Analysis 
Face to face 
interviews, 
telephone 
interviews, 
administered 
a survey 
For anal cancer in particular, as the 
number of years a given participant 
had been working with people living 
with HIV/AIDS increased, the 
likelihood that this participant would 
have extensive knowledge of anal 
cancer screening significantly 
increased (10% year).  Health 
education interventions, tailored to 
healthcare professionals who 
recently finished their formal 
education should be developed in 
HPV-related cancers. Such training 
would improve cancer prevention 
and control efforts, thereby 
benefitting the HIV population in 
Puerto Rico. 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
 MSM= men who have sex with men, HIV= Human immunosuppressive Virus, HSIL= High grade squamous epithelial neoplasia, Papanicolaou=Pap 
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Author, year 
published, 
Journal 
Type of 
study 
Purpose Sample Design Data 
collection 
Key Findings 
Vera et al, 2013, 
HIV Medicine, 
United Kingdom 
Quantitative Anal cancer 
screening in the 
United Kingdom:  A 
national survey on 
the perception and 
practices among 
sexual health clinics 
116 sexual 
health 
clinics from 
England, 
Wales, 
Scotland 
and 
Northern 
Ireland 
Web based 
Survey 
Questionnaire Awareness of risk factors and screening 
methods for HPV associated anal cancer 
among a sample of Sexual Health clinics 
in the UK is high.  Only a minority of 
Sexual Health Clinics are offering anal 
cancer screening at present despite the 
increasing risk of HPV associated anal 
cancer in high risk groups such as those 
with HIV infection.  Although more clinics 
are planning to offer anal screening in the 
future 
Blankenship et al, 
2015, Sexual 
Health, USA 
Quantitative Medical students’ 
perception of the 
acceptability of anal 
cytology screening 
among women 
308 Medical 
students 
Survey Questionnaire Future medical providers must improve 
their understanding of HPV and women’s 
expectations regarding anal cytology 
screening to effectively educate patients 
and increase acceptance of anal cytology 
screening 
Table 2 Characteristics, purpose, sample, design, data collection methods and findings 
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Appendix 4: Information Sheet for Patients 
 
 
 
To explore the perceptions and experiences of patients and clinicians in anal cytology 
screening and High Resolution Anoscopy  
 
• Invitation 
 
You are being invited to take part in the research project of Anal screening in your sexual 
health clinic.  Before you decide it is important for you to understand why the research is 
being done and what it would involve.  Please take time to read the following information 
carefully and discuss it with others if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.   Take time to decide whether or not you wish to take 
part. 
 
Thank you for reading this. 
 
• What is the purpose of the study? 
The study aims to explore the perceptions and experiences of patients who had 
anal cytology screening and high resolution anoscopy at your HIV outpatient clinic, 
which could inform clinical practice and guidelines for anal screening in the UK.  It 
can also assist in the development of more effective practice to all sexual clinics in 
the UK.   
 
• What will happen to me if I take part? 
You will be asked to participate in a tape-recorded interview.  This is a one-to-one 
face-to-face interview in an environment in which you should feel comfortable 
without any disturbances.  The interview will be at the outpatient clinic interviewing 
room.  The interviews would last at least 60-90 minutes.  We will maintain 
confidentiality and anonymity  
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throughout the interview without mentioning names and disclosing your  
 
person.  You will be shown the transcribed data once completed for your viewing. 
 
• What are the advantages and risks of taking part in this study? 
The benefits of this research are to explore your perceptions and experiences in 
anal screening and high resolution anoscopy in the UK which could inform clinical 
practice.  If you become distressed at any point a clinical psychologist has agreed 
to see you at any point during the research process.  Details provided below in the 
Contact details. 
 
• Do I have to take part? 
It is up to you to decide whether or not to take part.  If you decide to take part, you 
will be given this information sheet to keep and be asked to sign a consent form.  If 
you decide to take part, you are still free to withdraw at any time and without giving 
a reason. 
 
• What will happen to the results of the study? 
The results of the study will be used to provide an insight into anal screening.  It can 
also assist in the development of more effective practice and inform national, local 
guidelines as well as protocols for sexual clinics in the UK.  Currently this study is 
for a Professional Doctorate and the investigator may consider this study for 
publication at a later date or presented at a scientific conference.    
 
• Will the identity part of this study be confidential? 
Your identity as a participant will be protected in all communications and activities 
during research.  Anonymity as participants will be protected by giving each 
participant a code number. 
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• Who is organising the study? 
The researcher is organising the research study in conjunction with the learning 
institution, the employing trust and the supervisors.  There are not costs involved 
and no rewards offered. 
 
• Who has reviewed this study? 
This study has been reviewed by the National Research and Ethics Service.  
Management permission has sought from the Trust and relevant approval received 
from the NHS Trust 
 
• Contact for further information 
If you would like any further information, please contact any one of the lead 
research Co-ordinators listed below: 
 
Anosha Ramsammy (Principal Researcher) 
Mobile:  07861661321 
Email:  anoshar@hotmail.co.uk 
 
Email:  Gulen Addis (Supervisor-Buckinghamshire New University) 
Email:  Gulen.addis@bucks.ac.uk 
 
Keiran Henderson (Supervisor- Buckinghamshire New University 
Email:  Keiran.henderson@bucks.ac.uk 
 
Alan Spragg (Clinical Psychologist) 
Tel:  02089675000  
 
 
 
  
258 
 
Appendix 5 Information Sheet for Clinicians 
 
 
 
To explore the perceptions and experiences of patients and clinicians in anal cytology 
screening and High Resolution Anoscopy. 
 
• Invitation 
 
You are being invited to take part in the research project of Anal screening in your sexual 
health clinic.  Before you decide it is important for you to understand why the research is 
being done and what it would involve.  Please take time to read the following information 
carefully and discuss it with others if you wish.  Ask us if there is anything that is not clear 
or if you would like more information.   Take time to decide whether or not you wish to take 
part. 
 
Thank you for reading this. 
 
• What is the purpose of the study? 
The study aims to explore the perceptions’ and experiences of clinicians 
undertaking anal cytology screening and high resolution anoscopy in sexual health 
clinics in the UK, experiences which could inform clinical practice and guidelines for 
anal screening and high resolution anoscopy in the UK.  It can also assist in the 
development of more effective practice to all sexual clinics in the UK.   
 
• What is involved in participating? 
You will be asked to participate in a tape-recorded interview.  This is a one-to-one 
face-to-face interview in an environment in which you should feel comfortable 
without any disturbances.  The interview can be your own choice like your office or 
the conference room at your  
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institution.  The interviews would last at least 60-90 minutes.  We will maintain 
confidentiality and anonymity throughout the interview without mentioning names 
and disclosing your person.  You will be shown the transcribed data once 
completed for your viewing. 
 
• What are the possible advantages and risks of taking part? 
The benefits of this research are to explore your perceptions’ and experiences of 
anal screening which could help inform clinical practice.  If you become distressed 
at any point a clinical psychologist has agreed to see you at any point during the 
research process.  Details provided below in the Contact details. 
• Do I have to take part? 
It is up to you to decide whether or not to take part.  If you decide to take part, you 
will be given this information sheet to keep and be asked to sign a consent form.  If 
you decide to take part, you are still free to withdraw at any time and without giving 
a reason. 
 
• What will happen to the results of the study? 
The results of the study will be used to provide an insight into anal screening in the 
UK.  Currently this study is for a Professional Doctorate and the investigator may 
consider this study for publication at a later date or presented at a scientific 
conference.    
 
• Will my taking part in the study be confidential? 
Your identity as a participant will be protected in all communications and activities 
during research.  Anonymity as participants will be protected by giving each 
participant a code number.   All taped interviews will be coded respectively and 
locked safely.  Transcripts of data will be entered in the computer with code 
numbers for identification. 
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• Who is organising this study? 
The researcher is organising the research study in conjunction with the learning 
institution, the employing trust and the supervisors.  There are not costs involved 
and no rewards offered. 
• Who has reviewed this study? 
This study has been reviewed by the National Research and Ethics Service.  Management 
permission has sought from the Trust and relevant approval received from the NHS Trust 
 
• Contact for further information 
If you would like any further information, please contact any one of the lead 
research Co-ordinators listed below: 
 
Anosha Ramsammy (Principal Researcher) 
Mobile:  07861661321 
Email:  anoshar@hotmail.co.uk 
 
Email:  Gulen Addis (Supervisor-Buckinghamshire New University) 
Email:  Gulen.addis@bucks.ac.uk 
 
Keiran Henderson (Supervisor- Buckinghamshire New University 
Email:  Keiran.henderson@bucks.ac.uk 
Alan Spragg (Clinical Psychologist) 
Tel:  02089675000  
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Appendix 6: Clinical Psychologist 
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Appendix 7: Patient Consent Form 
 
 
To explore the perceptions and experiences of patients and clinicians in anal cytology 
screening and High Resolution Anoscopy 
 
Please tick the appropriate boxes 
 
I have read and understood the project information sheet 
..………………….…………………………………………………………………  
 
I have been given the opportunity to ask questions about the project 
…………………………………………………………………………………….  
 
I agree to take part in the project.  This is a questionnaire which is confidential and 
anonymous 
……………………………………………………………………………………  
 
I understand that my taking part is voluntary; I can withdraw from the study at any time 
and I will not be asked questions about why I no longer want to take part 
……………………………………………………………………………………  
 
I understand my personal details such as phone number or address will not be 
revealed to people outside of this project 
……………………………………………………………………………………  
 
I understand that my words may be quoted in publications, reports, web pages, and 
other research outputs but my name will not be used unless I  
requested it above 
……………………………………………………………………………………  
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I agree this study forms part a Professional Doctorate study and all interviews will be 
kept in a locked drawer and stored onto a data base which is secure, and passcode 
locked at the institution where the researcher is employed.  All questionnaires and 
computer data will be in line with Data Protection. 
……………………………………………………………………………………  
 
I understand that other researchers may use my words in publications, reports, web 
pages and other research 
……………………………………………………………………………………  
 
I agree to assign the copyright I hold in any materials related to this project to Anosha 
Ramsammy (Principal Researcher) 
 
……………………………………………………………………………………  
 
On this basis I am happy to participate in the study for the Professional Doctorate 
study 
 
 
Name of Participant …………………………
 Signature………………………… Date…………. 
 
Name of Researcher………………………...
 Signature………………………… Date…………. 
 
 
One copy to be kept by the participant, one to be kept by the researcher 
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Appendix 8: Clinician Consent Form  
 
 
 
To explore the perceptions and experiences of patients and clinicians in anal cytology 
screening and High Resolution Anoscopy 
 
Please tick the appropriate boxes 
 
I have read and understood the project information sheet 
..………………….…………………………………………………………………  
 
I have been given the opportunity to ask questions about the project 
……………………………………………………………………………………  
 
I agree to take part in the project.  Taking part in the project will include an audio tape 
interview lasting between 60-90 minutes 
……………………………………………………………………………………  
 
I understand that my taking part is voluntary; I can withdraw from the study at any time 
and I will not be asked questions about why I no longer want to take part 
……………………………………………………………………………………  
 
I understand my personal details such as phone number or address will not be 
revealed to people outside of this project 
……………………………………………………………………………………  
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I understand that my words may be quoted in publications, reports, web pages, and 
other research outputs but my name will not be used unless I requested it above 
……………………………………………………………………………………  
 
I agree this study forms part a Professional Doctorate study and all interviews will be 
audio taped and kept in a locked drawer at the institution where the researcher is 
employed.  All transcripts will be transcribed by the researcher and stored on the 
computer with codes and keeping in line with Data Protection 
……………………………………………………………………………………  
  
I understand that other researchers may use my words in publications, reports, web 
pages and other research 
……………………………………………………………………………………  
 
I agree to assign the copyright I hold in any materials related to this project to Anosha 
Ramsammy (Principal Researcher) 
……………………………………………………………………………………  
 
On this basis I am happy to participate in the study for the Professional Doctorate 
study 
 
 
Name of Participant …………………………
 Signature………………………… Date…………. 
 
Name of Researcher………………………...
 Signature………………………… Date…………. 
 
 
One copy to be kept by the participant, one to be kept by the researcher 
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Appendix 9: Peer Review 
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Appendix 10: Patient Trigger Questions 
Examples of guiding questions that may be used for the unstructured interview with 
Patients: 
1. Tell me about your experience of anal cytology screening and high    
           resolution anoscopy in your clinic? 
2. Tell me about information you were given on anal screening in your clinic? 
3. How did you feel when your doctor or nurse offered anal screening? 
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Appendix 11: Clinician Trigger Questions 
 
Examples of guiding questions that may be used for the unstructured interview with 
clinicians: 
1. Tell me about your current experience of anal cytology screening and high 
resolution anoscopy in your clinic? 
2. What are the advantages and disadvantages of offering this service in your clinic? 
3. Explain the training you had to undertake anal screening? 
4. How do feel about extending this role to other clinicians, e.g. nurses? 
5.       How do you feel about the information available on anal screening? 
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Appendix 12: Screenshot of Nvivo 
 
 
 
Appendix 13:  Screen shot of How I imported transcripts from word to Nvivo 
(v.9).  Importing Documents to Nvivo see red arrows with options to choose 
where documents are saved on your computer 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
270 
 
Appendix 13: Screenshots of Interview Scripts 
 
  
Appendix 14:  Screenshot example of interview transcripts uploaded onto Nvivo (v.9) 
 
 
 
 
 
 
 
 
 
 
 
 
  
271 
 
Appendix 14: Nodes/Codes 
 
 
Appendix 15:   Nodes the term used by NVivo (v.9) to represent a code, theme, or idea.  
The data in my study is referred to as codes but stored under nodes in Nvivo program. 
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Appendix 15:  Patient Information Leaflet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANOSCOPY 
CLINIC 
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WHAT CAN YOU EXPECT TO HAPPEN AT THE 
ANOSCOPY CLINIC? 
 
The main aim of the ‘Anoscopy clinic’ is to monitor anal 
dysplasia (see next page).  
 
A doctor/Nurse will perform the anoscopy  
You will be asked to lie on your left side and an anal smear 
test will be taken at the start of the procedure. It is important 
that your anus is clean for this. Please avoid very vigorous or 
repeated washing before the procedure. 
 
Anaesthetic gel will be applied and then a small telescope 
(proctoscope) will be inserted into the anus to enable the 
lining to be examined with a magnifying microscope. 
 
The surface of the anal canal may be gently examined to feel 
for any lumps.   
 
If any abnormalities are seen, then a tiny piece of tissue will 
be removed for analysis (biopsy). This is not painful but may 
cause temporary mild discomfort. 
 
The doctor will discuss what treatment and follow up (if any) 
that you may require. 
  
 
 
 
 
WHAT IS ANAL DYSPLASIA OR AIN? 
Anal dysplasia (AIN) is a slight thickening of the lining of 
the anus which is usually only detected by taking an anal 
smear test or from a tiny tissue sample (biopsy) using 
magnified vision (anoscopy).   
 
Anal dysplasia is caused by a long-standing infection with 
a virus called ‘Human Papilloma Virus’ or ‘HPV’.  
 
There are two ‘grades’ of AIN.    
 
The first type is known as low grade AIN.  It is extremely 
common, especially in people with HIV infection and is 
often associated with anal warts. The association between 
low grade AIN and anal cancer is weak and so it can 
therefore be monitored safely with yearly anal smear tests. 
 
The second type is known as high grade AIN.  It carries a 
small risk of developing into anal cancer.  For this reason, 
it is advisable that the condition is carefully monitored.  
 
If you have AIN, whether it is low grade or high grade, you 
are encouraged to practise regular self-examination of the 
anus with a finger. Your doctor or specialist nurse can 
instruct you how to do this. 
 
